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Abstract 
In developing countries, approximately 30-40% of school-age children suffer 
from iodine and iron deficiencies. Poverty and consumption of monotonous diets are 
underlying causes of inadequate intakes of micronutrients and omega-3 fatty acids 
and may have severe consequences for children’s cognitive development. Multiple 
micronutrient interventions have shown to benefit mental performance of children, 
but a systematic evaluation of the evidence is currently lacking. The omega-3 fatty 
acid, a-linolenic acid (ALA) is converted into docosahexaenoic acid (DHA), a major 
structural component of the brain, which is important for normal development and 
maintenance of brain function. At present, it is unclear whether additional intake 
of omega-3 fatty acids improves cognitive performance in children. 
The aim of this thesis was to investigate the role of multiple micronutrients 
and omega-3 fatty acids on cognitive performance in school-age children living in 
deprived environments, thereby addressing three main research questions. 
The first query concerned the investigation of the size of effects of multiple 
micronutrient interventions on different cognitive domains. Findings of our meta-
analysis comprising 17 studies in children 5-16 years of age, suggested that multiple 
micronutrients were beneficial for fluid intelligence (i.e. reasoning abilities) (0.14 
SD; 95% CI: -0.02, 0.29) and academic performance (0.30 SD; 95% CI: 0.01, 
0.58). Crystallized intelligence (i.e. acquired knowledge) seemed not affected 
(-0.03 SD; 95% CI: -0.21, 0.15) and for the other cognitive domains data were 
too limited to draw firm conclusions.
Secondly, we examined the role of omega-3 fatty acids on children’s cognitive 
development, for which a literature review was conducted. Associations between 
omega-3 fatty acid status or dietary intake and cognitive performance were 
investigated by cross-sectional analysis using baseline data of a randomized 
controlled trial in 598 Indian schoolchildren (see below for details). We found no 
evidence for a beneficial effect of additional intake of omega-3 fatty acids, and of 
DHA in particular, on cognitive development in school-age children. Neither there 
was a significant relationship between omega-3 fatty acid status and cognitive 
performance.
Lastly, we studied the effect of different doses of micronutrients and omega-3 
fatty acids, and their interaction, on cognitive performance. For that purpose, 
a randomized controlled trial in 598 Indian schoolchildren aged 6-10 years was 
conducted from November 2005 until March 2007. Children received either 15% 
or 100% of the Recommended Dietary Allowance of micronutrients in combination 
with either a low (140 mg ALA) or high dose (900 mg ALA plus 100 mg DHA) of 
omega-3 fatty acids for 12 months. Cognitive function was measured at baseline, 
6 and 12 months. Our results showed that with some small differential effects on 
short term memory at 6 months (0.11 SD; 95% CI: 0.01-0.20) and fluid intelligence 
at 6 months (-0.10 SD; 95% CI: -0.17, -0.03) and 12 months (-0.12 SD; 95% 
CI: -0.20, -0.04), the high and low dose of micronutrients were as effective for 
improving retrieval ability, cognitive speediness and overall cognitive performance. 
Neither there were differences between the omega-3 fatty acid treatments, nor an 
interaction between micronutrients and omega-3 fatty acids on cognitive outcomes. 
In conclusion, although multiple micronutrients may benefit intellectual 
performance of schoolchildren, development of public health guidelines is currently 
premature. Further investigation on doses and composition of micronutrients 
would be needed to identify a cost-effective micronutrient supplement to optimize 
cognitive performance in children. Presently, no evidence exists for a positive effect 
of omega-3 fatty acids on cognitive performance in healthy children. A final trial 
using a higher dose and sufficiently long duration would be needed to conclude 
whether omega-3 fatty acid supplementation improves mental development at 
school age.
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Today, more than 2 billion people world wide suffer from micronutrient deficiencies, 
of which deficiencies of iron, iodine, vitamin A and folate are most common (1). 
In school-age children living in developing countries, the prevalence rates of iron 
deficiency and inadequate iodine nutrition are estimated to be 40% (1) and 32% 
(2), respectively. Poverty and monotonous diets low in energy, protein, fat and 
micronutrients are the underlying causes of nutritional deficiencies, which may 
have severe consequences for physical growth, immune function and cognitive 
development of children (2). 
During the International Conference on Nutrition (ICN) organized by the World 
Health Organization (WHO) and the Food and Agricultural Organization (FAO) of the 
United Nations in 1992, 159 countries declared to make all efforts to improve the 
nutritional situation of their populations and eliminate micronutrient deficiencies. 
This message was reinforced in one of the Millennium Development Goals in 2000. 
Despite all efforts, the problem of undernutrition and related effects on development 
and health of children still exists. Recently, a series of three papers, have been 
published in The Lancet to raise awareness that more than 200 million of children 
under five years of age are not reaching their full developmental potential because 
of poverty, malnutrition, poor health and unstimulating home environments (3-
5). Improving the intake of iron and iodine has been shown to be an effective 
strategy to enhance cognitive performance in children. However, the effectiveness 
of multiple micronutrient and other interventions needed further investigation (4). 
The research described in this thesis focuses on the role of multiple micronutrients 
and omega-3 fatty acids on cognitive development in children.
Cognitive performance
Brain development
The development of the human central nervous system starts in the first 
weeks after conception with the formation of the neural tube, which subsequently 
differentiates into the brain and spinal cord. Brain development involves processes 
of neurogenesis, neuronal migration, synaptic formation and myelination (4;5). 
Most rapid brain growth takes place from the third trimester of pregnancy until 
the first two years of life (6). By the age of 6 years the brain reaches 95% of its 
full size (5). During childhood, the brain progresses to maturity by generation 
of neurons, formation of new connections (synaptogenesis) and myelination and 
these processes continue into adulthood (Figure 1) (4;5;7). The various areas 
in the brain develop and mature at different rates. In the first 2 years of life, the 
most basic functions, such as the senses (taste, audition, smell, vision, touch) 
and the mobility apparatus (movement, walking) are developed. Areas involved in 
advanced spatial orientation and language follow later. The frontal lobes mature 
last. This area of the brain harbors more complex functions, such as planning 
ahead, complex problem solving and memory (4). These high-level psychological 
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processes of memory, learning, reasoning, attention, language and coordination of 
motor outputs are classified under the broad term “cognition” (8). 
Cognitive development refers to the changes of the cognitive processes observed 
over longer periods of time (months or years) and is usually assessed in children 
by batteries of intelligence tests assessing specific cognitive abilities (8). The 
term cognitive performance is used when the intellectual ability of an individual 
is assessed at a certain time point. Cognitive development is determined by a 
number of factors, including socio-cultural, biological and psycho-social variables, 
and by genetic variation (4).
How nutrition affects cognitive development
Nutrition can have an impact on cognitive functioning directly and indirectly. 
Directly, nutrients are required as building blocks of the brain structures, and for 
the synthesis and function of neurotransmitters (6;7). Indirectly, nutrition may 
enhance cognitive development via general improvement of health and energy 
metabolism (8). Overall improvements in health status of a young child will result 
in more explorative behavior as the child will become more active. As a result, 
the caretaker will more frequently interact with the child and indirectly stimulate 
the child’s cognitive development (9). In older children, improved health status 
has a positive impact on school attendance, and also increases activity and social 
interactions with other children, leading to enhanced cognitive development and 
performance (10). Thus, when general aspects of psychological development, such 
as well-being, motivation and concentration improve, it is likely that intelligence 
will also be positively affected.
The development of infants and children is particularly vulnerable to nutrient 
deficiencies due to rapid physical growth, and especially growth of the brain (11). 
The timing of the nutrition intervention is important, because some brain functions 
develop early in life and nutritional deficits during this period may irreversibly impair 
brain development and later cognitive functioning. This has been indicated by several 
studies showing that effects of severe or chronic iron deficiency during infancy 
were associated with poor performance in late childhood, even after treatment with 
iron when children were young (12). Furthermore, children’s nutritional status at 
baseline may influence the efficacy of nutrition interventions on improving mental 
development. A meta-analysis on the effect of iron supplementation in children, 
demonstrated that effects on cognition were more pronounced in children who had 
iron deficiency (anemia) at the start of the intervention compared to non-deficient 
children (13). Thus, children with nutritional deficiencies may benefit more from 
nutrition interventions compared to children without deficiencies. Therefore, it 
may be hypothesized that micronutrient interventions may be more effective in 
improving cognition in malnourished populations in developing countries than in 
well-nourished children in developed nations.
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Measuring cognition in nutrition intervention studies
The effect of nutritional interventions on cognitive performance in children is 
usually measured through a set of psychological assessments. In infants and 
young children, these assessments mostly comprise measurements of general 
mental and psychomotor development, for example by the Bayley Scales of Infant 
Development. In children older than 2-3 years of age, the cognitive abilities start 
to differentiate and therefore testing becomes more specific. However, until 5 years 
of age some cognitive abilities such as reasoning and speed of processing are still 
very immature and difficult to assess. Intelligence is usually assessed by sets of 
short tests measuring various cognitive abilities that are collated and generate a 
general score of intelligence (14). The Kaufman Assessment Battery for Children 
and Wechsler Intelligence Scales for Children are examples of commonly used 
tools for assessment of intelligence. 
The quality of a cognitive test depends on its validity and reliability. The validity 
reflects the extent to which the test measures the underlying construct or cognitive 
ability (e.g. short-term memory). Validity of a test can be established by correlating 
the test outcomes to outcomes of other tests that are known to measure the same 
construct (15). Reliability refers to the degree to which the test outcome yields the 
same score when individuals with the same attributes are repeatedly assessed. 
Reliability can be measured by methods of test-retest (i.e. the level to which the 
same individual obtains the same score when given the same test), parallel forms 
(i.e. the extent to which the same individual obtains the same score when given a 
test with different but equivalent items) and internal consistency (i.e. the degree 
to which the different items are consistent with the score within a scale) (15).
Figure 2. The three stratum structure of cognitive abilities adapted from Carroll (18). 
Stratum I contains some examples of the 69 narrow cognitive functions that can be assessed by individual 
cognitive tests. Stratum II consists of eight broad cognitive domains which are represented in order of strength 
of correlations with general intelligence. Domains marked with an asterisk were postulated to be influenced by 
micronutrient interventions (19).
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For use in nutrition intervention trials it is essential that tests are sensitive 
(i.e. have a high resolution) in order to pick up small effects (16). For research in 
developing countries, it is important that cognitive tests that originate from western 
countries, will be thoroughly adapted to local language and culture to ensure their 
validity and reliability (16;17). Use of non-validated test batteries may lead to 
problems in the interpretation of findings as subjects may not have understood 
the tests in a correct manner or as test administrators may not be familiar with the 
scoring system. When tests are too difficult (resulting in floor effects) or too easy 
(leading to ceiling effects) the distribution of test scores will be highly skewed and 
it will therefore not be possible to distinguish differential performance in children 
and to detect effects of nutrition interventions. 
In this thesis, a hierarchical model of intelligence, named the three stratum 
structure of cognitive abilities by Carroll (18) will be used to classify cognitive 
tests into cognitive domains (Figure 2). The model is based on a factor-analytic 
survey of over 460 datasets reported in psychometric literature, covering about 
six decades of intelligence testing in various populations of different age, gender 
and culture. To construct the model, an exploratory factor analysis was employed 
on each individual dataset to identify the factors representing basic cognitive 
functions, which can be found in stratum I of Carroll’s model. To each factor, a 
name was assigned based on the representation of cognitive functions loading on 
that factor. Subsequently, higher-order factor analyses were conducted to identify 
broad cognitive abilities and general intelligence factor. Synthesis of outcomes of the 
individual datasets resulted in a framework in which general intelligence (stratum 
III) is composed of eight cognitive abilities (stratum II) that correlate with general 
intelligence; and of 69 more basic and specific cognitive processes (stratum I) that 
are underlying the eight cognitive domains. These narrow cognitive functions, such 
as general sequential reasoning, reading comprehension or memory span, can 
be measured by individual cognitive tests. The broad cognitive abilities in Figure 
2 are represented in order of strength of association of the ability with general 
intelligence. Thus, the factor fluid intelligence comprising reasoning abilities is 
most strongly related to general intelligence. 
Based on previous literature, it is expected that nutrition interventions will mainly 
affect the domains of fluid intelligence (or reasoning ability), memory and learning 
(which covers mainly short-term memory), visual perception, retrieval ability, and 
cognitive speediness. In addition, sustained attention and academic performance 
which are not part of the model may be enhanced by nutrition interventions (19).
Role of micronutrients and omega-3 fatty acids on cognition
In this thesis, we will focus on possible benefits of multiple micronutrients and 
omega-3 fatty acids on cognitive development. First, a brief overview on the role 
of single micronutrients on brain and cognitive function in school-age children 
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will be given, followed by a rationale for additional cognitive effects of multiple 
micronutrients compared to single micronutrients. Subsequently, the involvement 
of omega-3 fatty acids in mental development will be summarized and a justification 
for possible interactions between multiple micronutrients and omega-3 fatty acids 
on cognition will be presented.
Iron
Brain iron is required for proper myelination of the spinal cord and white matter 
of the cerebellar folds. In addition, iron is a cofactor for a number of enzymes 
involved in neurotransmitter synthesis and plays a role in neurotransmitter 
metabolism (8;20). Furthermore, iron deficiency may inhibit the synthesis of 
thyroid hormones and may indirectly hamper the development of the brain and 
central nervous system (21).
Longitudinal studies consistently indicate that children with early childhood 
anemia continue to have poor cognitive and motor development and school 
achievement into middle childhood (22). Recently, a meta-analysis of four trials 
showed a positive effect of iron supplementation of 30-100 mg/d (~100-300% 
of the Recommended Dietary Allowance (RDA)) on intellectual development in 
children ≥8 years of age (13). Effects were stronger in children who were iron 
deficient or anemic at baseline. 
To summarize, there is substantial evidence for a beneficial effect of iron on 
cognitive development in school-age children.
Iodine
Iodine is an essential micronutrient that forms a vital component of the 
thyroid hormones, thyroxine and triiodothyronine, which are crucial regulators 
of the metabolic processes and physical and mental development in humans. 
Thyroid hormones play a major role in the growth and development, function and 
maintenance of the central and peripheral nervous system (21;23). 
A meta-analysis of 18 studies in humans aged 2 months to 45 years, 
demonstrated a general loss of 13.5 IQ points in chronically iodine deficient 
populations, compared to non-iodine deficient groups (24). Eight randomized 
controlled intervention trials have addressed the question of reversibility of the 
consequences of iodine deficiency in school-age children using doses of 200-540 
mg/d (~200-500% of the RDA). Of these studies, three demonstrated that iodine 
supplementation improved mental performance (25-27) and two showed that an 
improvement in iodine status following iodine supplementation was associated with 
better cognitive performance (28;29). Three studies did not find an improvement 
on cognition which may have been due to the fact that iodine supplementation was 
not sufficient to increase iodine status or to other underlying factors in the study 
designs (30-32). Nevertheless, the majority of these studies suggest that iodine 
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supplementation improves mental development of children.
Zinc
Besides its important role in the immune system (33), zinc is a co-enzyme required 
for neurogenesis, neuronal migration, and synaptogenesis (34). Zinc deficiency 
may affect cognitive performance by alterations in attention, activity, neuro-
psychological behavior and motor development (35), but the exact mechanisms are 
unclear. Relatively few studies have examined the effect of zinc supplementation 
on cognitive performance in school-age children. Three randomized controlled 
trials in Chinese and Mexican-American children showed that zinc supplementation 
of 20 mg/d (~200% of the RDA) improved reasoning abilities (36-38), whereas 
two studies using doses of 10 mg/d (~100% of the RDA) in stunted Guatemalan 
and Canadian children did not (39;40). Therefore, evidence for a beneficial effect 
of zinc on cognitive performance is currently inconclusive.
B-vitamins
B-vitamins contribute to optimal functioning of the central nervous system 
through their role as cofactors in numerous catalytic reactions in the human body. 
Through these processes thiamine (vitamin B1), riboflavin (vitamin B2), pyridoxine 
(vitamin B6), folate and cobalamin (vitamin B12) are required for neurotransmitter 
synthesis and functioning (41-45), brain energy metabolism (46) and myelination 
of the spinal cord and brain (45). 
Evidence for beneficial effects of most B-vitamins on cognitive performance in 
children is limited, and for vitamin B6 and folate there are no studies reported 
in literature. One double-blind study in children aged 9-19 years showed that 
thiamine supplementation of 2 mg/d (~200% of the RDA) was beneficial for 
memory, intelligence and reaction time (47). Also, one human case study linked 
riboflavin to cognitive functioning by finding a reversible effect on neurological and 
visual abnormalities in a 2.5-year-old riboflavin deficient, anemic girl after a high 
dose of riboflavin (48). For vitamin B12, evidence is limited to two observational 
studies. The first study, conducted in the Netherlands, showed that children aged 
10-16 years, who consumed a macrobiotic diet early in life, performed less well on 
cognitive tests measuring fluid intelligence, spatial ability and short-term memory 
than omnivore children (49). Similarly, the second study, conducted in Guatemala, 
demonstrated that 8-12 year-old schoolchildren with vitamin B12 deficiency had 
poorer scores on cognitive tests than children with an adequate vitamin B12 status. 
However, these findings were not controlled for socio-economic status, hemoglobin, 
iron status, and blood lead levels (50). 
Thus, although there are plausible mechanisms for the role of B-vitamins in 
functioning of the central nervous system, there is insufficient evidence for a causal 
effect of B-vitamins on cognitive performance during childhood.
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Multiple micronutrients
Consumption of monotonous diets lacking important micronutrients will result 
in co-existing micronutrient deficiencies and therefore, multiple micronutrient 
interventions may be more effective to improving cognitive functioning than single 
micronutrient interventions (51). In addition, there may be synergistic effects of 
micronutrients on physical functions, such as involvement of iron and vitamin A in 
addition to iodine in thyroid metabolism (52;53) and requirements of vitamin A, 
B-vitamins and iron for erythropoeisis (54;55). On the other hand, micronutrients 
may interact negatively, by impairing their bioavailability and effectiveness in 
physiological processes which may hamper cognitive functioning. For instance, 
iron and zinc compete for intestinal uptake and high doses may inhibit mutual 
absorption and that of other minerals such as copper and manganese (56). 
In 2001, a review of 13 studies in school-age children from developed countries 
showed that in 10 of these studies multiple micronutrient supplementation was 
effective in improving non-verbal intelligence (57). Since then, seven additional 
studies conducted in developing countries in malnourished children assessed the 
effect of multiple micronutrient fortified foods on cognitive performance (58-63), 
of which five demonstrated significantly beneficial effects on at least one of the 
cognitive performance indicators measured in children (58-61). The doses of 
micronutrients used in these studies varied considerably (i.e. for iron from 1.2-24 
mg/d (~4-130% of the RDA)), but most trials provided micronutrients at doses 
between 30-100% of the RDA. Thus, doses given in multiple micronutrient studies 
are usually lower than those used in the trials investigating iron or iodine alone 
(>100% of the RDA), and it is currently unknown whether lower doses are as 
effective as higher doses. 
In conclusion, a relatively large number of studies indicate that multiple 
micronutrients may enhance on cognitive performance in school-age children. 
However, a systematic approach to evaluate the totality of evidence and to 
quantify the effect of multiple micronutrients is currently lacking. Furthermore, it 
remains unclear which of the cognitive domains are most sensitive to micronutrient 
supplementation, whether effects depend on the nutritional status of subjects and 
what dose of micronutrients would be most effective to improve cognitive function. 
Omega-3 fatty acids
Fatty acids are important for child growth and development. Approximately 
25-30% of the fatty acids in the human brain consist of polyunsaturated fatty 
acids (PUFA) of which the omega-3 fatty acid docosahexaenoic acid (DHA) and the 
omega-6 fatty acid arachidonic acid (AA) are major components. DHA and AA are 
rapidly incorporated in the nervous tissue of retina and brain during the brain’s 
growth spurt, which mainly takes place from the last trimester of pregnancy up 
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to 2 years of age (64-67). Beyond development of the central nervous system, 
omega-3 and omega-6 fatty acids may influence brain function throughout life by 
involvement in aspects of neuron function and of neurotransmitter synthesis (7). 
Although the human body can synthesize DHA from a-linolenic acid (ALA), the 
conversion of ALA to EPA and DHA is marginal (68-71), with an overall conversion 
rate of 4% at most (72). It is presently unclear whether conversion of dietary ALA 
is under all circumstances sufficient to meet optimal DHA requirements. 
At the time of the onset of our studies, research in healthy school-age children 
without developmental disorders, such as attention-deficit hyperactivity disorder, 
was limited to one observational study in the Netherlands, which did not find a 
relationship between DHA status measured and cognitive performance in children 
aged 7 years (73). Recently, three randomized controlled trials have been reported 
in literature. Two of these studies did not find any effects of supplementation with 
either a low dose of 110 mg EPA plus DHA (58) for one year or with higher dosages 
of 400 and 1000 mg DHA for 8 weeks (74) on cognitive performance in healthy 
children aged 7-12 years. In contrast, a third study conducted in South-African 
children 7-9 years of age showed that children receiving an omega-3 rich fish-
flour spread had better scores on verbal learning and memory tests compared to 
those receiving a control spread (75). However, it is possible that other nutrients 
in addition to the omega-3 fatty acids in the fish-flour have contributed to the 
cognitive effects.
In summary, evidence is currently too limited to conclude whether supplementation 
with DHA in addition to ALA may enhance intellectual development of children.
Interactions between micronutrients and fatty acids
Since diets of poor populations may lack both micronutrients as well as essential 
fatty acids, we hypothesized that supplementation of micronutrients with omega-3 
fatty acids could have synergistic effects on improving cognitive function. There 
are two hypotheses for additional effects of multiple micronutrient supplementation 
and omega-3 fatty acids on cognition. Firstly, micronutrients may increase the 
conversion of ALA to DHA and subsequently enhance the brain’s DHA status and 
improve cognitive function. Animal studies have indicated that iron, zinc, vitamin B6 
and vitamin E may enhance the conversion of ALA to DHA, through their role in the 
δ6-desaturation enzyme (76). In addition, a study in 6-11 year-old South African 
children showed that iron deficient children had lower concentrations of omega-3 
fatty acids in erythrocytes compared to controls. After 15 weeks of supplementation 
with iron and vitamin C, the erythrocyte omega-3 fatty acid concentrations had 
been restored to levels comparable to those of control children (77). Thus, this 
study suggests that micronutrient supplementation might improve omega-3 fatty 
acid status of undernourished children.
Secondly, as multiple micronutrients have been shown to influence cognitive 
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functioning and because DHA is an important structural component of the brain, 
supplementation with both may synergistically improve cognitive outcomes. 
However, after the onset of our studies, no interactions between multiple 
micronutrients and EPA plus DHA supplementation were found on plasma fatty 
acid status and cognitive function in children aged 7-10 years in Australia and 
Indonesia (58). 
Taken together, there are some indications that micronutrients may enhance 
omega-3 fatty acid status but the findings should be confirmed in a randomized 
controlled trial. Hypothetically, multiple micronutrients and omega-3 fatty acids 
may interact synergistically on cognitive performance, but this needs further 
investigation.
Aim and outline of this thesis
Although nutrition may have the largest impact on neurodevelopment from 
conception to the age of two years when the central nervous system is rapidly 
developing; diet may also influence cognitive performance during childhood as 
the brain continues to develop into adulthood. Whereas single micronutrient 
interventions showed that iron and iodine improve intellectual development in 
school-age children, the evidence for multiple micronutrients from a relatively large 
number of studies has yet not been evaluated in a systematic manner. Although 
an earlier review indicated that micronutrients would most benefit non-verbal or 
reasoning abilities (57), it is currently unclear which of the cognitive domains are 
most sensitive to micronutrient interventions. Also, no clarity exists whether the 
effects of micronutrients are dependent on nutritional status of children, and what 
dose of micronutrients would be required to optimize intellectual development. 
Furthermore, while much research has focused on the role of DHA in particular 
on mental development during infancy, little is known about effects of omega-3 
fatty acids, including DHA, on cognition in school-age children. Lastly, it is of 
interest to explore whether micronutrients and omega-3 fatty acids would interact 
synergistically on improving children’s intellectual development.
The objective of this thesis is to study the role of multiple micronutrients and 
omega-3 fatty acids on cognitive performance in school-age children living in 
deprived environments. More specifically, the following research questions are 
addressed:
1. To what extent do multiple micronutrient interventions influence different 
cognitive domains in children? 
This research question will mainly be answered through a meta-analysis of 
randomized controlled trials assessing the effect of multiple micronutrients on 
the different cognitive domains in children. Furthermore, associations between 
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micronutrient status and different cognitive domains have been explored using 
cross-sectional data and the effects of a high versus low dose of micronutrients 
on different cognitive abilities is investigated in a randomized controlled trial. We 
hypothesize based on observations from earlier micronutrient interventions that 
the size of effects of multiple micronutrients on cognitive outcomes will be small to 
moderate and that the domains of fluid intelligence, memory and learning, visual 
perception, retrieval ability, and cognitive speediness can be positively influenced. 
We expect effects to be larger in malnourished subjects with a higher risk of 
micronutrient deficiencies compared to well-nourished children. 
2. What is the role of omega-3 fatty acids on children’s cognitive development?
A literature review on the role and effect of omega-3 fatty acids on visual and 
cognitive development in infants and children has been conducted to address this 
question. In addition, the relationships between omega-3 fatty acid status and intake 
and cognitive function are explored using cross-sectional data and a randomized 
controlled trial has been conducted to investigate the effects of a high versus low 
dose of omega-3 fatty acids. As DHA is a major structural component of the brain 
and involved in neurotransmitter functioning, we postulate that supplementation 
with omega-3 fatty acids benefits cognitive performance of children.
3.  What is the effect of an intervention with different doses of multiple micronutrients 
and omega-3 fatty acids on cognitive performance in schoolchildren in India? Is 
there an interaction between multiple micronutrients and omega-3 fatty acids?
A randomized controlled trial with a 2x2 factorial design investigating different 
doses of micronutrients and omega-3 fatty acids on cognition in children has been 
used to investigate these research questions. We hypothesize that higher doses 
of multiple micronutrients (close to 100% of the RDA) and omega-3 fatty acids 
would be more effective in improving intellectual development in children than 
lower doses below 50% of the RDA of these nutrients and that there are additional 
effects of omega-3 fatty acids plus micronutrients on cognitive outcomes.
The outline of this thesis is as follow:
• Chapter 2. Systematic review and meta-analysis on the effect of multiple 
micronutrients on cognitive performance in schoolchildren.
• Chapter 3. Literature review on the role and effect of omega-3 fatty acids on 
visual and cognitive development in infants and children.
• Chapter 4. Cross-sectional study to investigate the associations of indicators 
of body size, micronutrient and fatty acid status on cognitive performance of 
Indian schoolchildren.
• Chapter 5. Randomized controlled trial to investigate the effect of foods 
fortified with either a low or high dose of micronutrients and omega-3 fatty 
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acids on cognitive performance and growth in schoolchildren in India. 
• Chapter 6. Cross-sectional study to assess the role of diet in relation to 
anthropometric measurements and cognitive performance of the Indian 
schoolchildren.
• Chapter 7. General discussion which comprises a reflection on the main 
outcomes of the work presented in chapters 2-6, followed by implications for 
public health and recommendations for future research.
The study location in India
The field work described in this thesis has been conducted in Bangalore city, 
Karnataka state, South India (Figure 3). Bangalore (re-named Bengaluru since 
2006) is located at 920 m above sea level and has a relatively mild climate with 
three seasons, including hot (April-May) wet (June-September) and cool (October-
March) seasons. With approximately 6 million inhabitants, Bangalore is the fifth 
largest city of India after Delhi, Kolkata, Mumbai and Chennai. As a consequence of 
rapid growth of the Information Technology industry sector and a rising economy, 
the vehicular traffic in Bangalore has increased enormously over the past ten years 
and has caused severe pollution to the environment. Besides the improvements in 
welfare, approximately 30% of the inhabitants live below the poverty line of US$2 
per day (less than 27,000 Indian rupees per year) (78).
The study was conducted in collaboration with nutrition scientists and 
psychologists of St. Johns Research Institute, Bangalore who had access to the 
communities in the urban slums. Two primary schools located in the North-East of 
Bangalore catering to children living in the surrounding slum areas were selected 
for participation in the study. In order to 
maximize the effect of our intervention, 
we chose a study population of children 
from a low socio-economic background. 
These children consume diets that are 
low in micronutrients and omega-3 fatty 
acids and have therefore a high risk of 
micronutrient deficiencies. 
Micronutrient deficiencies are thought 
to be widely prevalent among Indian 
schoolchildren. Approximately 40% of 
Indian schoolchildren suffer from iron 
deficiency (1), 23% from vitamin A 
deficiency (79), and 4% of 6-12 year-
old children have goitre (80). The 
prevalence of both zinc and vitamin B12 
deficiencies are estimated to be high Figure 3. Map of study location Bangalore, India.
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based on national stunting rates (81) and low consumption of animal foods (82). 
The two schools were selected out of eight primary schools that were screened 
for prevalence of anemia in children and feasibility to conduct the intervention 
study. No other nutrition or health interventions had taken place at the schools in 
the previous three months before the study start. Children were taught in the local 
Kannada language, which was important for the cognitive assessment.
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Abstract
Background: Although multiple micronutrient interventions have been shown to 
benefit children’s intellectual development, a thorough evaluation of the totality of 
evidence is currently lacking to direct public health policy.
Objective: This study aimed to systematically review the present literature and 
to quantify the effect of multiple micronutrients on cognitive performance in 
schoolchildren.
Methods: The Institute for Scientific Information Web of Knowledge and local 
medical databases were searched for trials published from 1970 to 2008. 
Randomized controlled trials investigating the effect of ≥3 micronutrients compared 
with placebo on cognition in healthy children aged 0-18 years were included 
following protocol. Data were extracted by two independent researchers. The 
cognitive tests used in the trials were grouped into several cognitive domains (e.g. 
fluid and crystallized intelligence) and pooled effect size estimates were calculated 
per domain. Heterogeneity was explored through sensitivity and meta-regression 
techniques.
Results: Three trials were retrieved in children <5 years, and 17 trials in children 
aged 5-16 years. For the older children, pooled random effect estimates for 
intervention were 0.14 SD (95% CI: -0.02, 0.29; P=0.083) for fluid intelligence 
and -0.03 SD (95% CI: -0.21, 0.15; P=0.74) for crystallized intelligence, both of 
which were based on 12 trials. Four trials yielded an overall effect of 0.30 SD (95% 
CI: 0.01, 0.58; P=0.044) for academic performance. For other cognitive domains 
no significant effects were found. 
Conclusions: Multiple micronutrient supplementation may be associated with 
a marginal increase in fluid intelligence and academic performance in healthy 
schoolchildren, but not with crystallized intelligence. More research is required 
however, before public health recommendations can be given.
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Introduction
Micronutrient malnutrition impairs children’s cognitive performance and 
developmental potential (1). Single micronutrient interventions have shown that 
iodine and iron, and possibly other micronutrients such as zinc and B-vitamins, 
may benefit children’s mental development (2). Because micronutrient deficiencies 
often coexist and synergistic effects of micronutrients on physical functions may 
indirectly affect cognition, supplementing children with multiple micronutrients 
could have advantages over single micronutrient supplementation. For example, 
iron and vitamin A have been shown to influence thyroid metabolism in addition 
to iodine (3;4) and B-vitamins and vitamin A are required for erythropoeisis in 
addition to iron (5;6). In contrast, micronutrients might also have antagonistic 
effects, affecting their bioavailability and their functioning in physiological processes 
that may lead to impaired cognitive functioning. Because iron and zinc, as well as 
copper and manganese compete for intestinal uptake, a high dosage of one of 
these minerals may limit the absorption of the others (7). 
In 2001, Benton (8) reviewed 13 studies investigating the role of multiple 
micronutrients on cognition in children aged 6-16 years of which the majority 
reported a positive effect of the micronutrient supplementation, mostly with non-
verbal measures. The author postulated that performance on non-verbal tests 
results, at least in part, from basic biological functions and could be influenced by 
diet. In contrast, verbal intelligence comprises the acquired knowledge which was 
thought not to be affected by nutrition on the shorter term. Some limitations of the 
review were that no strict selection criteria were applied for inclusion or exclusion 
of studies and that the results of the studies were not pooled to quantify the effect 
of micronutrients on cognition. Furthermore, it remained unclear whether there 
are other specific cognitive domains, beyond non-verbal intelligence that could be 
influenced by micronutrient supplementation and whether the effects would depend 
on other factors, such as age, nutritional and socio-economic status. Since Benton’s 
review, more trials have been published in literature, most of which were conducted 
in developing countries. Children in developing countries have, in general, a more 
monotonous diet and may have a higher risk of micronutrient deficiencies. Hence, 
these children might benefit more from micronutrient supplementation than their 
peers in developed countries.
In the present study, we aimed to systematically review the current literature 
and to perform a meta-analysis to quantify the effect of multiple micronutrient 
interventions on cognitive performance in children, from infancy until late 
adolescence, i.e. 0-18 years of age. Moreover, because we expected heterogeneity 
among the studies, we explored whether factors such as age, country, nutritional 
status, duration and type of micronutrient supplementation would predict the 
effects of micronutrients on cognition.
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Methods
Identification of trials
We searched in titles and abstracts of trials published between 1970-2008 in 
databases of the Institute for Scientific Information Web of Knowledge, Cochrane 
(CENTRAL), EmBase, Australasian Medical Index, Chinese Biomedical Literature, 
Latin American Caribbean Health Sciences Literature and Japan Information Centre 
of Science and Technology File on Science, Technology and Medicine. A search 
string consisting of a combination of the following terms was used: trace element, 
vitamin, carotenoid, micronutrient, mineral, multiple micronutrient; with cognition, 
memory, mental performance, child development, infant development, school 
performance, academic achievement, psychomotor; and with child, adolescent, 
infant, pre-schooler, toddler. Additionally, we performed a lateral search, checked 
lists of references of publications found and searched the past three issues of 
conference proceedings of the International Union of Nutritional Sciences (IUNS) 
and the International Life Sciences Institute (ILSI) conferences.
Selection criteria
Type of trials: All randomized (also cluster randomized) placebo-controlled trials 
evaluating micronutrient supplementation of children aged 0-18 years for a period 
of ≥4 weeks and its effect on cognitive performance, regardless of language and 
publication status were considered for inclusion. Also, trials using a factorial design 
with multiple intervention groups were eligible.
Type of participants: Trials conducted in apparently healthy children were 
included. Trials conducted in selected subjects with learning disabilities, neuro-
psychiatric disorders or chronic psychiatric health conditions were excluded.
Types of intervention: We included trials in which children were supplemented 
with at least three different micronutrients compared with a placebo, as well as 
studies that compared foods fortified with ≥3 micronutrients with non-fortified 
foods. Moreover, trials that had given other interventions along with the multiple 
micronutrients, such as deworming tablets or omega-3 fatty acids were also 
included provided that the addition of multiple micronutrients was the sole difference 
between the intervention and control group. When studies used supplements which 
contained also bio-active substances such as flavonoids and carotenoids, which are 
commonly found in micronutrient supplements, these studies were included provided 
that the supplement predominantly consisted of micronutrients. A combination 
of ≥3 B-vitamins only was not considered to qualify as a multiple micronutrient 
intervention, as B-vitamins are involved in similar biological processes. Studies in 
which (omega-3) fatty acids, proteins or herbals were part of the micronutrient 
mix were excluded when the intervention was compared with a placebo.
Type of outcomes: Studies reporting cognitive performance as primary or 
secondary outcome measure of the intervention were included.
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Data handling
Data were extracted by two independent people (AE and TG), using a pre-
defined data extraction sheet. Possible relevant publications in languages other 
than English were translated. If needed and wherever possible, authors were 
contacted to retrieve missing data.
For each trial we tried to retrieve scores on all cognitive subtests measured 
rather than combined scores. The cognitive tests were grouped by two independent 
people (TG and CT) into the cognitive domains defined by Carroll (9) including fluid 
intelligence, crystallized intelligence, short-term memory (referred to as learning 
and memory in the original model), visual perception, retrieval ability, and cognitive 
processing speed (consisting of the two domains cognitive speediness and processing 
speed in the original model), presented here in descending order of correlation 
with intelligence. We added the cognitive domains sustained attention and motor 
skills as these domains are frequently found in neuropsychological scales, and we 
added academic performance. Fluid intelligence comprises reasoning abilities and is 
generally measured through tasks of analogies and series completions. Crystallized 
intelligence reflects a set of acquired skills and knowledge, and assessed by tasks 
of verbal comprehension, vocabulary and evaluation of semantic relationships. 
It is seen as more dependent on experience and education within a culture than 
fluid intelligence. Following a priori decision, a meta-analysis was performed at 
the cognitive domain level, provided that ≥3 trials assessing that domain were 
available.
 
Statistical analysis
The primary outcome was the difference in change in cognitive test scores 
from baseline to trial termination, and sensitivity analysis end scores were also 
evaluated. If the number of trials reporting end scores was higher than trials 
reporting change scores, then the end scores were used as primary outcome 
variable for that subset. For trials assessing one cognitive domain with more 
than one cognitive test, we computed a standardized mean difference (SMD) by 
taking the mean of the standardized scores of the cognitive tests used. We pooled 
data reported for subgroups (e.g. boys and girls) and intervention groups (e.g. 
different dose of micronutrients) that were a priori decided not to be of interest 
for investigation of heterogeneity. To avoid multiple counting of the control group 
in trials with multiple intervention groups and a single control group, we divided 
the sample size of the control group equally between the number of intervention 
groups, while retaining the mean change and its SD (10). This method will reduce 
the probability of type 1 error.
The following principles were employed when variables required for the meta-
analysis were not stated in the publication or available from authors: 1) within a 
group, the lower of the two stated sample sizes in the beginning or the end of a trial 
was assumed to be the sample size for the change; 2) the mean change in outcome 
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variable was computed as the difference of mean post and pre-intervention levels; 
3) wherever feasible, standard deviations were imputed (back calculated) from the 
stated standard errors (SE), t, F or P values; or if not possible, standard deviations 
were computed assuming a correlation of 0.5 between the pre-intervention and 
post-intervention variances (11); 4) the mean age of subjects was computed as 
the average of the stated range.
Effect sizes for individual trials were calculated by dividing the difference between 
the mean change in intervention and control group by the pooled SD. The overall 
mean effect size was calculated using the random effects model. The presence 
of bias in the extracted data was evaluated graphically using the funnel plot and 
Begg and Egger’s regression tests(12;13). The I2 (variation in overall effect size 
attributable to heterogeneity) and Cochran Q statistics were computed to test for 
heterogeneity of the effect sizes. 
Stratified analyses, specified in advance, were conducted for the following 
variables: quality of methods (concealment of allocation (adequate compared 
with unclear, inadequate, or not used); blinding (double blinding compared with 
single blinding, no blinding, or unclear); attrition (<10% compared with ≥10% or 
unknown)), comparability of intervention groups at baseline (yes compared with no 
or unclear), compliance to intervention (adequate ≥70% compared with others), 
type of analysis (intention-to-treat compared with others), country development 
status (medium compared with high rank on Human Development Index (HDI) 
defined by the United Nations Development Programme), supplementation vehicle 
(fortification compared with tablet), number of micronutrients provided (≤20 
compared with >20) duration of supplementation (≤12 weeks compared with >12 
weeks) and, inclusion of either iron or iodine in intervention (yes compared with 
no). Because of the limited number of trials in children <5 years, the meta-analysis 
was only performed on trials conducted in children ≥5 years. This prevented us 
from including age in subgroup analysis. To further explore heterogeneity between 
the studies, a meta-regression analysis was conducted to investigate effects of 
these variables and mean age of subjects. Because of the limited number of trials 
available, no sensitivity analyses were conducted for the cognitive domains other 
than fluid and crystallized intelligence. All analyses were conducted with STATATM 
(version 9.2; StataCorp, College Station, TX) software.
Results
Nineteen publications described 20 trials that were eligible for inclusion in the 
meta-analysis (see Figure 1), of which three were conducted in children <5 years 
of age (14-16) (see Table 1 for an overview of the trial characteristics). Because 
only two of these studies measured gross motor development, and the third study 
conducted more general tests of development, it was not possible to classify the 
outcomes in the cognitive domains for the children >5 years, and there were too 
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few trials to conduct a separate meta-analyses for these trials. Therefore, we 
briefly review them here. Faber et al (15) investigated the effect of a fortified 
compared with unfortified porridge on gross motor development of South-African 
infants aged 6-12 months. After 6 months of intervention, infants receiving the 
fortified porridge achieved significantly higher motor development scores than 
infants receiving the unfortified porridge. Similarly, Olney et al (16) showed that 
infants aged 5-11 months (n=90) from Zanzibar who received iron, folate and zinc 
for 1 year achieved walking unassisted 1 month earlier than infants receiving a 
placebo (n=103). Dhingra et al (14) conducted a trial in 633 young children aged 
1-3 years from India who received fortified or unfortified milk. After 1 year of 
supplementation, no significant differences between the two groups were found 
on the Bayley’s mental and motor development scores, behavior and language 
development.
Figure 1. Flow diagram for inclusion of randomized controlled trials (RCT).
Sixteen publications with trials in children ≥5 years of age were found (17-32) 
(see Table 1), of which one trial (25) was reported as an abstract. One publication 
(24) described two trials following the same design but conducted in two different 
countries, hence a total of 17 trials were identified. Six trials were conducted 
in developing countries (21;22;24;30-32). Nine trials were conducted in children 
References excluded, with reasons:
No placebo group (n=10)
No RCT (n=7)
Intervention included also energy, fatty acids,     
protein or amino acids (n=6) 
Placebo group received also micronutrients (n=5)
Intervention included only B-vitamins (n=3)
Intervention existed of <3 micronutrients (n=2)
Study conducted in adults (n=1)
Potentially relevant references 
identified and screened for 
review (n=2,332)
Obviously irrelevant references excluded (n=2,279)
Potentially relevant references 
retrieved for more detailed 
evaluation (n=53)
References (n=19) with trials 
meeting the in- and exclusion 
criteria (n=20)
Trials with usable information, by 
outcome (n=20)
Trials excluded (n=0)
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5-12 years of age, four trials in children 12-16 years of age and four trials in 
children 5-16 years of age. The duration of the interventions varied from 4 to 60 
weeks. The number of micronutrients provided ranged from 5 to 25. The range 
of doses of micronutrients was 1.2-24 mg/d (4-133% Recommended Dietary 
Allowance (RDA)) for iron, 50-100 µg/d (40-110% of the RDA) for iodine, 2.5-
20 mg/d (20-180% of the RDA) for zinc, 35-450 µg/d (12-150% of the RDA) for 
folate and 0.45-10 µg/d (25-420% of the RDA) for vitamin B12. Subjects received 
micronutrient supplements in 11 trials and, a micronutrient fortified beverage, 
biscuit or seasoning powder in six trials. The cognitive tests used in the trials were 
clustered into the cognitive domains as shown in Table 2. 
Fluid intelligence
Twelve trials assessed the domain of fluid intelligence, of which 10 measured this 
domain by a combined score of subtests for non-verbal intelligence (17-20;23;26-
29;31) and two by individual tests (25;30). The funnel plot looked somewhat 
asymmetrical (see Figure 2), however there was no evidence for publication bias 
by Begg (P=0.14) and Egger (P=0.15) tests. 
0
0.1
0.2
0.3
0.4
0.5
-1 -0.5 0 0.5 1
SMD
S
E
 (S
M
D
)
Figure 2. Funnel plot for fluid intelligence with 95% confidence limits. SMD, standardized mean difference.
The heterogeneity among trials was significant (P<0.001) and the overall effect 
size of multiple micronutrients on fluid intelligence was 0.14 SD (95% CI: -0.02, 
0.29), P=0.083 (see Figure 3). On influence analysis, the effect size did not 
change significantly when trials were omitted one at a time. Subgroup analyses 
revealed that compliance, method of randomization, method of analysis, country 
development status, supplementation vehicle and number of micronutrients 
provided were significant predictors of heterogeneity (see Table 3). Only country 
development status, supplementation vehicle and number of micronutrients 
provided were also significant in univariate regression analysis (Table 4). In 
multivariate regression analysis using a model with country development status 
and number of micronutrients, these variables were no longer significant (Table 4).
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NOTE: Weights are from random effects analysis
Overall  (I2 = 67.3%, P<0.001)
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-0.18 (-0.73, 0.38)
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100.00
5.25
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9.24
5.20
SMD (95% CI) Weight (%)
0-2.22 2.22
Figure 3. Forest plot for fluid intelligence, SMD, standardized mean difference.
Crystallized intelligence
Crystallized intelligence was assessed in 12 trials, of which eight 
measured  this domain by a combined score of subtests for verbal intelligence 
(17;19;20;23;26;28;29;31), and three trials by 3-4 subtests (24;30) and one trial 
by one subtest (21). From statistical tests by Begg (P=0.95) and Egger (P=0.77) 
there was no evidence for publication bias, but the funnel plot looked slightly 
asymmetrical (see Figure 4). There was significant heterogeneity between the 
0
0.1
0.2
0.3
0.4
0.5
-1 -0.5 0 0.5 1
SMD
S
E
 (S
M
D
)
Figure 4. Funnel plot for crystallized intelligence with 95% confidence limits. SMD, standardized mean difference.
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trials (P<0.001). Overall, there was no significant effect (-0.03 SD, 95% CI: -0.21, 
0.15; P=0.74) of multiple micronutrients on crystallized intelligence (see Figure 
5). When trials were omitted one at a time, the overall effect size did not change 
significantly (data not shown). Significant predictors of heterogeneity on subgroup 
analyses were allocation concealment, compliance, method of randomization, 
method of analysis, and inclusion of iodine (Table 3), whereas no variables 
significantly explained heterogeneity in univariate analyses (Table 4).
NOTE: Weights are from random effects analysis
Overall  (I2 üüüü P<0.001)
Jinabhai et al (2001)
Solon et al (2003)
Osendarp et al (2007) Australia
Vazir et al (2006)
Trial
Southon et al (1994)
Schoenthaler et al (1991)
Nelson et al (1990) 11-12 years
Osendarp et al (2007) Indonesia
Crombie et al (1990)
Snowden (1997)
Benton & Cook (1991)
Benton & Roberts (1988)
-0.03 (-0.21, 0.15)
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100.00
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11.09
Weight (%)
5.74
10.26
8.99
10.56
7.14
2.52
5.28
6.49
SMD (95% CI)
0-1.93 1.93
Figure 5. Forest plot for crystallized intelligence, SMD, standardized mean difference.
Other cognitive domains
For the other cognitive domains ≤7 trials were available. For all domains, except 
short-term memory and sustained attention, there was significant heterogeneity 
between the trials. The overall effect sizes are presented in Table 5. A significant 
positive overall effect of micronutrient supplementation was found on academic 
performance (0.30 SD, 95% CI: 0.01, 0.58; P=0.044) based on four trials 
(22;26;31;32). These studies had a relatively large sample size of 220-869 
subjects, and three of them (22;31;32) were conducted in developing countries. 
There were no significant overall effects on the domains of short-term memory, 
visual perception, retrieval ability, cognitive processing speed and sustained 
attention.
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Table 5. Overall effect size estimates per cognitive domain 
Cognitive domain No of trials
Overall effect size1 Tests for heterogeneity
(95% CI) P-value I2(%); Q P-value
Short-term memory 6 0.05 (-0.11, 0.21) 0.55 24.7; 6.6 0.25
Visual perception 4 0.14 (-0.28, 0.56) 0.51 91.7; 36.1 <0.001
Long term memory 4 0.01 (-0.15, 0.17) 0.89 58.9; 7.3 0.06
Cognitive processing speed 7 -0.20 (-0.61, 0.22) 0.35 94.3; 105.2 <0.001
Sustained attention 3 0.13 (-0.11, 0.36) 0.30 49.1; 3.9 0.14
Academic performance2 4 0.30 (0.01, 0.58) 0.04 86.9; 22.9 <0.001
1 Obtained by using a random effects model.
2 Effect size estimated from end scores. 
Discussion
This meta-analysis suggests the possibility of a small positive effect of multiple 
micronutrient supplementation on fluid intelligence (reasoning ability), which was 
not statistically significant (P=0.083) and, a positive effect on academic performance 
(based on a limited number of four trials, P=0.044) in children 5-16 years of age. 
There were no effects on crystallized intelligence (acquired knowledge) and other 
cognitive domains. 
 
Strengths and limitations of the review
We conducted an up-to-date systematic review employing rigorous selection 
methodology, including studies from both developed and developing countries. 
Furthermore, we performed a meta-analysis at the level of the different cognitive 
domains, which has not been shown before in literature. We realize that our 
definition of multiple micronutrients is arbitrary, however others have used the 
same definition as ours (33-35). Furthermore, micronutrient interventions varied 
across trials; hence, results should be interpreted accordingly. We found no evidence 
for publication bias among trials assessing the domains of fluid and crystallized 
intelligence and influence analyses did not indicate that any of the trials had a 
significant impact on the overall effect sizes for these domains. In the cluster 
randomized trial (31), a correction for design effects was not possible. We conducted 
a large number of subgroup and meta-regression analyses and given the increased 
risk of false positive results, significant findings should be interpreted with caution. 
Unfortunately, we lacked data on indicators of nutritional status to explore whether 
malnourished children would benefit more from multiple micronutrients than well-
nourished children. However, our main conclusions regarding fluid and crystallized 
intelligence did not change after performance of the sensitivity analyses.
Choice of outcome measures
We included trials that measured cognitive performance as primary or secondary 
outcome. Although the cognitive test batteries differed by trial, most of them 
comprised subtests from reliable and valid test batteries such as the Wechsler’s 
Intelligence Scale for Children or validated adapted versions (29;31). In addition, 
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measuring a similar domain with different subtests can be viewed as a more robust 
assessment of that particular domain (36). However, the lack of availability of data 
on subtest level for most of the older trials (published in the 1990s) hampered 
the initial aim to classify subtests into cognitive domains and therefore combined 
scores were used for classification. 
Predictors of heterogeneity
There was significant heterogeneity among the trials. For fluid intelligence, 
heterogeneity could be explained by the difference in development status of the 
countries, supplementation vehicle and number of micronutrients in both subgroup 
and univariate meta-regression analyses. Our findings suggest that development 
status of countries, supplementation vehicle and number of micronutrients 
provided, could each individually explain the different findings of the different 
studies in the meta-analysis, as suggested by the univariate regression analysis. 
However, in the multiple regression analysis, including all of these variables in one 
model together with the treatment, these variables were not significant predictors 
anymore probably due to confounding (i.e. dependency in the model). 
Contrary to our expectations, for trials conducted in developed countries with 
high HDI rank and presumingly a better nutritional status, which also provided 
micronutrient in tablets, the overall effect on fluid intelligence was significantly 
larger compared to trials conducted in developing countries, with an estimated 
lower nutritional status, using fortified products. Differences between developed 
and developing countries may be explained by the fact that most of the cognitive 
test batteries originated from developed countries and were validated in Western 
populations, and may therefore be more sensitive than adapted test batteries 
used in developing countries. Also, an overall lack of energy and protein in diets of 
children in developing countries may have overruled the effect of micronutrients. 
This may also explain why provision of micronutrients in fortified foods containing 
energy and protein may not have resulted in clear benefits of micronutrients only. 
Furthermore, a higher number of different vitamins and minerals may lead to 
larger improvements in cognitive performance; however we lack data to clarify 
what type and dose of micronutrients would be most effective. 
Comparisons with earlier reviews 
Our results for fluid and crystallized intelligence seem to confirm the observations 
from the earlier review (8), indicating that non-verbal or fluid intelligence, but not 
verbal or crystallized intelligence, might be improved by micronutrient interventions. 
Several mechanisms have been described how micronutrients can influence 
cognition. For instance, iron is required for myelination and neurotransmitter 
neurochemistry (37) and neurotransmitter processes are impaired in the presence 
of iron deficiency anemia, which is most probably caused by a reduction in oxygen 
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availability (38).  Zinc is as coenzyme required for neurogenesis, neuronal migration, 
and synaptogenesis (39) and B-vitamins are required for neurotransmitter synthesis 
and functioning (40-44), brain energy metabolism (45) and myelination of the 
spinal cord and brain (44). 
There are several hypotheses why the impact of micronutrients might be beneficial 
to fluid, but not crystallized intelligence. Possibly, the cognitive tests assessing 
fluid intelligence and the lower cognitive abilities would be more sensitive to pick 
up subtle differences compared to those for crystallized intelligence. In addition, 
it may take more time, may be several years, to show significant differences 
in acquired skills and knowledge following nutritional interventions than for the 
other cognitive domains, and the duration of the trials may have been too short 
to demonstrate effects. Furthermore, environmental factors, such as education, 
parenting styles and socio-economic status may be more important determinants 
of crystallized intelligence than nutrition.
The overall effect of multiple micronutrients on fluid intelligence (0.14 SD) found 
in the current meta-analysis is smaller compared to that of iron supplementation 
alone on mental development (0.41 SD) in children ≥8 years (46). This may be 
attributed to the fact that doses of iron provided in the meta-analysis on iron only 
were higher (30-100 mg/d) compared to doses of iron in multiple micronutrient 
interventions in our meta-analysis (1.2-24 mg/d). In addition, whereas trials on 
iron only used iron tablets, the studies on multiple micronutrients used food as 
delivery system.  The extra energy and protein provided in the food matrix may 
have overruled the effects of the micronutrients in these studies. In addition, 
perhaps single iron supplementation may be as or even more effective for children’s 
development than multiple micronutrients. However, two studies in infants have 
shown that zinc in addition to iron and folate was equal or more beneficial for 
their development than iron and folate alone (16;47). Therefore, future, properly 
designed studies are recommended to determine whether multiple micronutrients 
are more advantageous than single micronutrients. 
Implications for public health policy and recommendations for future 
research
This meta-analysis suggests the possibility of a marginal positive effect of 
micronutrients on reasoning abilities and academic performance (limited data) of 
children. However, the evidence is currently not robust enough to recommend routine 
multiple micronutrient supplementation for improving cognitive performance. 
To decide whether multiple micronutrients should be recommended for optimal 
mental development in children, more research is needed, taking into account the 
observed heterogeneity among the studies, to assess whether multiple micronutrient 
supplementation has advantages over that of single micronutrients in randomized 
controlled trials. Furthermore, because of limited data, more trials in developing 
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countries are needed to investigate whether micronutrients improve cognition and 
to assess whether perhaps protein and energy in addition to micronutrients would 
be required to optimize intellectual development of malnourished children. Future 
trials should include various cognitive domains, such as short-term memory, visual 
perception, retrieval ability, sustained attention and cognitive processing speed 
to investigate whether multiple micronutrients affect the cognitive domains in 
different ways.
Conclusions
In conclusion, this meta-analysis suggests that multiple micronutrient 
supplementation in healthy school-age children may be associated with a small 
increase in fluid intelligence, while crystallized intelligence seems unaffected. 
However, development of public health guidelines specifically designed to improve 
cognitive performance of children through routine micronutrient interventions is 
currently considered premature. 
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Abstract
The present paper evaluates the most recent randomized controlled trials 
assessing the efficacy of omega-3 long chain polyunsaturated fatty acid (LCPUFA) 
supplementation (with or without omega-6 LCPUFA) during pregnancy, lactation, 
infancy and childhood on visual and cognitive development. 
Available evidence suggests a beneficial effect of maternal omega-3 LCPUFA 
supplementation during pregnancy and lactation on cognitive development of 
infants and children, but not for visual development. Evidence for an effect of 
LCPUFA supplementation of preterm and term infants on cognitive development of 
infants remains inconclusive. However, supplementing term infants with daily doses 
of 100 mg docosahexaenoic acid plus 200 mg arachidonic acid improves visual 
development as measured by electrophysiological tests. Evidence for benefits of 
omega-3 LCPUFA on cognitive development in healthy children older than two 
years of age is too limited to allow a clear conclusion. 
Taken together, the evidence for potential benefits of LCPUFA supplementation 
is promising but yet inconclusive. 
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Introduction
There is considerable interest in the role of certain long chain polyunsaturated 
fatty acids (LCPUFA), in visual and cognitive development throughout childhood. 
The omega-3 fatty acid docosahexaenoic acid (DHA) and the omega-6 fatty acid 
arachidonic acid (AA) are the major LCPUFA in the brain (1). DHA and AA are 
rapidly incorporated in the nervous tissue of retina and brain during the brain’s 
growth spurt, which mainly takes place from the last trimester of pregnancy up 
to 2 years of age (1-4). Beyond development of the central nervous system, 
omega-3 and omega-6 fatty acids may influence brain function throughout life by 
modifications of neuronal membrane fluidity, membrane activity-bound enzymes, 
number and affinity of receptors, function of neuronal membrane ionic channels, 
and production of neurotransmitters and brain peptides (5). Although DHA and 
AA are the major structural components of the central nervous system, there is 
currently no consensus whether dietary supplementation of LCPUFA has benefits 
for visual and cognitive development of infants. Two Cochrane reviews conclude 
that for preterm infants, there are no positive long-term effects (>6 months of age) 
of LCPUFA on visual or intellectual development, while evidence for a beneficial 
effect of LCPUFA supplementation on early visual development of preterm infants 
(<6 months of age) is inconclusive (6). For term infants there is little evidence 
for a benefit of LCPUFA supplementation on visual or general development (7). 
Recently, McCann & Ames (8) reviewed evidence from human and animal studies 
to assess whether DHA is required for development of normal brain function. They 
concluded that evidence is too inconsistent to conclude that infant formula should 
be supplemented with DHA. 
Since publication of the Cochrane reviews and review by McCann & Ames, several 
new human intervention studies on this topic appeared in literature. Additionally, 
new research focused on the effect of maternal omega-3 LCPUFA supplementation 
during pregnancy and lactation on visual and cognitive function of infants. In this 
paper, we therefore aim to re-evaluate the currently available evidence on the effect 
of LCPUFA on visual and cognitive function during infancy and later childhood. We 
focus on human nutrition intervention studies on LCPUFA supplementation during 
pregnancy, lactation, infancy and childhood. 
Methodology
Literature search
For assessment of the effects of LCPUFA supplementation on visual and cognitive 
development of children, we divided the literature into four topic areas:
1. Supplementation of mothers during pregnancy and lactation and effects on 
visual and cognitive development of their infants.
2. Supplementation of preterm infants during the first two years of life and 
effects on their visual and cognitive development.
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3. Supplementation of term infants during the first two years of life and effects 
on their visual and cognitive development.
4. Supplementation of children older than 2 years of age and effects on their 
cognitive development.
For identification of studies, we searched the literature databases of Web 
of Science (Institute for Scientific Information). The search string consisted of 
combinations of the following terms: long chain polyunsaturated fatty acids, 
docosahexaenoic acid, eicosapentaenoic acid, linolenic acid, arachidonic acid, 
linoleic acid, omega-3 fatty acids, omega-6 fatty acids; with infants, children, 
preschoolers, toddlers, complementary feeding, neonates, offspring, babies; and 
with cognition, development, mental, learning, brain, visual acuity, neurology. In 
addition, lists of references in the identified publications were checked. We restricted 
this review to randomized controlled trials that supplemented subjects for periods 
of at least four weeks, and in which supplementation with LCPUFA was the sole 
variable differing between treatment and control groups. Therefore, comparisons 
of groups fed supplemented formula with groups fed human milk, as in some of 
the trials, are beyond the scope of this review and will not be discussed. When less 
than three controlled human trials one of the five selected topics were available, 
we also searched for observational data. This was the case for supplementation 
of children older than two years. For studies in preterm and full term infants, 
we restricted our review to studies published after the two Cochrane reviews on 
effects of LCPUFA on development (6;7).
Definitions and methods of investigation of visual and cognitive 
development
Two major outcomes that may be influenced by omega-3 LCPUFA supplementation 
are visual and cognitive development.
Visual development reflects maturation of visual (cerebral) function and retinal 
(sensory) function. Retinal function can be assessed by electroretinography (ERG) 
which measures the electrical responses of sensory cells in the retina. Visual acuity 
is a measure of clearness of vision. Visual acuity can be measured by visual evoked 
potentials (VEP) which is the electrical response of the brain to a visual stimulus 
(electrophysiological methods) or by preferential looking techniques which are 
behavioral reactions to cards presenting different visual contrasts that are compared 
and assessed by a technician (behavioral methods). Most studies investigating 
the effects of LCPUFA on visual development measured grating acuity. This is the 
spatial threshold for resolving dark and light stripes, which can be studied by both 
electrophysiological and behavioral methods (9). Stereo acuity is another measure 
of visual function of depth perception, assessing the minimum detectable binocular 
disparity (9).
The term cognition is broad and covers various high-level psychological 
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processes, such as memory, learning, reasoning, attention and language. Cognitive 
development refers to the changes of the cognitive processes observed over longer 
periods of time (months or years) and is usually assessed in children by batteries 
of performance tests assessing specific cognitive abilities. Mental or cognitive 
development of infants and young children is multidimensional and nonlinear. It is a 
result of physical growth, neurological maturation, interactions with the environment 
and the integration of stimuli provided by immediate caregivers and broader social 
and economic context. Therefore, the assessment of mental development of infants 
requires the examination of multiple domains and multiple sources of information; 
the comparison of developmental milestones with standardized population is 
essential. The Bayley Scales of Infant Development (BSID) is used infants and 
young children and measures general development. The BSID has strong technical 
characteristics, because it has been standardized on a very large population. It 
has, however, a poor predictive validity for later intelligence (10). More specific 
cognitive functions, such as gross motor skills, parent-child interaction, language 
comprehension, sleep-wake behavior, and attention can be assessed in infants and 
young children with more precise methods. However, these assessments are rarely 
used as they require time-consuming observation, specific experimental settings 
and multiple sources of information. 
In older children (>3 years), intelligence is usually assessed by sets of short 
tests measuring various cognitive abilities all correlated with a general factor of 
intelligence, such as the Kaufman Assessment Battery for Children (K-ABC) and 
Wechsler tests (WISC) (11).
Results
Maternal omega-3 LCPUFA supplementation and effect on visual and 
cognitive development of their neonates
Six studies have been found in literature assessing the effect of maternal 
supplementation during pregnancy and/or lactation with omega-3 LCPUFA on 
visual and cognitive development of their infants. The characteristics of these trials 
are shown in Table 1.
Supplementation during pregnancy
Three trials investigated maternal supplementation before birth, when the 
fetus is developing, and measured effects on visual and/or cognitive development 
after birth. One of these trials was excluded because no results on effects of 
DHA supplementation of mothers on cognitive development of the infants were 
reported (12). Another trial by Malcolm et al (13;14) assessed the effect of fish 
oil supplementation (0.2 g DHA/d) to mothers from week 15 of pregnancy to 
delivery, on infant retinal and visual development. No differences were found, 
neither in maturity of the retina at 1 week of age, nor in visual function measured 
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by VEP to flash and pattern reversal stimuli at birth and at 10 and 26 weeks of age, 
between neonates born to mothers supplemented with fish oil versus those from 
mothers supplemented with high-oleic acid sunflower oil. A third trial by Tofail et 
al (15) investigated the effect of supplementing 249 pregnant Bengalese women 
with either fish oil (1.2 g DHA + 1.8 g EPA/d) or soy bean oil (2.25 g LA + 0.27 
g ALA/d) from the 25th week of pregnancy until delivery on cognitive outcomes 
of her infant. Cognitive development was measured using the BSID when infants 
were 10 months of age. Furthermore, measurements of infant’s behavior, quality 
of stimulation at home (Home Observation for Measurement of Environment) and 
socio-economic indicators were used to control outcomes of the intervention (15). 
The mean Mental Development Index (MDI) and Psychomotor Development Index 
(PDI) sub-scores of the BSID did not differ significantly between the two groups.
The studies by Malcolm and Tofail did not detect an effect of maternal omega-3 
LCPUFA supplementation during pregnancy on visual function or cognitive 
development in the first year of life. Explanations for this could be that the dose 
and/or duration of the DHA supplementation were not sufficient. In fact, the dose 
used in the study by Malcolm et al (13;14) was low (0.2 g DHA/d) and did not 
significantly increase the infant’s DHA status (16). 
Tofail et al (15) used a high dose of DHA (1.2 g/d) for a supplementation period 
that was 6-10 weeks shorter than in the study by Malcolm et al (13;14), but no 
biochemical parameters were measured to confirm that the DHA status of the infant 
increased. Cross-sectional analyses of the data of Malcolm et al (13;14) showed 
that maturity of the retina at 1 week, and visual acuity at 10 and 26 weeks of age 
were positively associated with the DHA status of infants at birth. This indicates 
that the outcome measures in Malcolm et al (13;14) were sufficiently sensitive to 
detect effects on retinal and visual function, while there is no such evidence for the 
BSID measurement in the study by Tofail et al (15). Because of the differences and 
limitations in the designs of these two studies, it is yet uncertain whether omega-3 
LCPUFA supplementation during pregnancy can have a beneficial effect on visual 
or cognitive development of the infants.
Supplementation during pregnancy and lactation
One study by Helland et al (17) investigated the effect of supplementing mothers 
with either cod liver oil (1.2 g DHA/d) or corn oil (4.7 g linoleic acid (LA)/d) from week 
17-19 of pregnancy until delivery and continued for three months during lactation. 
No treatment differences between the groups were found in electroencephalogram 
(EEG) maturity of the two-day old neonates, EEG maturity at 3 months of age 
and for novelty preference at 6 and 9 months of age. When these children were 
4 years of age, however, IQ estimated by the Mental Processing Composite of 
the K-ABC was significantly (4 points) higher in the cod liver oil group than in the 
control group (18). It is unclear whether this can be ascribed to supplementation 
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during pregnancy, during lactation or both. The dose of DHA used was effective 
in increasing infant’ DHA status, and the Mental Processing Composite score was 
significantly positively correlated with infants’ DHA status at 4 weeks of age (18). 
No positive correlations were found between EEG maturity at 3 months and novelty 
preference and DHA umbilical plasma, except for EEG maturity at 2 days of age 
(17). Outcomes of this study suggest that effects of DHA supplementation during 
pregnancy and lactation may appear later in life, when cognitive function is more 
mature and cognitive psychometric tests have higher discriminative power.
Supplementation during lactation 
Three randomized controlled trials have assessed the effect of supplementing 
lactating mothers with omega-3 LCPUFA, on cognitive development of their children. 
Gibson et al (19) investigated the effect of supplementing lactating women with 
one of five increasing doses of DHA (0-1.3 g/d) from algae oil for the first 12 weeks 
postpartum on visual and cognitive development of their infants. No significant 
effects of DHA supplementation were found on visual acuity at 12 and 16 weeks 
of age and on MDI and PDI sub-scores of the BSID at 1 and 2 years of age. 
Nevertheless, a small but statistically significant association of infant DHA status 
and breast milk DHA concentration at 12 weeks of age with the MDI measured at 1 
year was found. This positive correlation disappeared, however, when the children 
were 2 years old. No relationships with infant DHA status or breast milk DHA were 
observed for either the PDI or for visual acuity. In a study in Danish lactating 
women with low fish intake, Lauritzen et al (20) found no significant effects of fish 
oil supplementation on visual acuity of infants at 2 and 4 months (1.3 g omega-3 
LCPUFA/d for 16 weeks) as compared to olive oil supplementation. However, in a 
cross-sectional analysis of the fish oil supplemented infants, a significant positive 
association was demonstrated between infant DHA status and visual acuity at 4 
months, but not at 2 months of age.
Infants were followed to investigate the effects of the supplementation on motor 
function at 2, 4 and 9 months, problem solving ability at the age of 9 months and 
linguistic development at 1 and 2 years of age (21). Fish oil supplementation had 
a significant positive effect on problem solving in girls at 9 months, while no such 
effect was detected in boys and the total group. In contrast, fish oil supplementation 
resulted in a significantly negative effect on vocabulary comprehension at 1 year 
in the total group and in boys, and on sentence complexity in boys. However, no 
differences between groups were found on vocabulary tests when children were 
2 years of age. Correlation of infant DHA status at 4 months with cognitive tests 
yielded a significant positive relationship with problem solving in girls at 9 months 
and a significant negative relationship with vocabulary comprehension in boys at 
12 months. No significant correlations were found for any of the other outcome 
measures or at other ages. In the third study, Jensen et al (22) investigated the effect 
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of supplementing lactating mothers with either DHA from algae oil (200 mg DHA/d) 
or vegetable oil for 4 months on visual function and neurodevelopment of their 
infants. Visual function was assessed with the Teller Acuity Card procedure, and by 
measuring sweep and transient VEP at 4 and 8 months of age. Neurodevelopment 
status was evaluated by the BSID at 30 months. At 12 and 30 months of age, 
gross motor development (Gesell Development Inventory), language development 
(Clinical Linguistic and Auditory Milestone Scale), and visual-motor problem-solving 
(Clinical Adaptive Test) were also determined. No significant effects of intervention 
were observed, with the exception of significantly higher scores on the PDI sub-
score of the BSID in 30 months old infants of mother supplemented with DHA 
compared to controls. No significant correlations were found between infant DHA 
status and any of the functional outcome measures.
In the three randomized controlled trials summarized above, DHA  supplementation 
during 4 months increased the DHA content of human milk and that of infant 
blood DHA status in a dose-dependent way. However, none of the three trials 
found significant effects of supplementation on any of the indicators of visual 
development. It could be speculated that supplementation during 3-4 months is 
too short to have a beneficial effect on visual development and should even start 
during pregnancy. However, it may also be DHA supplementation during lactation 
has no relevant effect on visual development.
For cognitive development, the effects of DHA supplementation during lactation 
are inconsistent. The study by Gibson et al (19) with only 52 children was considered 
too small to detect any effect. Jensen et al (22) and Lauritzen et al (21) had 
adequate power and found mixed effects of DHA supplementation at 9-30 months 
of age. No effects of the interventions were observed on motor development before 
the age of 12 months, but Jensen et al (22) showed a large positive effect of DHA 
supplementation on psychomotor development at 30 months. This finding indicates 
that effects of supplementation on motor development may appear later in life. No 
positive effects of DHA supplementation were shown on any of the measures of 
general intelligence in the three studies, except for problem solving ability in girls 
at 9 months in the study by Lauritzen et al (21). Effects of DHA supplementation 
on language development were not consistent between the studies by Lauritzen 
et al (21) and Jensen et al (22). This could be explained by use of different test 
methodologies, the higher dose of DHA and higher sensitivity of mothers with low 
fish intake to fish oil supplementation in the study by Lauritzen et al (21). There 
is no good explanation why some positive effects on cognitive development were 
only found in girls and why negative but transient effects on language development 
were more pronounced in boys.
In conclusion, DHA supplementation during lactation seems not effective for 
visual development of breastfed infants, but there is some evidence for a beneficial 
effect on psychomotor and cognitive development of the infant. An important 
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question is whether these positive effects would be sustainable in later childhood.
Effect of LCPUFA supplementation on visual and cognitive development in 
preterm infants
Preterm born infants have significantly lower LCPUFA concentrations than infants 
born after a full term pregnancy, because preterm infants miss the major period 
in utero of DHA and AA accretion in the brain, which is during the third trimester 
of gestation (4). Simmer & Patole (6) concluded in a Cochrane review of nine 
studies published between 1990 and 2002, that there were no positive long-term 
effects (>6 months of age) of LCPUFA supplementation on visual or intellectual 
development in preterm infants. Evidence for a beneficial effect of LCPUFA on 
early visual development (<6 months of age) was inconclusive (6). Since that 
review, two large randomized controlled trials and one smaller trial assessing the 
effect of LCPUFA supplemented formula on visual and general development of 
preterm infants were published (Table 2). Fewtrell et al (23) investigated the 
effects of supplementing 204 preterm infants of tuna oil in combination with 
borage oil rich in g-linoleic acid (GLA) (0.5 g DHA and 0.9 g GLA/100g fat) on 
mental and psychomotor development and neurological status at 9 and 18 months 
after term. GLA is a precursor of AA; it is readily converted to AA in human body 
(23). No significant differences in MDI and PDI sub-scores of the BSID were found 
between the groups. However, pre-planned subgroup analysis showed that LCPUFA 
supplemented boys, but not girls, had significantly higher mental development 
scores at 18 months after term than controls. Authors suggested that boys may be 
more sensitive to the effects of suboptimal early nutrition on neurodevelopment 
(24). In another recent study, Clandinin et al (25) found significantly higher MDI 
and PDI sub-scores of the BSID at 18 months after term in 179 preterm infants 
who received LCPUFA supplemented formula (0.32 g DHA from algae or fish oil 
plus 0.67 g AA from fungi oil/100 g fat), compared to the control group. Subgroup 
analyses to assess effects in boys or girls were not conducted.
Fang et al (26) showed in a small study of 27 preterm infants a significant 
beneficial effect of LCPUFA supplemented formula containing 0.05 g DHA and 0.10 
g AA/100 g fat on the PDI and MDI sub-scores of the BSID at 6 and 12 months 
of age compared to the controls. The source of DHA and AA was not reported. No 
differences were found in the different measures of visual development at 4 and 6 
months of age. Formula was supplemented from birth to 6 months. Infants were 
less premature (born at 30-37 wk of gestation) and had a higher birth weight 
(nearly 2000 g) than infants in the studies by Fewtrell and Clandinin (born <35 wk 
of gestation, birth weight <2000 g). The dosage LCPUFA was low and duration of 
the intervention was short compared to the other two studies. Other limitations of 
the study were the small sample size and a complete description of the composition 
of the formula was lacking. Therefore, these outcomes should be interpreted with 
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care. Simmer & Patole (6) reviewed five studies that assessed the effect of LCPUFA 
supplemented formula on cognitive development of preterm infants as measured 
by BSID and Fagan Test. These studies had mixed results. Five studies assessed 
cognitive development only when infants were 12 months after term or older. Two 
of these five studies (27;28) measured also effects of LCPUFA supplementation at 
18 and 24 months after term using BSID, but no significant effects on cognitive 
development of infants were found. However, the duration of supplementation in 
these studies, 1 (27) and 6 (28) months, was much shorter than the 12 months in 
the study by Clandinin et al (25).
Taken together, there are indications for a beneficial effect of LCPUFA 
supplementation on cognitive development of preterm infants. The three studies 
mentioned above showed positive effects, but evidence is as yet inconclusive. 
It may be that effects of LCPUFA supplementation are larger when the duration 
of supplementation is continued until the age of 12 months after term; or that 
the effect can be better detected at older ages, when cognitive tests are more 
sensitive and reliable. 
Effect of LCPUFA supplementation on visual and cognitive development in 
full term infants
Simmer (7) concluded in a Cochrane review that there was little evidence for a 
benefit of LCPUFA supplementation on visual or general neural development in the 
first 36 months of age. This conclusion was based on systematic review of nine 
randomized controlled trials of term infants fed infant formulas with or without 
LCPUFA. However, they concluded that supplementation of LCPUFA appeared to be 
beneficial on information processing during the first year of life (7). SanGiovanni 
et al (29) performed a meta-analysis of five of these nine studies and assessed 
the effect of DHA supplementation on visual acuity in term infants. A significant 
better visual acuity at 2 months of age (0.32 ± 0.09 octaves better acuity in DHA 
supplemented groups) was found when visual acuity was measured using behavioral 
tests, but not when measured with electrophysiological tests. At older ages up to 
12 months, no significant effects could be detected at all. In a meta-regression 
analysis of 14 intervention studies, Uauy et al (30) demonstrated a significant 
positive association (r2=0.35) between the DHA provided by the supplement and 
higher visual acuity at 4 months of age. These data suggest that when increasing 
the DHA content of formula with 10% of total fatty acids (28 mg DHA/d), the visual 
acuity response improves with –0.067 log of the minimum angle of resolution 
(logMAR). When taking into account also the hypothetical DHA converted from ALA 
(1, 5 or 10%) and EPA (18%) plus DHA content of the formula  (DHA equivalents), 
then the association was stronger (r2=0.53-0.68) and improvements in visual 
acuity response were higher. Increasing formula with 28 mg DHA equivalents 
would result in an improvement of visual acuity response of –0.252 logMAR (30). 
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After the review by Simmer in 2001 (7), there were nine new randomized 
controlled trials published on the effect of LCPUFA supplementation in full term 
infants on visual and cognitive development (Table 3). Four of these nine studies 
have also recently been reviewed by McCann & Ames (8). Auestad et al (31) found no 
beneficial effects on visual acuity and mental development in the first 14 months of 
life after supplementation with infant formula with 0.14% DHA and 0.45% AA from 
egg-derived triglyceride or from a combination of fish and fungal oil for 12 months. 
The authors applied multiple measures of general development, including the Fagan 
Test assessing general information processing and the BSID. Furthermore, they 
measured language development using MacArthur Communicative Development 
Inventories and overall behavior and well-being of children by the Infant Behavior 
Questionnaire and Behavior Rating sub-score of the BSID. In the follow-up of an 
earlier supplementation study (32), Auestad et al (33) also observed no significant 
effects of infant formula on visual acuity, visual-motor function, IQ and language 
assessments when children were 39 months of age (32). These children were 
initially fed formula with either 0.14% DHA and 0.45% AA from egg-derived 
phospholipids, or with 0.23% DHA only from fish oil, or control formula without 
added LCPUFA during their first year of life. Bouwstra et al assessed the effect 
of infant formula supplemented with 0.23% DHA, 0.39% AA, and 0.18% GLA 
during the first two months of life on neurodevelopment as reflected by general 
movements (34) and the Hempel test and BSID (35). The source of LCPUFA was a 
combination of egg-yolk, tuna and fungal oil which resembled the composition of 
LCPUFA in human milk. LCPUFA supplementation reduced the occurrence of mildly 
abnormal general movements of infants at 3 months of age compared to control 
formula (34). However, no significant effects were observed on neurodevelopment 
when infants were 18 months of age (35). Similarly, Ben et al (36) found no 
significant effects of supplementing Chinese infants with formula containing 0.18% 
DHA and 0.18% AA (source unknown) for a period of 6 months on MDI and PDI 
sub-scores of the BSID when infants were 3 and 6 months of age. In contrast, two 
trials by Birch et al (37;38) demonstrated significant improvement in visual acuity 
and visual stereo-acuity throughout the first year of life in LCPUFA supplemented 
infants compared to controls. Infants received formula supplemented with 0.36% 
DHA and 0.72% AA from single-cell oil or control formula for 12 months. Also, Ünay 
et al (39) showed a significantly more rapid maturation of the auditory brainstem 
response as measured by changes in auditory evoked potentials in infants who 
were supplemented with 0.5% DHA from unknown source during the first 16 weeks 
of life compared to controls (39). 
Two studies conducted by Hoffman et al assessed the effects of formula 
supplemented with 0.36% DHA plus 0.72% AA from single-cell oil (40) or baby 
food with egg yolk enriched with 83 mg DHA versus non-enriched egg-yolk (41) on 
visual function in infants. Supplementation occurred only during the complementary 
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feeding period from 4-6 months until 12 months of age following exclusive 
breastfeeding. Both studies showed that visual acuity at age 9 and 12 months, but 
not visual stereo-acuity, was significantly more mature in LCPUFA supplemented 
infants. The studies by Hoffman suggest that DHA supplementation may be of 
benefit during the period of weaning when infants receive complementary foods 
next to breast feeding or infant formula, as these foods may be low in omega-3 
LCPUFA.
Data from four studies by the groups of Birch and Hoffman, all showing positive 
effects of LCPUFA supplementation on visual development, were combined by 
Morale et al (42) to assess the effect of duration of supplementation. This analysis 
demonstrated that longer duration of LCPUFA supplementation by either human 
milk or formula was associated with higher improvement in visual acuity at 52 
weeks of age, i.e. –0.002 logMAR improvement per week of LCPUFA supply.
Four out of five trials mentioned above showed beneficial effects of LCPUFA 
on visual development. All these studies used higher doses of LCPUFA compared 
to the study that did not find a benefit. Also, all four studies measured visual 
acuity by the more sensitive electrophysiological tests (9). This is consistent with 
findings from earlier studies reviewed by Simmer (7), of which Makrides et al (43) 
and Birch et al (44) found significant effects on VEP using formula with 0.36% 
DHA, while Auestad et al (45) found no effects using a formula with 0.12% DHA. 
Also, no major effects of LCPUFA supplementation were found when visual acuity 
was assessed with behavioral methods in the studies reviewed by Simmer (7). 
However, these findings are in contrast with earlier findings of the meta-analysis 
by SanGiovanni et al (29), who found no significant effects of DHA supplementation 
on visual acuity measured with behavioral tests only.
Taken together, above studies suggest that LCPUFA supplementation to formula 
in high dose of 0.36% DHA plus 0.72% AA and prolonged supplementation up to 
12 months benefits visual development of infants. These high dosages of LCPUFA 
compare with a daily intake of approximately 100 mg DHA plus 200 mg AA; based 
on a 4% lipid content of formula, a 92.5% fatty acid content in milk total lipids, 
and a volume intake of 750 mL/d as proposed by Uauy et al (30).
In agreement with the conclusions by Simmer based on results of earlier studies 
(7), most of the more recent studies on LCPUFA supplementation in term infants 
failed to demonstrate effects on various aspects of cognitive development. Studies 
seemed to have sufficient power to detect relevant effects. Studies by Auestad et 
al (31;33) used a broad assessment of various tests that have been conducted at 
standardized circumstances, which are expected to be sufficiently sensitive to detect 
effects. Possible explanations for not finding effects are that doses in these studies 
were relatively low (<0.23% DHA), or that effects of LCPUFA supplementation 
appear at older ages, or that LCPUFA supplementation does not materially affect 
cognitive development. Future studies are needed to assess the effect of LCPUFA 
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supplementation on cognitive development at high dose (100 mg DHA plus 200 
mg AA) and prolonged duration (preferably 12 months); conditions under which 
significant effects on visual development were found.
Omega-3 fatty acid status and cognitive performance in older children
There are no randomized controlled trials published in literature investigating 
the potential effects of omega-3 fatty acids supplementation after the age of 
2 years on cognitive performance in children. We found one prospective Dutch 
cohort study by Bakker et al (46) assessing the relationship of DHA status at birth 
and 7 years of age with cognitive performance (K-ABC ) measured when children 
were 7 years old. No significant relationships were found. Zhang et al (47) studied 
the association between PUFA intake and psychosocial and cognitive performance 
of children aged 6-16 years in a cross-sectional analysis on data from the Third 
National Health and Nutrition Survey in the USA. Higher intake of total omega-3 
and omega-6 PUFA (10 g/day increase) was associated with better performance 
on the digit span test, but not with performance on block design, arithmetic, and 
reading comprehension tests. These data suggest that higher PUFA intake could 
be beneficial for children’s working memory. However, no data were available on 
dietary intakes of omega-3 and omega-6 fatty acids separately.
In contrast to the limited data in healthy children, there is more evidence for a 
beneficial effect of PUFA supplementation in children with diagnosed mental disorders 
and children with phenylketonuria (PKU). Three (48-50) out of five (48-52) double 
blind randomized controlled trials showed promising results of supplementation 
with a combination of omega-3 and omega-6 fatty acids on diminishing some 
behavioral symptoms in school-age children with attention-deficit hyperactivity 
disorder (ADHD). Supplementation with omega-3 fatty acids alone (DHA, EPA) 
seemed not  effective (51;52).These studies mostly failed to show any improvement 
of attention or cognitive performance in controlled conditions. Only one of the 
five studies demonstrated significant improvements of PUFA supplementation on 
spelling and reading using tests that could also be applied in healthy children (50). 
However, outcomes of this study can not be extrapolated to healthy children as 
significant diminishing of symptoms of hyperactivity and inattention are likely the 
underlying factors of improvement on spelling and reading. Children with PKU 
consume diets restricted in animal foods and therefore have a low intake of AA 
and DHA resulting in a poor LCPUFA status which may negatively influence their 
development (53). A randomized controlled and an uncontrolled trial in children 
aged 1-12 years with PKU have demonstrated that supplementation with omega-3 
fatty acids (10-15 mg DHA/kg bodyweight) improved their visual function as 
measured by VEP (54;55). Although these children were diagnosed for PKU, the 
studies suggest that visual function can be affected by DHA supplementation in 
children older than 2 years of age with a poor LCPUFA status.
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In conclusion, there are no trial data and only one prospective cohort study 
on the effect of omega-3 fatty acid supplementation on cognitive performance 
in healthy children older than two years of age. However, it remains conceivable 
that omega-3 fatty acid supplementation could be beneficial in these children, in 
particular when intake of omega-3 fatty acids is low and nutritional status is poor. 
This should be addressed in future randomized controlled trials. 
Discussion and conclusion
We reviewed the available data from randomized controlled trials that investigated 
effects on visual and cognitive development of omega-3 fatty acid supplementation 
to pregnant and lactating women, infants and children. With the exception of studies 
in term infants, the total number of randomized controlled trials on this topic is still 
very limited, especially for supplementation in older children. It is difficult to directly 
compare studies, as they assessed visual and cognitive development by many 
different outcome measures, and also had multiple differences in design that could 
influence the outcomes and interpretation. In particular, studies differed in the type 
and dose of fatty acids supplied to the intervention and control groups, duration of 
supplementation, age of subjects at cognitive assessment, and methodology used 
for assessment of cognitive outcomes. Thus, there is a large heterogeneity among 
studies. Nevertheless, we can conclude from these studies that:
• For supplementing pregnant and or lactating women with DHA, there is 
currently no supporting evidence for a beneficial effect on visual development, 
but there is suggestive evidence for a beneficial effect of supplementation 
during pregnancy and lactation or lactation only on mental development and 
on longer-term cognition.
• For supplementing preterm infants with DHA and AA, evidence for benefits 
on visual development at <6 months of age remains inconclusive, while there 
are indications from two studies for a beneficial effect of supplementation in 
early in life on cognitive development at >12 months of age.
• For supplementing term infants, with LCPUFA in high doses (100 mg DHA 
and 200 mg AA per day), there is consistent evidence for a beneficial effect 
on visual development during the first year of life, while there is hardly such 
evidence for beneficial effects on cognitive development. 
• For supplementing healthy children older than two years of age with DHA, 
there is no evidence for beneficial effect on cognitive performance. 
Although the totality of the evidence is still inconclusive, there are promising 
indications that supplementation with DHA and other omega-3 fatty acids, either 
or not in combination with omega-6 fatty acids, during pregnancy, lactation and 
infancy may benefit for visual and cognitive development early in life.
As the incorporation of DHA and AA in the developing brain is particularly high in 
the prenatal period (3;4), supplementation during pregnancy would theoretically 
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be expected to have the largest impact on visual and cognitive development of 
infants. However, the evidence from supplementation studies in pregnant women 
is currently too limited to support this notion. The benefit of DHA supplementation 
on cognition in older children has not been investigated yet, but the potential for 
beneficial effects is expected to be smaller than in younger infants or the fetus, as 
brain development and the potential incorporation of DHA becomes slower after 
the age of 2 years (56). However, it remains possible that an increased supply of 
DHA to the brain in this period results in changes in fatty acid composition of brain 
tissue or that DHA has other metabolic effects that could affect brain function (5). 
Obviously, such effects are very difficult or impossible to measure in humans.
When all intervention studies are taken together, most positive effects of the 
LCPUFA supplementation on cognitive development were detected by general tests 
of intelligence, such as the BSID. Motor function was less frequently improved 
by LCPUFA supplementation and language development may even be negatively 
affected. 
The difficulty of measuring mental development during infancy may partly explain 
why studies have yielded conflicting results. The central nervous system of infants is 
developing and therefore all the various cognitive skills have not been differentiated 
yet. Therefore, it is hard to reliably measure cognitive development at young 
ages. Methodologies should be both sensitive and both general, assessing a broad 
spectrum of cognitive functions to detect effects during early life. Measurements 
should take place in a standardized way, preferably at the same age and under the 
exact same conditions, which requires a laboratory setting. Alternatively, the effect 
of supplementation may be measured when children are older (≥3 years of age), 
when the brain is more differentiated and different test can be applied that assess 
more specific aspects of cognition. Also, new methodologies such as brain imaging 
techniques could help in future trials to detect subtle effects on brain structure and 
function (57).
The available data do not allow formulation of specific recommendations for 
optimal dosages, types, forms and ratio of omega-6 and omega-3 fatty acids for 
optimal development. Optimal brain development during infancy and childhood 
and maintenance of brain function throughout life requires an adequate and 
balanced supply of the EFA, LA and a-linolenic acid (ALA) in the diet (5;58). It is 
generally assumed that LA and ALA will at least partly be converted into DHA and 
AA, respectively. However, it is presently unclear whether conversion of dietary EFA 
is under all circumstances sufficient to meet optimal DHA and AA requirements. A 
limited number of studies in human adults show that conversion of ALA to EPA and 
DHA synthesis is only marginal (59-62), with an overall conversion rate of at most 
some 4% (63). For infants, conversion rates could be higher to cover the needs 
for brain development (30), but quantitative data on ALA conversion in infants and 
children are lacking. However, a few studies demonstrated that supplementing 
Review on omega-3 fatty acids and cognition                                                                                                                              71
preterm infants with ALA (64) improved retinal function in early life, suggesting 
that ALA is converted to such an extent that DHA content of the retina can be 
influenced. 
A relatively high ratio of omega-6 to omega-3 fatty acids in diet could theoretically 
impair the conversion of ALA to DHA in vivo (65), as ALA and LA compete for 
the same desaturation enzymes needed for the conversion of ALA to EPA and 
DHA and for conversion of LA to AA. Studies on LCPUFA supplementation and 
visual and cognitive development in children investigated effects of omega-3 fatty 
acids alone or omega-3 fatty acids in combination with omega-6 fatty acids, but 
there are no studies specifically investigating the role of omega-6 fatty acids alone 
on development and function of the central nervous system. The rationale for 
adding AA or other omega-6 fatty acids to omega-3 fatty acid supplementation is 
to prevent a decline in AA status (66) and prevent infants from possible growth 
faltering (67). Although evidence from human studies is lacking, it is believed 
that sufficient supply of omega-3 fatty acids is more important for visual and 
cognitive development and function. Therefore, it would be of value to investigate 
how mental development in infants and children may be affected by using different 
types of omega-3 fatty acids and at different omega-6:omega-3 fatty acid ratio’s 
in the diet.
More recently, research has focused on the bioavailability of DHA from diet to 
the brain. Animal studies have suggested that DHA in phospholipid form would be 
more effective in crossing blood-brain barrier compared to DHA in triglyceride form 
(68;69). In the intervention studies reviewed DHA was mostly delivered in the 
triglyceride form or a combination of both. The studies by Auestad (31;33) have 
investigated different forms of DHA but did not show beneficial effects on cognitive 
development, but dosages may have been too low.
In conclusion, there is still limited and inconsistent evidence that supplementing 
mothers, infants or children with longer chain omega-3 fatty acids (possibly with 
additional omega-6 fatty acids) can improve visual and cognitive development of 
infant or child. However, there are promising indications for effects of supplementing 
pregnant and lactating mothers with omega-3 LCPUFA on cognitive development 
of their children, that warrant further studies in these and other target groups.
Future studies should specifically address the dose, type, form and ratio of 
omega-6 and omega-3 fatty acids and duration of supplementation required for 
optimal visual and cognitive development. These studies should be designed 
with high enough statistical power to detect small but relevant effects on visual 
and cognitive function by using standardized, sensitive test methodologies for 
measuring visual function and specific cognitive abilities, and measure effects over 
a longer period of child development. New techniques for investigating nutritional 
influences on the developing brain structures, such as brain imaging techniques, 
should also be explored. 
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Abstract
Background: While undernutrition and anemia have previously been linked to 
poor development of children, relatively little is known about the role of B-vitamins 
and fatty acids on cognition.
Objective: The present study aims to explore the associations between indicators 
of body size, fatty acid and micronutrient status on cognitive performance in 598 
Indian schoolchildren aged 6-10 years.
Methods: Baseline data of a clinical study were used to assess these associations 
by analyses of variance adjusting for age, gender, school, maternal education and 
cognitive tester. The Kaufman Assessment Battery for Children II was used to 
measure four cognitive domains, including fluid reasoning, short-term memory, 
retrieval ability and cognitive speediness. Scores were combined into an overall 
measure, named Mental Processing Index (MPI). 
Results: Body size indicators and hemoglobin concentrations were significantly 
positively related to cognitive domains and MPI, such that increases of 1 SD in height-
for-age and weight-for-age z-scores would each translate into a 0.09 SD increase 
in MPI, P=0.0006 and P=0.002, respectively. A 10 g/L increase in hemoglobin 
concentrations would translate into a 0.08 SD increase in MPI, P=0.0008. Log- 
transformed vitamin B12 concentrations were significantly inversely associated with 
short-term memory, retrieval ability and MPI (β=-0.124; 95% CI: -0.224, -0.023, 
P=0.02). Other indicators of iron, iodine, folate and fatty acid status were not 
significantly related to cognition.
Conclusions: Our findings for body size, fatty acids and micronutrients are in 
agreement with previous observational studies. The inverse association of vitamin 
B12 with mental development was unexpected and needs further study.  
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Introduction
Low intakes of energy, protein and other nutrients, together with high infection 
rates and poor socio-economic status may lead to linear growth retardation and 
impaired child development (1). Cross-sectional studies have linked stunting 
(short stature for age) and low weight for age to poor development and school 
achievement in infants and children (2). The detrimental effects of undernutrition 
early in life (<2 years of age) on intellectual development seem irreversible and 
remain apparent during childhood and adolescence (3;4).
The omega-3 fatty acid DHA and the omega-6 fatty acid arachidonic acid are 
important structural components of the human central nervous system (5) and play 
a role in brain functioning through their involvement in aspects of neuron function 
and of neurotransmitter synthesis (6). These two fatty acids can be synthesized by 
the human body from the a-linolenic acid (ALA) and linoleic acid. However, dietary 
intake of the omega-3 fatty acid ALA in children is considered to be low (7;8), 
which possibly limits adequate cognitive functioning. In fact, high fish intake during 
pregnancy has been associated with better cognitive development of infants (9-
11) and maternal and infant DHA supplementation may benefit visual, motor and 
mental development of infants and young children (12-18). For healthy children 
>2 years of age such evidence is currently limited (19).
Among the micronutrients, iron and iodine interventions have been shown to 
improve intelligence scores of children (20;21). Iron is needed for the formation of 
hemoglobin for adequate oxygen transport in the human body. In the brain, iron is 
required for myelination and neurotransmitter synthesis (22). Iodine is an important 
component of the thyroid hormones, thyroxin and triiodothyronine, which play a 
major role in the growth and development, function and maintenance of the central 
and peripheral nervous system (23). For the B-vitamins, however, little research has 
been conducted to investigate whether these vitamins are of influence on mental 
development in children. Vitamin B12 (cobalamin) deficiency has been associated 
with lower scores on cognitive tests in Guatemalan (24) and Dutch (25) children. 
Folate is important for closure of the neural tube during fetal development (26), but 
no studies have investigated the role of folate on cognitive functioning in children 
after birth. In the brain, folate is required for neurotransmitter production and 
myelination (27;28). Because of the interactions with folate metabolism, vitamin 
B12 is indirectly involved in neurotransmitter synthesis. Furthermore, the vitamin 
B12 cofactors adenosylcobalamin and methylcobalamin are involved in myelination 
of the spinal cord and brain (29). 
The primary objective of the current study is to investigate the associations 
between indicators of body size, fatty acid status, and iron, iodine and B-vitamin 
status on overall cognitive performance in 598 Indian school-age children. 
Secondary, we will explore the relationships of the nutritional parameters with 
specific cognitive domains known to be sensitive to differences in nutritional 
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status in children. We hypothesize that the indicators of body size, fatty acid and 
micronutrient status (iron, iodine, folate, and vitamin B12) will be positively related 
to overall cognitive performance and specific cognitive domains.
Experimental Methods
The CHAMPION (Children’s Health And Mental Performance Influenced by 
Optimal Nutrition) study was designed to investigate the efficacy of foods fortified 
with omega-3 fatty acids and micronutrients on improving intellectual performance 
and growth in Indian schoolchildren (30). The baseline data of this study, collected 
in the period between November 2005 and February 2006, were used to assess 
the associations between height-for-age and weight-for-age z-scores, hemoglobin 
concentration and indicators of omega-3 and omega-6 fatty acid, iron, iodine, folate 
and vitamin B12 status and cognitive performance. These nutritional parameters were 
selected based on their possible relationship with children’s mental development.
Subjects
Two primary schools serving children from a poor socio-economic background in 
Bangalore city, India were selected for participation in the study. Almost all children 
living in the surrounding communities attended these schools, where they were 
taught in the local Kannada language. Before study start, parents or caretakers of 
all children aged 6-10 years, attending grades 2-5 of these schools were invited for 
a meeting during which the study procedures were explained to them. Informed, 
written consent from the parents and verbal assent from their children was obtained 
from 645 parent-child pairs. Children were included in the study if they were: 1) 
apparently healthy, without any chronic illness and physical/mental handicaps; 
2) not severely anemic (hemoglobin <80 g/L); 3) not severely undernourished 
(<-3 SD for weight-for-age (WAZ) and height for age (HAZ) z-scores of National 
Health Centre for Statistics/World Health Organization standards (NCHS/WHO) 
(31)); 4) not intending to use micronutrients supplements during the study; and 
5) planning to reside in the study area during the next 12 months. Children who 
were frequently absent from school (>40 days during 6 months prior to start of the 
study)  and children who took micronutrient supplements in the period of 3 months 
prior to the study start were excluded. A total of 598 children were enrolled in the 
study. Details on the enrolment, including a flow chart of children recruited in the 
study have been published elsewhere (30). 
Socio-demographic information
Socio-demographic information on household composition, parental education, 
income, and use of fortified foods was collected by a structured questionnaire 
which was administered to the mother or primary caretaker of the subjects. The 
age of the children was verified by the school records. 
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Cognitive performance
Cognitive performance was evaluated using age-appropriate, validated 
psychometric tests that were administered by seven masters-level psychologists in 
Kannada language. The psychologists were trained extensively during three weeks 
before the study to ensure standardization in the test administration and scoring 
procedures. The cognitive test battery was administered to each child on a single 
day over three sessions of which two took place in the morning and one in the 
afternoon. Care was taken to ensure all children had breakfast before testing began 
in the morning since omitting breakfast is known to impair cognitive performance 
(32). The cognitive test battery consisted of 11 subtests, including six core tests 
of the Kaufman Assessment Battery for Children, second edition (KABC-II) for 
children 3-18 y (pattern reasoning, triangles, rover, number recall, word order, 
atlantis) (33), two tests from Wechsler Intelligence Scale for Children-Revised 
and Wechsler Intelligence Scale for Children-4 (picture arrangement, coding) and 
three additional tests from Rey Auditory-Verbal Learning Test (auditory-verbal 
learning test), Neuropsychological Assessment tool (verbal fluency), and number 
cancellation, which was specifically designed for the study. The 11 subtests covered 
four cognitive domains as specified in Carroll’s model as described in the KABC-II 
manual (33), including fluid reasoning, short-term memory, retrieval ability and 
cognitive speediness (see Figure 1).
Picture Arrangement
Pattern Reasoning
Triangles
Rover
Number Recall
Word Order
Verbal Learning
Atlantis
Verbal Fluency
Coding
Number Cancellation (time)
Fluid Reasoning
Short-term Memory
Retrieval Ability
Cognitive Speediness
Mental Processing Index
Cognitive Tests Cognitive Domains Overall Cognitive
Performance
Figure 1. Clustering of cognitive tests in domain scores. 
Fluid reasoning involves basic processes of reasoning and other mental activities that depend only minimally on 
learning and acculturation; short-term memory is an ability that requires apprehending and holding information 
in immediate awareness briefly and then using that information within a few seconds; retrieval ability comprises 
the capacity to store information in long-term memory and to retrieve that information fluently and efficiently; 
cognitive speediness measures the ability of rapid cognitive processing of information involving attention.
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These domains were chosen because they have shown to be influenced by 
previous nutritional interventions (34). The test battery underwent an extensive 
adaptation process to ensure its suitability in the local cultural context (35). For each 
subtest, a sum score was calculated and converted into a standardized z-score. The 
domain score was composed by taking the average of standardized z-scores for the 
tests constituting a domain. The average of the domain scores named the Mental 
Processing Index (MPI) was a composite measure of overall cognitive performance 
based on the KABC-II manual (33). Our model of clustering of individual sum 
scores to form a composite score in four separate cognitive domains showed good 
validity assessed by structural equation modeling techniques (36).
Anthropometry
Anthropometric measurements were conducted in duplicate according to 
standard techniques (37) by trained research assistants. Height was recorded to 
the nearest 0.1 cm using a locally made stadiometer (Biorad, Chennai, India) that 
was fixed to a wall. Body weight was recorded to the nearest 0.1 kg using a digital 
weighing scale (Breuer, Germany). During the measurements, children wore their 
school uniform and no shoes, caps or hats. Height-for-age z-scores (HAZ) and 
weight-for-age z-scores (WAZ) were computed by data on height, weight, age and 
gender using the NCHS/WHO growth reference data (31). Children with HAZ and 
WAZ <-2 SD of this reference median were classified as stunted and underweight, 
respectively. We did not include weight-for-height z-scores, because NCHS/WHO 
reference data are lacking for children >10 years of age, which concerned 57 
children aged 10-11 years in our study.
Biochemical indicators
A whole blood sample (10 mL) was collected in the morning from non-fasted 
children by venipuncture in an EDTA vacutainer. A spot urine sample was also 
collected in a sterile plastic container, and the samples were transported to the 
laboratory on ice. Care was taken to limit the exposure of the samples to light. 
Hemoglobin concentrations were determined within 4 hours of collection using 
an AcT Diff2 Counter (Beckman Coulter Inc, Fullerton, CA, USA). One aliquot of 
whole blood for erythrocyte folate estimation was immediately treated with freshly 
prepared 1% ascorbic acid. The remaining blood was immediately centrifuged (3000 
rpm, 10 min, 4 ºC), and the plasma was stored in 2 mL eppendorf tubes at –80 ºC 
until analysis. One milliliter of erythrocytes was washed with 5 mL saline containing 
EDTA (1 L normal saline + 0.00324 g Disodium EDTA), flushed under nitrogen and 
stored at –80 ºC until analysis for fatty acid content. Serum ferritin was measured 
by an enzyme immunoassay (Access® 2 Beckman Coulter autoanalyser, Brea, 
CA, USA (38) against an external 3-level control material (WHO Standard 80/578; 
Ramco Laboratories Inc., Houston, TX, USA). Serum soluble transferrin receptor 
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(sTfR) was measured by using an enzyme immunoassay (Ramco Laboratories Inc.) 
with two-level control materials provided by the manufacturer. C-reactive protein 
(CRP) was analyzed by a turbidimetric method (Roche Hitachi 902, Indianapolis, 
IN, USA (38). Plasma vitamin B12, and red blood cell folate were analyzed using 
a Chemiluminescence System (ACS:180, Bayer Diagnostics, Tarrytown, USA 
(39;40). Fatty acid content of erythrocyte membrane phospholipids was analyzed 
using gas chromatography with a flame ionization detector (Varian 3800, Palo 
Alto, CA, USA). The procedure involved the extraction of total lipids, isolation 
of phospholipid fraction by thin- layer chromatography and transmethylation of 
phospholipids (41-43). The fatty acid methyl esters were separated by chain length 
and degree of saturation by injection onto a 50 m × 0.2 mm capillary column 
(FAME, Varian, Palo Alto, CA, USA) with nitrogen as carrier gas. Urinary iodine 
was measured using the Sandell-Kolthoff reaction as modified by Pino et al. (44). 
Satisfactory agreement in urinary iodine was obtained on urine samples at four 
different concentrations measured and the EQUIP-Network (Ensuring the Quality 
of Urinary Iodine Procedures, Centers for Disease Control and Prevention, Atlanta, 
GA). The following criteria were used to define micronutrient deficiencies: anemia: 
hemoglobin <115 g/L (45); iron deficiency: serum ferritin <15 mg/L and/or sTfR 
>7.6 mg/L (46); folate deficiency: erythrocyte folate <305 nmol/L (47); vitamin 
B12 deficiency: plasma vitamin B12 <148 pmol/L (48) and; iodine deficiency: 
urinary iodine <100 µg/L) (49).
Statistical analyses
Values for serum ferritin concentrations from subjects with elevated CRP (>10 
mg/L) were excluded from statistical analyses. Body iron stores were calculated 
from serum ferritin and sTfR concentrations using the formula by Cook et al (50). 
Differences in mean cognitive outcomes between boys and girls, schools and 
different levels of education of the mother were assessed by t-tests. Distributions 
of parameters of fatty acid status, serum ferritin and sTfR, erythrocyte folate, 
plasma vitamin B12 and urinary iodine were normalized by natural logarithm (ln) 
transformation before analysis. Associations between the nutritional parameters 
and the cognitive scores were analyzed using analysis of variance (SAS General 
Linear Modeling procedure) taking into account age, gender, school, maternal 
education level and assessor of cognitive tests as covariates. All available data 
were analyzed, missing values were not replaced. All analyses were performed 
using SAS version 9.1 statistical software package (SAS Institute Inc, Cary, NC). 
This study was conducted according to the guidelines laid down in the Declaration 
of Helsinki and all procedures involving human subjects were approved by the 
ethics committees at St John’s National Academy of Health Sciences, Bangalore, 
India and Wageningen University, the Netherlands. Written informed consent was 
obtained from the parents of all subjects and verbal assent from all subjects. 
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Verbal consent was witnessed and formally recorded.
Results
Five hundred and ninety eight children completed the baseline measurements 
on cognitive performance, anthropometry and hemoglobin concentrations. Data 
on biochemical indicators of micronutrient and fatty acid status were available for 
at least 529 and 541 children, respectively. The socio-demographic characteristics 
and nutritional status of subjects are presented in Table 1. 
Table 1. Characteristics of the study population 
Characteristic N
Sociodemographic parameters
   Gender (% males) 598 49
   Age (y) 598 8.7 ± 1.21
   Family income (Indian rupees/month) 598 2700 (2000, 3800)2
   Uneducated mothers (%) 571 45.5
Anthropometric measures
   Height (m) 598 122.9 ± 7.8
   Weight (kg) 598 21.4 ± 3.8
Erythrocyte phospholipid fatty acid status
 (% of total fatty acids (wt/wt))
   Linoleic acid 541 14.12 (13.07, 15.21)
   Arachidonic acid 541 14.61 (12.75, 16.18)
   a-Linolenic acid 541 0.21 (0.17, 0.25)
   EPA 541 0.16 (0.13, 0.20)
   DHA 541 3.21 (2.70, 3.65)
Micronutrient status
   Blood hemoglobin (g/L) 598 127.8 ± 9.9
   Serum ferritin (µg/L) 535 23.6 (14.9, 34.2)
   Serum soluble transferrin receptors (mg/L) 538 5.7 (4.9, 6.8)
   Total body iron stores (mg/kg) 535 3.22 ± 3.20
   Erythrocyte folate (nmol/L) 529 515 (371, 745)
   Plasma vitamin B12 (pmol/L) 533 197 (151, 266)
   Urinary iodine (µg/L) 542 108 (66, 200)
1 Mean ± SD (all such values).
2 Median (25th, 75th percentiles) (all such values).
Mean age of the children was 8.7 ± 1.2 years and 49% of them were boys. 
Nearly half of the mothers were uneducated and median family income was 2700 
Indian rupees per month, which is close to the poverty line of US$2 per day. 
Twenty-two percent of the children were stunted and 30% were underweight. The 
prevalence of anemia was 9%, while that of iron, folate, vitamin B12 and iodine 
deficiencies were 31%, 17%, 23% and 47%, respectively. 
Associations of covariates with cognitive performance
Age was significantly positively related with all cognitive outcomes (β=0.31; 
95% CI: 0.27, 0.35), P<0.0001 for MPI). Mean cognitive scores for boys and 
girls are presented in Table 2. Scores on the domains of retrieval ability and 
cognitive speediness, and MPI were significantly lower in boys compared to girls 
Association between nutrition and cognition                                                                                                                             85
(P<0.001). These findings did not change when scores were corrected for age 
(data not shown). There was a significant difference in performance on short-term 
memory and retrieval ability between the two schools (data not shown). Children 
of mothers with <6 y of education had significantly lower MPI scores compared to 
children of mothers with ≥6 y of education (mean ± SD were -0.05 ± 0.66 vs 0.07 
± 0.63, P=0.03, respectively).
Table 2. Cognitive domain scores for boys and girls (mean ± SD)1
Boys (n=293) Girls (n=305)
Mental Processing Index -0.09 ± 0.642 0.09 ± 0.64
Fluid reasoning 0.01 ± 0.81 -0.01 ± 0.77
Short-term memory -0.06 ± 0.92 0.05 ± 0.88
Retrieval ability -0.12 ± 0.762 0.11 ± 0.75
Cognitive speediness -0.21 ± 0.882 0.20 ± 0.83
1 Domain scores are expressed in z-scores.
2 Scores between boys and girls were significantly different, t-test P<0.001.
Associations of nutritional parameters with cognitive performance
Table 3 provides an overview of the associations between the nutritional 
parameters and the indicators of cognitive performance. Scatter plots of 
the correlations between the MPI and HAZ, WAZ, hemoglobin and vitamin B12 
concentrations are shown in Figure 2. HAZ scores were significantly positively 
related to all cognitive domains and MPI. WAZ were significantly positively associated 
with all cognitive parameters, except cognitive speediness. The associations of HAZ 
and WAZ would in theory mean that an increase of 1 SD in HAZ and WAZ would 
correspond with 0.09 SD increase in MPI, P=0.0006 and P=0.002, respectively.
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Figure 2. Scatterplots of correlations between the Mental Processing Index and height-for-age z-score (r=0.10, 
P=0.012), weight-for-age z-score (r=0.11, P=0.007), hemoglobin concentration (r=0.21, P<0.0001) and log-
transformed vitamin B12 (r=-0.09, P=0.046).
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No significant relationships were detected between linoleic acid, arachidonic 
acid, EPA and DHA and any of the cognitive parameters. a-Linolenic acid was 
significantly inversely related to the MPI, but no significant associations were 
observed with the separate cognitive domains.
Hemoglobin concentrations were significantly positively related to all cognitive 
domains and MPI. Our findings suggest that an increase of 10 g/L in hemoglobin 
concentration would translate into a 0.08 SD increase in MPI, P=0.0008. There 
was a significant inverse association between sTfR concentrations and retrieval 
ability. Other indicators of iron status were not significantly related to cognitive 
performance. Similarly, there were no significant associations between urinary 
iodine concentrations and cognitive parameters. 
In contrast, significantly inverse relationships were found between erythrocyte 
folate concentrations and fluid reasoning (β=-0.10; 95% CI: -0.19, -0.01) and short-
term memory (β=-0.11; 95% CI: -0.23, 0.02). However, when vitamin B12 status 
was added to the model, these inverse associations were not significant anymore 
for fluid reasoning (β=-0.07; 95% CI: -0.17, 0.02) and for short-term memory 
(β=-0.08; 95% CI: -0.21, 0.05)). Vitamin B12 concentrations were significantly 
inverse related to short-term memory and retrieval ability, and the MPI. These 
associations remained significant after further adjusting for hemoglobin and folate 
status and HAZ: β=-0.19; 95% CI: -0.36, -0.03 for short-term memory; β=-0.20; 
95% CI: -0.33, -0.08 for retrieval ability and; β=-0.12; 95% CI: -0.22, -0.02, 
P=0.02 for MPI). 
Discussion
This study shows that indicators of body size, HAZ and WAZ, and hemoglobin 
concentrations were significantly positively related to various cognitive domain 
scores and MPI, while plasma vitamin B12 concentrations were significantly 
inversely associated with short-term memory and retrieval ability and the MPI. 
Other indicators of iron, folate, iodine and fatty acid status were not significantly 
related to cognitive performance.
Strengths of this cross-sectional study were the availability of biochemical 
parameters of micronutrient and fatty acid status in a relatively large sample of 
>500 children from a low socio-economic background. The sample is representative 
for schoolchildren aged 6-10 years from poor socio-economic classes in Bangalore 
city and the surrounding peri-urban areas, based on a similar prevalence of 
anemia measured and similar average heights and weights in our and other studies 
conducted in children in Bangalore (51). The cognitive test battery was thoroughly 
adapted to local language and culture and showed good internal and external 
validity, which is essential to detect any associations between cognitive functioning 
and nutritional status (52). In addition, we chose to assess the cognitive abilities 
that have been shown to be influenced by nutritional interventions before (34). 
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A limitation of a cross-sectional study design is the inability for causal inference. 
Furthermore, the high number of comparisons made between nutritional and 
cognitive variables may have yielded false-positive findings (type I error). However, 
we tried to limit the number of comparisons by the use of composite scores for 
the cognitive tests. In addition, we aimed to look for patterns among our findings, 
such as the consistent positive association of HAZ with all cognitive parameters. 
Another limitation of the study was the finding that our overall model explained 
only 10%-40% of the variation in cognitive parameters. Genetic variation and 
environmental factors such as socio-emotional stimulation at home may account 
for this unexplained variation. In additional analyses we explored whether the 
interactions of age and gender with the nutritional indicators could explain any 
variation in cognitive test scores, but the results of these analyses did not yield 
further insights. 
In agreement with our findings, lower HAZ, reflecting longer term undernutrition, 
has previously been associated with poorer cognitive performance in younger (1-3 
years) (53-55) and school-age children (56-58). Moreover, intervention studies 
have demonstrated that protein-energy supplementation in young children benefits 
cognitive development on the longer term (4;58;59) and therefore an adequate 
intake of energy and protein is required for optimal development. 
Erythrocyte fatty acid status was unrelated to cognitive performance, which is in 
line with findings from a cohort study in children aged 7 years of age (60). Possibly, 
the range in fatty acid status among the children was too narrow to determine 
effects on cognition. It may also be that erythrocyte or plasma fatty acid status 
does not resemble brain fatty acid status at school age when most brain growth 
has been completed. A study in humans estimated that DHA requirements of the 
brain are rather low and the authors suggested that the liver may synthesize 
sufficient amounts of DHA to maintain brain DHA concentrations, provided that 
dietary intake of the precursor a-linolenic acid is adequate (61). Moreover, animal 
studies indicated that synthesis of DHA in the liver is enhanced and the turnover 
of DHA in the brain is reduced when diets were low in a-linolenic acid and free of 
DHA (61). Thus, intake and erythrocyte concentrations of omega-3 fatty acids may 
not be related to brain function. Besides, there is some evidence that children with 
attention-deficit hyperactivity disorders (ADHD) have lower plasma/erythrocyte 
DHA and higher linoleic and arachidonic acid concentrations than control children 
(62-65), which could be attributed to differences in fatty acid metabolism (66). 
Therefore, more research is needed to investigate whether specific subgroups of 
children may be sensitive to fatty acid interventions and whether fatty acids may 
predominantly influence certain aspects of behavior, such as attention. 
For hemoglobin, we showed a very small but significant positive relationship 
with mental performance. However, for the other parameters of iron status, no 
such relationships could be detected. Possibly, this relationship becomes only 
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apparent when iron deficiency has caused anemia, which was the case in only 6% 
of our study population. This has also been reported in a review of literature of 
observational studies showing that (iron deficient) anemic children have poorer 
cognitive development and school performance than non-anemic children, and it 
was concluded that it is unclear whether iron deficiency without anemia impairs 
mental performance (67). In contrast, iron supplementation has been shown to 
improve mental performance in children >2 years of age in (iron deficient) anemic 
as well as non-anemic children (20;21), indicating that extra iron may also be 
beneficial for development of non-anemic children. The higher cognitive scores 
with increasing hemoglobin concentrations found in our study, suggest that the 
hemoglobin level for optimal mental performance may be higher than the current 
definition of anemia (<115 g/L). 
Against our expectations, both folate and vitamin B12 were inversely associated 
with some of the cognitive domain scores. For folate these inverse relationships 
disappeared after controlling for vitamin B12 status, while for vitamin B12 the 
inverse associations with memory remained significant even after controlling 
for folate, hemoglobin and height-for-age. Our findings are in contrast with two 
earlier observational studies indicating that children with lower plasma vitamin B12 
concentrations had poorer cognitive test scores (24;25), and could be due to chance. 
In elderly, however, eight studies did not show significant associations between 
plasma vitamin B12 and cognitive test performance (68) and one study showed an 
inverse relationship (69). Our finding and the observations in elderly contradict to 
the overt clinical signs of vitamin B12 deficiency of neurological damage. Therefore, 
it has been questioned whether plasma vitamin B12 is a suitable indicator to study 
effects on cognition (68;70). It is of interest to investigate whether higher plasma 
homocysteine concentrations are related to poorer mental performance in children, 
as has been observed in elderly (68;69). In both children and adults, plasma 
homocysteine concentrations are increasing when folate and vitamin B12 intake 
are low (71) and elevated homocysteine may impair cognitive functioning through 
neurotoxic and vasotoxic effects (72). Also other indicators of vitamin B12 status, 
such as holotranscobalamin and methylmalonic acid may be worth evaluating in 
future research (70). 
In addition, we could speculate on other confounding factors that influence the 
relationship between higher plasma vitamin B12 concentrations and poorer cognitive 
performance. Possibly, consumption of animal products infected with pathogens or 
vegetables contaminated with vitamin B12–producing bacteria from manure may 
improve vitamin B12 status (73;74) and simultaneously increase the risk of disease, 
resulting in poor school attendance and impaired cognition. However, no literature 
is available to support this hypothesis. 
Despite the evidence in literature that iodine deficiency is detrimental to 
cognitive development (75) and that iodine supplementation improves cognitive 
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functioning in children (76), we failed to detect any association between urinary 
iodine concentrations and cognition, which may be due to day-to-day within subject 
variation in iodine excretion in urine (49). 
In conclusion, findings of the current study are in agreement with other 
observational studies showing that undernutrition (lower HAZ and WAZ) and 
lower hemoglobin concentrations adversely influence cognitive performance in 
school-age children, while serum ferritin and sTfR concentrations, and indicators 
of iodine, folate and fatty acid status were unrelated and an inverse association 
was found for vitamin B12 and memory. Future research is needed to elucidate the 
role of B-vitamins and homocysteine in cognitive development of children and to 
investigate whether fatty acid status at school age may be of influence on specific 
cognitive functions not measured in our study, such as attention.
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Abstract
Background: Fortification with multiple micronutrients has been shown to improve 
growth and cognitive performance among children in developing countries, 
but it is unknown whether higher concentrations are more effective than lower 
concentrations.
Objective: We compared the effect of two different concentrations of a combination 
of micronutrients and omega-3 fatty acids on indicators of growth and cognitive 
performance in low-income, marginally nourished schoolchildren in Bangalore, 
India.
Design: In a 2x2 factorial, double-blind, randomized controlled trial, 598 children 
aged 6–10 years were individually allocated to 1 of 4 intervention groups to receive 
foods fortified with either 100% or 15% of the Recommended Dietary Allowance 
of micronutrients in combination with either 900 mg a-linolenic acid plus 100 mg 
docosahexaenoic acid or 140 mg a-linolenic acid for 12 months. Anthropometric 
and biochemical assessments were performed at baseline and 12 months. Cognitive 
performance was measured at baseline and at 6 and 12 months.
Results: The high micronutrient treatment significantly improved linear growth at 
12 months (0.19 cm; 95% CI: 0.01, 0.36) and short-term memory at 6 months 
(0.11 SD; 95% CI: 0.01, 0.20) and was less beneficial on fluid reasoning at 6 (-0.10 
SD; 95% CI: -0.17, -0.03) and 12 months (-0.12 SD; 95% CI: -0.20, -0.04) than 
was the low micronutrient treatment, whereas no differences were observed on 
weight, retrieval ability, cognitive speediness, and overall cognitive performance. 
No significant differences were found between the omega-3 treatments.
Conclusions: The high micronutrient treatment was more beneficial for linear 
growth than was the low micronutrient treatment. However, with some small 
differential effects, higher micronutrient concentrations were as effective as lower 
concentrations on cognitive performance.
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Introduction
Micronutrient deficiencies are a critical concern among children in developing 
countries affecting their growth and cognitive development (1). They are 
commonly associated with the consumption of monotonous diets lacking important 
micronutrients. An effective strategy to combat these deficiencies is the fortification 
of commonly consumed foods (2). Whereas some studies of multiple micronutrient 
supplement trials in marginally nourished schoolchildren have reported increases in 
ponderal (3-6) and in linear (4) growth, others have shown no effects (7;8). Most 
studies that have assessed the effect of multiple micronutrient fortified foods on 
cognitive performance in school-age children in developing countries have shown 
beneficial effects on at least one of the cognitive performance indicators measured 
(7;9-11) or in subgroups (8;12), with the exception of one study (13). Only one 
study has thus far been conducted to investigate the different effects of various 
amounts of micronutrients on growth and intellectual performance in children. 
The authors investigated the effect of different doses of a multiple micronutrient 
tablet (50%, 100%, 200% of the Recommended Dietary Allowance (RDA)) on 
intelligence in US children aged 12-16 years, but results have been inconclusive 
(14;15). While planning food fortification programs, safety, sensory aspects and 
cost-effectiveness have to be considered and it is therefore important to know the 
effect of different concentrations of micronutrients on health outcomes (16). 
Essential fatty acids are required for optimal growth and development in children 
(17). In humans, a-linolenic acid (ALA) is converted into the long chain omega-3 
fatty acid docosahexaenoic acid (DHA), a major constituent in membranes of 
the brain and retina (18) and important for the maintenance of optimal brain 
function (19). Although there is some evidence that supplementation with DHA 
during infancy may be beneficial for cognitive development (20), such evidence is 
currently lacking for healthy children older than 2 years of age (21). In populations 
in developing countries such as in India, vitamin and mineral deficiencies (22) 
coexisting with a low intake of omega-3 fatty acids (23) could have synergistic 
adverse effects on the intellectual performance of children. We therefore sought 
to investigate the efficacy of foods fortified with either low or high concentrations 
of a micronutrient mix consisting of iodine, iron, riboflavin, vitamin B6, vitamin 
B12, folate, zinc, calcium, vitamin A and vitamin C in combination with low or high 
concentrations of omega-3 fatty acids on improving cognitive performance and 
growth in Indian schoolchildren over one year. We hypothesized that fortification 
of foods with vitamins and minerals with the addition of omega-3 fatty acids would 
act synergistically to improve cognitive function and that the higher amounts 
of micronutrients and omega-3 fatty acids would be more beneficial than lower 
amounts.
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Subjects and methods
Selection of study sites
The CHAMPION (Children’s Health And Mental Performance Influenced by 
Optimal Nutrition) study was conducted between November 2005 and March 2007 
among marginally nourished children attending two primary schools in Bangalore, 
India, which serve communities from a poor socio-economic background in the 
vicinity. The schools participated in the local Government’s subsidized lunch 
feeding program, which provided all of the children with a daily meal of cooked rice 
(250–350 g). Children attending these schools were taught in the local Kannada 
language. Before the study began, the parents of all children aged 6-10 years, who 
were attending grades 2-5 in both of the schools, were invited to attend a meeting 
at which the study procedures were explained. Written informed consent from the 
parents and verbal assent from their children were obtained (n=645 parent-child 
pairs). The protocol of the study was approved by the ethical committees at St 
John’s National Academy of Health Sciences, Bangalore, India and Wageningen 
University, the Netherlands.
Subjects
The 645 children were eligible for inclusion in the study if they were 1) apparently 
healthy, with no chronic illness or physical or mental handicaps; 2) not severely 
anemic (hemoglobin <80 g/L); 3) not severely undernourished (< -3 SD for weight-
for-age (WAZ) and height for age (HAZ) z-scores of the National Health Centre 
for Statistics/World Health Organization standards (NCHS/WHO) (24)); 4) not 
intending to use micronutrient supplements during the study; and 5) planning to 
reside in the study area during the next 12 months. Children who were frequently 
absent from school (>40 days during the 6 months before the study began) were 
also excluded. Severely anemic children received supervised treatment with oral 
iron tablets (60 mg Fe as ferrous sulfate) 4 d/wk for 12 weeks. Children with other 
illnesses were referred to a physician. In total, 645 children were screened, 47 
children of whom were not eligible because they did not fulfill the inclusion criteria 
(Figure 1) and the remaining 598 children of whom were randomly assigned into 
the study intervention groups.
Design
The study used a randomized, double-blind, controlled, 2x2 factorial design, with 
four parallel treatment groups providing 100% of the RDA (high) or 15% of the RDA 
(low) of micronutrients and/or high (900 mg ALA plus 100 mg DHA) or low (140 
mg ALA) concentrations of omega-3 fatty acids as follows: 1) high micronutrient, 
high omega-3 fatty acid treatment; 2) low micronutrients, high omega-3 fatty acid 
treatment; 3) high micronutrients, low omega-3 fatty acid treatment; and 4) low 
micronutrients, low omega-3 fatty acid treatment. All treatment groups consumed 
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two fortified products daily: a fruit flavored wheat biscuit with a creamy filling 
inside and a flavored milk powder drink providing 420 kcal and 13.5 g protein/d. 
The biscuits were manufactured by Unilever Israel (Arad, Israel) and the drinks by 
Huijbregts Group, Helmond, the Netherlands (blending) and Budelpack Poortvliet 
BV, Poortvliet, the Netherlands (packaging).
The 598 children were enrolled into the study in a phased manner in groups 
of 60-105 children every week over a 3-month period. The enrolled children also 
completed the study in the same phased manner over 3 months so that all children 
received the intervention for 12 months. Randomization was performed by means 
of a computer-generated list in blocks of eight, and the enrolled children were 
assigned intervention codes in sequence. Before randomization, baseline data for 
demography and socio-economic status, health status, cognitive and academic 
performance, dietary intake, blood hematology, blood and urine biochemistry, 
immune status and intestinal permeability were collected. 
Intervention
The high micronutrient treatment provided 100% of the RDA of iodine, iron, 
riboflavin, vitamin B6, vitamin B12, folate and vitamin A for children 7-9 years of age 
(25) (Table 1). In order to optimize the bioavailability of iron, zinc was provided at 
92% of the RDA based on a molar ratio of 2 (iron) to 1 (zinc), vitamin C at 650% 
of the RDA based on a molar ratio of 4 (vitamin C) to 1 (iron), and calcium was 
provided at 33% to minimize possible inhibition of iron absorption (26-28). The 
low micronutrient treatment delivered micronutrients per kcal proportional to that 
consumed by the children in their habitual diet (S Muthayya, 2006, unpublished 
observations). This amounted to 15% of the RDA provided in 420 kcal. The high 
omega-3 treatment provided 900 mg ALA, which is 50% of the recommended 
intake of ALA for children aged 2-12 years (29) and 100 mg DHA which corresponds 
with ~50% of the recommended fish intake for children (30). The low omega-3 
treatment provided 140 mg ALA, which is 15% of the amount provided by the high 
omega-3 treatment, and no DHA. The nutritional composition of each batch of 
intervention products was assessed before and after consumption of the products 
by Institut Kuhlmann (Analytik Zentrum Ludwigshafen, Germany) to ensure that 
designated amounts of the active ingredients were provided. 
The drink was prepared daily for each child individually, by mixing 65 g of the 
powder in 160 mL of boiled water. The fortified products in the four treatment 
groups were each assigned a specific color code, which was displayed on the 
package but were otherwise indistinguishable in color, appearance and taste. The 
investigators, assessors of cognitive tests and participants were blinded until the 
study was completed, all data were entered, and initial analyses were performed.
At the schools, the treatment assignment of the participating children was 
identified by using a color-coded personal badge. The children, in groups separated 
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by color code, consumed the products 6 d/wk at the end of the school day while 
in a large hall under the direct supervision of the study team. After consumption, 
visible leftovers of the biscuit and drink were individually estimated and the data 
recorded. Children were encouraged to consume their habitual diet during the 
intervention period. Parents were advised not to give their children any fortified 
products or dietary supplements during the intervention period. During school 
holidays that lasted >1 week, children consumed the fortified products at home, 
after clear instructions were given to their parents on how to administer the 
products to the children. Compliance during holidays was calculated on the basis 
of the number of sachets issued and returned, and self-report calendars.
Table 1. Nutritional composition of the intervention products (total/d)1
High micronutrient 
High omega-3
High micronutrient 
Low omega-3
Low micronutrient 
High omega-3
Low micronutrient 
Low omega-3
Vitamin A (µg RE) 500 500 75 75
Riboflavin (mg) 0.9 0.9 0.14 0.14
Vitamin B6 (mg) 1 1 0.15 0.15
Vitamin B12 (µg) 1.8 1.8 0.27 0.27
Folate (µg) 300 300 45 45
Vitamin C (mg)2 227.1 227.1 5.25 5.25
Calcium3 231 231 105 105
Iodine (µg) 100 100 15 15
Iron (mg) 18 18 2.7 2.7
Zinc (mg)4 10.5 10.5 1.7 1.7
Total omega-3 (g) 1.03 0.14 1.03 0.14
     ALA (g)5 0.93 0.14 0.93 0.14
     DHA (g)6 0.10 0 0.10 0
1 All intervention products contained 420 kcal, 13.5 g protein, 9.3 g fat (3.7 g omega-6 fatty acids), and 3.6 
mg of vitamin E. The high micronutrient treatment was targeted to deliver 100% of the RDA of micronutrients 
for children aged 7-9 years (25). The low micronutrient treatment provided 15% of the RDA of micronutrients 
for children aged 7-9 years (25), which was comparable with the micronutrient density of the habitual diet. The 
nutritional composition of each batch of products was analyzed before and after consumption of the products and, 
on average, met the target values. RE, retinol equivalents; ALA, a-linolenic acid; DHA, docosahexaenoic acid.
2  Vitamin C in the high micronutrient treatment was provided at 650% of the RDA based on a molar ratio of 4 
(vitamin C) to 1 (iron) in order to optimize the bioavailability of iron (27).
3 Calcium in the high micronutrient treatment was provided at 33% of the RDA to prevent inhibition of iron 
absorption (28).
4 Zinc in the high micronutrient treatment was provided at 92% of the RDA based on a molar ratio of 2 (iron) to 
1 (zinc) known to minimize the interaction between these nutrients (26). 
5  The high omega-3 fatty acid treatment delivered 50% of the recommendation for ALA for children aged 2-12 
years (29). The low omega-3 fatty acid treatment contained 15% of the amount provided by the high omega-3 
treatment.
6  The high omega-3 fatty acid treatment delivered 100 mg DHA which corresponds with 50% of the recommended 
fish intake for children (30), and the low omega-3 fatty acid treatment did not contain DHA.
Socio-demographic information
At baseline, information on household composition, parental education, 
occupation, income, housing, household possessions, languages spoken at home, 
dietary regimes (e.g. vegetarianism), and use of fortified foods was collected by a 
structured questionnaire administered to the mothers or the primary caretakers of 
the study participants. 
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Anthropometry
Anthropometric measurements were recorded in duplicate at baseline and at 6 
and 12 months according to standard techniques (31) by three trained research 
assistants, each of whom was specifically trained to measure weight, height, and mid-
upper arm circumference (MUAC). To exclude individual variation, anthropometric 
measurements were taken by the same research assistant throughout the study. 
Body weight was recorded to the nearest 0.1 kg using a digital weighing scale 
(Breuer, Germany) while the subjects were wearing their school uniforms, whereas 
height was recorded to the nearest 0.1 cm with a locally manufactured stadiometer 
(Biorad, Mumbai, India). MUAC was recorded to the nearest 0.1 cm with a plastic 
tape. The anthropometric data, age and gender of the child were used to calculate 
WAZ and HAZ by using the NCHS/WHO growth reference data (24). Children with 
WAZ and HAZ < -2 SD of this reference median were classified as underweight and 
stunted, respectively. 
Cognitive performance
Cognitive performance was evaluated at baseline and at 6 and 12 months by 
using age-appropriate, validated psychometric tests that were administered by 
masters-level psychologists in the local Kannada language. The cognitive test 
battery consisted of 11 subtests, including six core subtests of the Kaufman 
Assessment Battery for Children, second edition (KABC-II) for children 3-18 years 
(pattern reasoning, triangles, rover, number recall, word order, and atlantis) (32); 
two from the Wechsler Intelligence Scales for Children (WISC-R and WISC-4, 
picture arrangement, and coding); and three additional tests from Rey Auditory 
Verbal Learning Test (RAVLT, auditory-verbal learning test), Neuropsychological 
Assessment Tool (NEPSY, verbal fluency), and number cancellation, which was 
specifically designed for the study. The 11 subtests covered four cognitive domains 
as specified in Carroll’s model as described in the KABC-II manual (32): 1) fluid 
reasoning (pattern reasoning, picture arrangement, triangles, and rover), 2) short-
term memory (number recall and word order), 3) retrieval ability (auditory-verbal 
learning test, verbal fluency, and atlantis), and 4) cognitive speediness (number 
cancellation and coding). See supplementary material at the end of the chapter for 
details of individual tests. 
These domains were chosen because they were previously been shown to 
be influenced by nutritional interventions (33). Fluid reasoning involves basic 
processes of reasoning and other mental activities that involve solving novel 
problems by using reasoning abilities such as induction and deduction but depend 
only minimally on learning and acculturation. Short-term memory is an ability that 
requires apprehending and holding information in immediate awareness briefly 
and then using that information within a few seconds. Retrieval ability comprises 
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the capacity to store information in memory over the long-term and to retrieve 
that information fluently and efficiently. Cognitive speediness measures the ability 
of rapid cognitive processing of information involving attention. 
The test battery underwent an extensive adaptation process to ensure its 
suitability in the local cultural context (34). The qualitative procedure for this 
adaptation consisted of changing some instructions to ensure understanding, such 
as replacing some visual items when it required a high familiarity and translation-
adaptation of linguistic materials to ensuring their high familiarity. The statistical 
validation showed that the adapted test battery had good internal consistency 
and proper external validation with regard to gender and age effects. The normal 
distributions of the test scores at baseline and at 6 and 12 months indicated that 
there were no floor and ceiling effects. The conceptual validity of clustering of 
individual sum scores to form a composite score in four separate cognitive domains 
against an a priori specified model was assessed by a confirmatory factor analysis 
(structural equation modeling technique (35)) gave a Comparative Fit Index of 
0.97, which indicated good conceptual validity. 
A team of seven psychologists were trained extensively for three weeks before 
the study began to ensure standardization in the test administration and scoring 
procedures; re-training was provided as needed throughout the study period. The 
training was repeated in the week before the cognitive assessments at 6 and 12 
months. The cognitive test battery was administered to each child on a single day 
over 3 sessions. It consisted of two sessions (30 minutes each) in the forenoon, 
with a break of 15 minutes between sessions. Care was taken to ensure all children 
had breakfast before testing began in the morning, because missing breakfast is 
known to impair cognitive performance (36). The third session took place after the 
lunch break and lasted ~45 minutes. 
For each subtest, a sum score was calculated and converted into a standardized 
z-score. The domain score was composed by taking the average of the standardized 
z-scores for the tests constituting a domain. The average of the domain scores, 
termed the Mental Processing Index (MPI), was a composite measure of overall 
cognitive performance based on the KABC-II manual (32). The test scores measured 
at 6 and 12 months were converted to z-scores by using the baseline standardized 
scores as a reference.
Biochemical indicators
At baseline and at 12 months, whole blood (10 mL) was collected from 
nonfasting children by venipuncture in an EDTA vacutainer. Care was taken to limit 
the exposure of the samples to light. Hemoglobin concentrations were measured 
within 4 hours of collection using an AcT Diff2 Counter (Beckman Coulter Inc, 
Fullerton, CA, USA). One aliquot of whole blood for erythrocyte folate estimation 
was immediately treated with freshly prepared 1% ascorbic acid. The remaining 
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blood was immediately centrifuged (3000 rpm, 10 min, 4 ºC), and the plasma 
was stored in 2 mL eppendorf tubes at –80 ºC until analyzed. One milliliter of 
erythrocytes was washed with 5 mL saline containing EDTA (1 L normal saline 
+ 0.00324 g disodium EDTA), flushed under nitrogen and stored at –80 ºC until 
analyzed for fatty acid content. Serum ferritin was measured with an enzyme 
immunoassay (Access® 2 Beckman Coulter autoanalyser, Beckman, Brea, CA, 
USA (37) against an external 3-level control material (WHO Standard 80/578; 
Ramco Laboratories Inc., Houston, TX, USA). Transferrin (TfR) was measured by 
using an enzyme immunoassay (Ramco Laboratories Inc.) with 2-level control 
materials provided by the manufacturer. C-reactive protein (CRP) was analyzed by a 
turbidimetric method (Roche Hitachi 902, Indianapolis, IN, USA (37). Serum vitamin 
B12, and red blood cell folate were analyzed using a Chemiluminescence System 
(ACS:180, Bayer Diagnostics, Tarrytown, NY, USA (38;39). The fatty acid content 
of erythrocyte membrane phospholipids was analyzed using gas chromatography 
with a flame ionization detector (Varian model 3800; Palo Alto, CA, USA). The 
procedure involved the extraction of total lipids, isolation of phospholipid fraction 
by thin-layer chromatography, and transmethylation of phospholipids (40-42). The 
fatty acid methyl esters were separated by chain length and degree of saturation 
by injection onto a 50 m × 0.2 mm capillary column (Varian) with nitrogen as 
carrier gas. Anemia was defined as a hemoglobin concentration <11.5 g/dL (43). 
Iron deficiency was defined as a serum ferritin concentration <15 µg/L (25), or 
as a TfR concentration >7.6 mg/L (44). Serum ferritin values from subjects with 
elevated CRP (>5 mg/L) were excluded from the analysis. Folate and vitamin B12 
deficiency were defined as an erythrocyte folate concentration <305 nmol/L, and 
serum vitamin B12 concentration <148 pmol/L, respectively. 
Data handling and quality checks
All study forms were checked for inconsistencies and the data double-entered 
into a structured query language database by two dedicated data entry operators. 
Cognitive test forms and test scores were double checked by the psychologists 
before data entry. Discrepancies or mismatches in the data entry were corrected 
by a senior investigator. In ~20% of the subjects, random data checks between 
data on paper forms and data entered into the database were conducted.
Statistical analyses
Differences in baseline characteristics between the four intervention groups 
were analyzed by analysis of variance (ANOVA), Kruskal-Wallis H test and Chi-
square test. Effect of the high compared with the low micronutrient treatments 
and the high compared with the low omega-3 treatments, and their interaction 
were examined by using a 2 factor analysis of covariance (ANCOVA) with baseline 
cognitive scores, age and gender as covariates. To estimate the expected change 
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in cognitive performance over 12 months, we calculated the regression coefficient 
of the baseline cognitive scores with age. The difference between this expected 
change in cognitive performance scores with age and the observed improvement 
in cognitive scores at the end of the study was considered to be the effect of the 
total intervention that included the effect of intervention products together with 
expected practice effects, placebo effects, and the attention and extra medical 
care that these participating children received during the course of the study. 
A similar analysis was conducted for growth outcomes (ANCOVA and regression 
analysis) and biochemistry (ANCOVA). An a level <0.05 was considered significant. 
All analyses were performed by using SPSS version 13.0 (SPSS Inc, Chicago, IL) 
and SAS version 9.1 statistical software package (SAS Institute Inc, Cary, NC). 
Results
Of the 598 children randomly allocated into the study, 550 children completed 
the study, of whom 548 completed the cognitive assessments. The dropout rate (7-
10%) was similar among the four study groups, and the main reason for dropout 
was relocation out of the study area (see Figure 1 for other reasons for drop out). 
Baseline data available for the subjects who were lost to follow-up did not differ 
from data for those included in the present analysis (data not shown). 
The baseline profile of the study participants by treatment group is shown in 
Table 2. There were no significant differences in any of the baseline characteristics 
between treatment groups. The mean age of the children was 8.7 ± 1.2 years. 
Mean total family income was 3033 ± 1687 Indian rupees/month (equivalent to 
Table 2. Baseline characteristics of the study population1
High micronutrient 
High omega-3
High micronutrient 
Low omega-3
Low micronutrient 
High omega-3
Low micronutrient 
Low omega-3
N (% girls) 150 (53) 148 (49) 149 (48) 151 (54)
Age (y) 8.7 ± 1.12 8.7 ± 1.2 8.7 ± 1.2 8.7 ± 1.1
Education level of the mother
(% no education)
50 45 48 40
Family income (rupees/month) 3230 ± 1956 3182 ± 1871 3000 ± 1528 2723 ± 1281
Stunting (% < -2SD HAZ) 18 22 22 29
Underweight (% < -2SD WAZ) 27 30 28 39
Anemia (hemoglobin <11.5 g/
dL) 15/150 (10.0)
 3 15/148 (10.1) 9/149 (6.0) 15/151 (9.9)
Iron deficiency 
(serum ferritin <15 mg/L and/
or serum transferrin receptor 
>7.6 mg/L)
38/139 (27.3) 50/132 (37.9) 42/132 (31.8) 36/134 (26.9)
Folate deficiency
(erythrocyte folate <305 
nmol/L)
17/137 (12.4) 25/134 (18.7) 22/136 (16.2) 26/132 (19.7)
Vitamin B12 deficiency 
(serum cobalamin <148 
pmol/L)
37/138 (26.8) 31/133 (23.3) 31/133 (23.3) 26/129 (20.2)
1 There were no significant differences between the 4 groups.
2 Mean±SD (all such values).
3 n deficient/n total (% deficient) (all such values).
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Table 3. Effects of treatment on biochemical indicators of micronutrient and omega-3 fatty acid status over 12 
months1
Intervention group
Treatment effect after 12 
months2
High 
micronutrient 
High omega-3
High 
micronutrient 
Low omega-3
Low 
micronutrient 
High omega-3
Low 
micronutrient 
Low omega-3
High vs low 
micronutrient
High vs low 
omega-3
Blood hemoglobin (g/dL)
n 138 134 139 140
Baseline 12.7 ± 1.03 12.7 ± 1.0 12.9 ± 0.9 12.7 ± 1.0 0.40
(0.28, 0.52)
-0.02
(-0.14, 0.10)12 months 13.6 ± 0.8 13.7 ± 0.8 13.4 ± 0.9 13.2 ± 1.0
Serum ferritin (µg/L)
n 127 120 118 123
Baseline 23.9  (15.6, 35.5)4
21.9 
(12.9, 31.4)
25.9 
(16.7, 38.7)
24.1 
(14.9, 1.7) 0.79 
(0.71, 0.86)
0.07 
(-0.01, 0.14)
12 months 48.2  (36.2, 61.2)
47.5  
(35.2, 60.8)
25.3 
(18.5, 35.9)
21.7 
(14.4, 0.6)
Serum transferrin receptor (mg/L)
n 128 116 121 124
Baseline 6.1 ± 2.1 6.2 ± 2.3 6.1 ± 1.7 6.1 ± 2.1 -0.74
(-1.00,-0.51)
0.02
(-0.22, 0.24)12 months 5.3 ± 1.3 5.5 ± 1.4 6.2 ± 1.6 6.1 ± 2.3
Body iron stores (mg/kg)5
n 122 108 112 116
Baseline 3.3 ± 3.2 2.7 ± 3.4 3.6 ± 2.7 3.1 ± 3.2 3.25
(2.93, 3.57)
0.15
(-0.17, 0.47)12 months 6.5 ± 1.8 6.2 ± 1.7 3.6 ± 2.6 3.0 ± 3.1
Red blood cell folate (nmol/L)
n 127 120 125 121
Baseline 562 ± 261 618 ± 395 616 ± 351 558 ± 335 348
(310, 386)
19
(-20, 57)12 months 1075 ± 268 1058 ± 279 732 ± 233 697 ± 239
Serum vitamin B12 (pmol/L)
n 127 119 120 120
Baseline 229 ± 121 217 ± 101 234 ± 116 213 ± 102 116
(94, 138)
6
(-16, 27)12 months 389 ± 171 378 ± 165 283 ± 161 253 ± 136
Total omega-3 (% of total fatty acids)
n 125 119 123 124
Baseline 3.6 ± 0.8 3.6 ± 0.9 3.6 ± 1.0 3.9 ± 2.6 -0.04
(-0.23, 0.15)
1.68
(1.48, 1.87)12 months 5.7 ± 1.3 4.1 ± 0.8 5.8 ±1.2 4.1 ± 1.1
ALA (% of total fatty acids)
n 125 119 123 124
Baseline 0.25 ± 0.18 0.25 ± 0.16 0.26 ± 0.17 0.26 ± 0.17 0.01
(-0.01, 0.02)
0.01
(-0.00, 0.03)12 months 0.23 ± 0.10 0.22 ± 0.08 0.23 ± 0.09 0.21 ± 0.07
EPA (% of total fatty acids)
n 125 119 123 124
Baseline 0.17 ± 0.07 0.17 ± 0.08 0.18 ± 0.10 0.18 ± 0.07 -0.02
(-0.05, 0.01)
0.11
(0.08, 0.14)12 months 0.35 ± 0.16 0.25 ± 0.14 0.39 ± 0.19 0.26 ± 0.18
DHA (% of total fatty acids)
n 125 119 123 124
Baseline 3.2 ± 0.7 3.2 ± 0.8 3.2 ± 0.9 3.3 ± 0.9 -0.03
(-0.21, 0.15)
1.55
(1.36, 1.73)12 months 5.2 ± 1.2 3.6 ± 0.8 5.2 ± 1.2 3.6 ± 1.0
1 Fatty acids were measured in erythrocytes membranes in the phospholipid fraction. ALA, a-linolenic acid; DHA, 
docosahexaenoic acid; EPA, eicosapentaenoic acid. There was no significant interaction between the micronutrients 
and the omega-3 fatty acids.
2 Treatment effects estimated by ANCOVA adjusted for baseline values, gender, and age; 95% CIs in parentheses.
3 Mean ± SD (all such values).
4 Median; 25th, 75th percentile in parentheses; data were log-transformed to perform the ANCOVA, actual values 
and are presented.
5 Total body iron stores were calculated based on Cook et al (45).
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US$78). Approximately half of the mothers were uneducated. Thirty percent of 
the children were underweight and 21.8% were stunted. The overall prevalence of 
anemia, iron, folate and vitamin B12 deficiencies were 9.0%, 30.9%, 16.7% and 
23.5%, respectively. Compliance with the consumption of intervention products 
averaged 75% for the biscuits and 70% for the drinks, with no differences between 
the four treatment groups.
Biochemical indicators
The concentrations of micronutrients and omega-3 fatty acids at baseline 
and after 12 months of intervention are presented in Table 3. The increases in 
hemoglobin, ferritin, body iron stores, vitamin B12 and folic acid concentrations in 
the high micronutrient groups were significantly larger than the changes in the low 
micronutrient treatment groups (all P<0.001). Increases in erythrocyte membrane 
concentrations of ALA, eicosapentaenoic acid (EPA), DHA and total omega-3 fatty 
acids in the high omega-3 treatment groups were significantly higher than the 
changes in the low omega-3 treatment groups (all P<0.001). Consequently, after 
12 months of intervention, the prevalence of anemia, iron, folate and vitamin B12 
deficiencies dropped significantly more in the high micronutrient groups (data not 
shown).
Growth
All the four treatment groups showed similar, significant improvements in weight, 
height and MUAC after 12 months of intervention, when compared to their baseline 
values (Table 4). After 12 months of intervention, the high micronutrient treatment 
was more beneficial for linear growth than the low micronutrient treatment (2 mm, 
P=0.05). There were no differences between the two micronutrient treatments for 
weight and MUAC. Similarly, no differences were found between the high and the 
low omega-3 fatty acid treatments and there was no interaction of the micronutrient 
Table 4. Treatment effects on indicators of growth over 12 months1
Intervention group
Treatment effect after 12 
months2
High 
micronutrient 
High omega-3 
(n=138)
High 
micronutrient 
Low omega-3 
(n=133)
Low 
micronutrient 
High omega-3 
(n=139)
Low 
micronutrient 
Low omega-3 
(n=140)
High vs low 
micronutrient 
High vs low 
omega-3 
Height (cm)
Baseline 123.1 ± 7.73 122.7 ± 8.1 123.0 ± 7.8 123.0 ± 8.3 0.19
(0.01,0.36)
-0.05
(-0.22,0.13)12 months 129.3 ± 7.8 129.0 ± 8.2 129.0 ± 7.8 129.0 ± 8.5
Weight (kg)
Baseline 21.5 ± 3.6 21.3 ± 3.7 21.6 ± 4.0 21.4 ± 4.1 0.16
(-0.09,0.41)
-0.002
(-0.25,0.24)12 months 25.2 ± 5.1 25.2 ± 5.3 25.4 ± 5.6 24.9 ± 5.4
MUAC (cm)
Baseline 17.1 ± 1.4 17.0 ± 1.3 17.1 ± 1.6 17.0 ± 1.7 0.05
(-0.08,0.19)
-0.03
(-0.17,0.11)12 months 17.7 ± 2.0 17.8 ± 1.9 17.8 ± 2.1 17.6 ± 2.0
1 There was no significant interaction between the micronutrients and the omega-3 fatty acids.
2 Treatment effects estimated by ANCOVA adjusted for baseline values, gender, and age; 95% CIs in parentheses.
3 Mean ± SD (all such values).
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and omega-3 fatty acid treatments on any of the anthropometric parameters. For 
the total group, the prevalence of stunting and underweight decreased significantly 
from baseline, from 21.8 to 16.0% (P<0.001) and from 30.0 to 18.6% (P<0.001), 
respectively, but this decrease did not differ significantly between the four groups.
Cognitive performance
All groups showed a significant improvement in short-term memory, retrieval 
ability, fluid reasoning and cognitive speediness and the MPI compared with 
baseline (see Table 5). The gain in the MPI score was significantly higher than 
the expected improvement after 12 months (Figure 2), which was calculated by 
the regression coefficient of the baseline cognitive scores with age. Similarly, the 
scores on the four cognitive domains increased more than expected based on 
the baseline data (data not shown). The high micronutrient treatment was more 
beneficial than was the low micronutrient treatment, for short-term memory at 
6 months (effect size 0.11, P=0.025), but this effect was no longer evident at 
12 months. The low micronutrient treatment was more beneficial than the high 
micronutrient treatment for fluid reasoning at both 6 months (effect size 0.10, 
P=0.004) and 12 months (effect size 0.12, P=0.004). There were no significant 
differences between the high and the low omega-3 fatty acid treatment and no 
interactions between the micronutrient and omega-3 fatty acid treatments on any 
of the cognitive measures. 
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Figure 2. Effect of the intervention on Mental Processing Index (MPI) after 12 months compared to the effect 
expected from a regression model of MPI scores and age at baseline. 
Bars represent improvement in MPI score after 12 months from baseline corrected for age, gender and baseline 
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MPI score with 95% CI. Horizontal line with 95% CI represents the expected improvement in MPI score calculated 
by the regression coefficient of the baseline cognitive scores with age.
Discussion
Our study was designed to investigate the effect of two different concentrations 
of a combination of micronutrients and omega-3 fatty acids on growth and cognitive 
performance of marginally nourished school-age children. We showed that the 
high micronutrient treatment was more beneficial for linear growth at 12 months 
and for short-term memory at 6 months, but that the low micronutrient treatment 
was more beneficial for fluid reasoning at 6 and 12 months. The high and low 
micronutrient treatments had similar effects on changes in body weight, MUAC 
Table 5. Treatment effects on cognitive performance over 6 and 12 months1
Intervention group
Treatment effect
after 6 and 12 months2
High 
micronutrient 
High omega-3 
(n=137)
High 
micronutrient 
Low omega-3 
(n=133)
Low 
micronutrient 
High omega-3 
(n=139)
Low 
micronutrient 
Low omega-3 
(n=138)
High vs low 
micronutrient 
High vs low 
omega-3 
MPI
Baseline -0.01 ± 0.673 0.00 ± 0.66 0.01 ± 0.63 0.02 ± 0.64
6 months 0.29 ± 0.31 0.31 ± 0.29 0.32 ± 0.26 0.30 ± 0.27
-0.01
(-0.06, 0.03)
0.00
(-0.04, 0.05)
12 months 0.62 ± 0.32 0.63 ± 0.32 0.65 ± 0.30 0.64 ± 0.31
-0.02
(-0.07, 0.03)
0.00
(-0.05, 0.05)
Short-term memory
Baseline 0.08 ± 1.04 -0.02 ± 0.85 -0.02 ± 0.82 -0.03 ± 0.87
6 months 0.13 ± 0.66 0.21 ± 0.55 0.12 ± 0.57 0.04 ± 0.58
0.11
(0.01, 0.20)
0.01
(-0.08, 0.11)
12 months 0.42 ± 0.60 0.43 ± 0.54 0.37 ± 0.66 0.38 ± 0.65
0.06
(-0.04, 0.16)
0.00
(-0.10, 0.10)
Fluid reasoning
Baseline -0.06 ± 0.71 0.02 ± 0.82 0.02 ± 0.81 0.04 ± 0.81
6 months 0.39 ± 0.43 0.36 ± 0.40 0.48 ± 0.45 0.48 ± 0.42
-0.10
(-0.17, -0.03)
0.01
(-0.06, 0.08)
12 months 0.72 ± 0.48 0.70 ± 0.45 0.84 ± 0.51 0.82 ± 0.47
-0.12
(-0.20, -0.04)
0.02
(-0.06, 0.10)
Retrieval ability
Baseline -0.04 ± 0.79 0.04 ± 0.80 0.01 ± 0.73 0.00 ± 0.74
6 months 0.25 ± 0.55 0.28 ± 0.49 0.32 ± 0.47 0.29 ± 0.53
-0.03
(-0.11, 0.04)
0.00
(-0.08, 0.08)
12 months 0.55 ± 0.59 0.59 ± 0.60 0.60 ± 0.51 0.58 ± 0.56
-0.02
(-0.11, 0.06)
-0.02
(-0.10, 0.07)
Cognitive speediness
Baseline -0.01 ± 0.88 -0.05 ± 0.89 0.02 ± 0.89 0.05 ± 0.87
6 months 0.37 ± 0.54 0.38 ± 0.55 0.37 ± 0.61 0.39 ± 0.57
-0.01
(-0.10, 0.07)
-0.01
(-0.09, 0.08)
12 months 0.80 ± 0.61 0.81 ± 0.57 0.79 ± 0.56 0.76 ± 0.59
0.02
(-0.06, 0.11)
0.02
(-0.06, 0.11)
1 MPI, Mental Processing Index. There was no significant interaction between the micronutrients and the omega-3 
fatty acids.
2 Treatment effects estimated by ANCOVA adjusted for baseline values, gender, and age; 95% CIs in parentheses.
3 Mean ± SD (all such values).
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and cognitive functions such as, retrieval ability, cognitive speediness, and the 
MPI. No significant differences between the omega-3 treatments were observed 
for growth and cognitive performance. The effects observed did not depend on 
maternal education and degree of compliance with consumption of the intervention 
products.
The strengths of our study were the low attrition rate, adequate consumption 
of the intervention products and significant increases in biochemical indicators 
for micronutrients and omega-3 fatty acids in the high micronutrient and high 
omega-3 groups, respectively. The study was sufficiently powered to detect very 
small but significant effects of the intervention on growth (2 mm) and cognitive 
performance (0.10-0.12 SD).
One of the limitations of the study design was the lack of a real placebo group 
in the study. It was, however, considered unethical to provide substantial amounts 
of energy and protein foods devoid of essential micronutrients over a prolonged 
period. Inclusion of a placebo group would have enabled us to disentangle the 
effect of micronutrients from that of omega-3 fatty acids on study outcomes. On 
the basis of the records kept on the diets of the study children, it was clear that 
the children maintained their regular intake and that the study products did not 
replace their meals (data not shown). This resulted in two design disadvantages: 
1) all children in all four treatment groups received substantial amounts of energy 
and protein in addition to their habitual diet, which may have contributed to the 
improvements in growth and cognitive performance (46), and 2) children in the 
low micronutrient groups received 15% of the RDA of micronutrients, which, for 
some micronutrients, was 50% more than the amount consumed in their poor 
habitual diets, which may have resulted in a larger than expected effect on growth 
and cognitive outcomes in the low micronutrient groups. 
We showed a small but significant effect of the high micronutrient treatment 
on height, but not weight and MUAC, which is likely to be attributed to synergetic 
effects of the micronutrients, and the presence of zinc (47). Only one placebo-
controlled study that provided micronutrients at 35% of the RDA demonstrated 
significant positive effects on linear growth in schoolchildren (4), whereas others 
providing micronutrients at 30-100% of the RDA showed trends towards a positive 
effect (3;5-7). At 12 months, all intervention groups showed significant increases in 
body weight (3.7 kg) and height (6.1 cm) compared with baseline, which exceeded 
the increase expected from Indian growth norms (2.4 kg and 5.5 cm, respectively) 
(48). This may have been partly attributed to the additional 40% energy and 50% 
protein in the intervention products, because deficiencies of energy and protein 
have long been known to impair linear growth (49;50). The finding that all children 
grew more than expected is in line with the findings of the placebo-controlled 
trials that showed positive effects of micronutrients on growth (3-7). However, we 
cannot conclude whether the improvements in growth in all four groups were due 
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to the extra protein and energy or to the micronutrients. 
The significantly higher increases in cognitive scores than expected by growing 
one year older could have been the effect of extra energy, protein and micronutrients; 
however our study design does not allow us to distinguish the micronutrient effect 
from the protein and energy effect. Also extra attention and (medical) care by 
the study staff may have had an effect on the children’s cognitive performance as 
care-giving and adequate environmental stimulation are known to be important for 
optimal intellectual development (51). In addition, training effects of performing 
cognitive tests repeatedly at 6 and 12 months may have had  an influence on 
cognitive performance, but the size of these effects are mostly unknown, except 
for short-term memory where no practice effects are expected (52).
Whereas the high micronutrient treatment was more beneficial for short-term 
memory than was the low micronutrient treatment, it was less beneficial for fluid 
reasoning. The effect sizes were extremely small, and we have no satisfactory 
explanation for the findings on fluid reasoning. We speculate that a type I error 
or an imbalance in the micronutrient status occurred in the high micronutrient 
treatment group, as high doses of iron and zinc may influence the absorption of 
other minerals such as copper (53). However, an analysis of covariance with the 
biochemical status of micronutrients at the end of the intervention as covariate 
confirmed that the micronutrient status had no influence on fluid reasoning. We 
therefore conclude that, overall, there was no difference in cognitive performance 
between the high and low micronutrient treatment groups. This is in agreement 
with a previous study in US children that investigated the effect of multiple 
micronutrient tablets supplying 50%, 100% and 200% of the RDA on intelligence 
which showed no difference between the three doses (14;15). Regardless of the 
amount of micronutrients, there is evidence from six studies that food fortification 
with multiple micronutrients benefits cognitive performance in marginally nourished 
schoolchildren, which suggests that a lower dose (30-50% of the RDA) (7;11) may 
be as effective as a higher dose (100% of the RDA) (8-10;12).
We found no differences between the low omega-3 treatment and the high 
omega-3 treatment on any of the growth and cognitive performance outcomes, 
despite significant increases in biochemical indicators. Our results agree with an 
earlier study in 7-10 year-old children in Indonesia and Australia, which failed to 
show any significant effect of 110 mg EPA + DHA on cognitive performance (12). 
In contrast, in a study involving only children with neurodevelopmental disorders, 
positive effects on attention and learning were observed after an intake of 250-500 
mg EPA + DHA (54-57). Possibly, the cognitive domains assessed in our study may 
not be affected by DHA supplementation, or the concentrations used in our study 
may have been too low. It is currently unknown whether additional dietary DHA 
may improve cognition in children at all, because humans are able to synthesize 
DHA from ALA and there is currently no evidence whether low intakes of DHA will 
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impact physical functioning in healthy children (30). On the basis of all evidence 
combined, it is currently too premature to either accept or dismiss a benefit of DHA 
on cognitive performance in schoolchildren. More research is required to clarify 
such.
In conclusion, compared with a lower concentration of micronutrients (15% of 
the RDA), our study showed that a higher concentration of micronutrients (100% 
of the RDA) was more beneficial for linear growth and had differential effects on 
two of the four cognitive domains, whereas there were no differences on ponderal 
growth and overall cognitive performance. These findings suggest that lower 
concentrations of micronutrients might be as effective as higher concentrations 
for some, but not all, health outcomes in school-age children living under deprived 
conditions. Further research is recommended to identify the optimal amount of 
micronutrients for growth and cognitive performance and to identify the specific 
cognitive domains sensitive to nutrient interventions.
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Supplementary material
Description of cognitive test battery
Cognitive 
domain
Indivivual 
test Description of test
Fluid 
reasoning
Picture 
arrangement
This test presents four pictures to be arranged in an order predicted by social 
conventions. The pictures are presented in a random order; the child has to put 
them back in the correct order. This test evaluates some aspects of the inductive 
reasoning. It requires the child to analyze the cues provided in complex pictures and 
induce the issues, the development and the solution to a problem or the outcome 
of a scenario.
Pattern 
reasoning
The principle of this test is to present a series of drawings (objects, animals, plants…) 
organized according to a certain pattern (AAAA; ABAB;…). One drawing is missing 
in the series, symbolized by a “?”. The series is followed by 4 drawings among 
which the child must choose one to make the first series complete. This subtest 
measures inductive reasoning. It requires that the child induces the underlying rules 
organizing the series. This process requires also planning abilities because the child 
has to ‘try’ (visualize mentally) one answer, check what would be the series if the 
answer was a certain one; then conclude whether his answer is correct or not; and 
if not try another solution, etc.
Triangles The child is given simple and abstract geometric shapes of primary colors (red, blue, 
yellow). The child is required to produce new shapes based on models provided by 
the assessor. The complexity of the models augments progressively. The accuracy 
and the production time are recorded. This test evaluates visual processing (or 
simultaneous processing). It requires planning abilities and is fairly correlated with 
general intelligence.
Rover “Rover” is the name of a dog that is placed on a small ‘chess board’ with ‘obstacles’ 
represented on it. The dog has to go to his “bone” by jumping on a minimum amount 
of squares to jump in. A short training takes place to explain to the child how to move 
the dog and how to count the points it takes for him to reach his bone. New rules 
are progressively introduced during the test. It is therefore a complex test requiring 
planning abilities and counting abilities. The test is a measure of simultaneous 
processing abilities because the information is provided simultaneously.
Short-term 
memory
Word order In the subtest word order, a series of frequent and concrete words are read aloud by 
the assessor. The child is presented with a series of picture and has to point out the 
pictures in the same order in which they were mentioned to him. This test measures 
short-term memory: it provides a measure of the memory span of the child. This 
concerns verbal memory with meaningful content; the fact that the answers are 
given by pointing instead of verbally (repetition) should minimize possible effects of 
language production difficulties.
Number 
recall
The principle is to present a series of digits which the child has to repeat in the 
same order (“1-6-4” => “1-6-4”) immediately after hearing the last digit of the 
series. The second part of the test consists of asking the child to repeat the digits in 
the reverse order (“9-2-4” = “4-2-9”); this is “number backward” condition.  Digit 
span in general measures auditory short-term memory, sequencing skills, attention 
and concentration. The first part of the test, the forward recall, evaluates short-
term memory. The digit Span Backward in particular involves working memory, 
transformation of information and mental manipulation, and according to some 
authors, visual-spatial imaging.
Retrieval 
ability
Atlantis The principle of the test is to present pseudo words to children and ask them to 
remember them in a recognition task. Children are presented with an imaginary sea 
animal and are given its name (“Tra”); then a series of sea animals are presented 
and the child has to find out “Tra”. More and more pseudo words are introduced 
progressively and the child has to point out several of them. The test evaluates the 
learning abilities of the children in the long-term on verbal non-meaningful (new) 
information. This is a recognition test and no verbal production is expected from 
the child.
Verbal 
fluency
In verbal fluency tests, the child is required to retrieve as many words as possible with 
specific properties. We asked them to retrieve as many names of animals as possible 
(“cow, goat, dog…”). We repeated the test with different instruction, replacing the 
animal names by first names. The scores are the number of names given by the 
child for both tests. This test measures the ability to retrieve information.
RAVLT The administration of the RAVLT consists into reading a list of 15 unrelated, concrete 
nouns aloud and ask for a free recall (‘free” means here that the order has no 
importance). There were three recall trials given in the short-term, and one after 20 
min for the delayed recall. Three lists of words were created for repeated measures at 
baseline, 6 and 12 months. The score on the delayed recall was taken into statistical 
analyses. This test evaluates long-term memory and retrieval ability of the child.
Cognitive 
speediness
Number 
cancellation
Long series of digits ranging from 1 to 5 were presented in random order. Children 
had to cross systematically 2 digits (3 and 5 for example). This task activates 
sustained attention as well as selective attention.
Coding In this test, the child copies symbols that are paired with numbers. Using a key, the 
child draws each symbol in its corresponding shape or box within a specified time 
limit. This test involves visual-motor processing speed, but also short-term memory, 
learning ability, visual perception, visual-motor coordination, visual scanning ability, 
cognitive flexibility, attention and motivation.
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Abstract
Objective: This study aimed to investigate the associations between diet, including 
energy, protein and polyunsaturated fatty acid (PUFA) intake and micronutrient 
adequacy, and indicators of body size and cognitive performance in children.
Subjects/Methods: Baseline data of a clinical study in 598 children aged 
6-10 years living in the urban slums of Bangalore, India were used to explore 
relationships between energy and nutrient intake, anthropometry and cognitive 
performance using analyses of variance adjusted for several confounding factors. 
Dietary intake was measured by a 24-h recall administered to both mother and 
child. The Kaufman Assessment Battery for Children II was used to measure mental 
performance.
Results: Most children had a diet inadequate with regard to energy (98%), total 
fat (100%), PUFA (91%) and micronutrients (85%). Energy intake was positively 
associated with body size and cognitive performance, with (borderline) significant 
linear trends for height (P=0.03), weight (P=0.01), mid-upper arm circumference 
(P=0.10) and cognition (P=0.09). Total PUFA intake was positively related to 
cognitive performance (P=0.06), but not to body size. Intakes of protein and 
a-linolenic acid and adequacy of micronutrients were not significantly linked to 
anthropometric and cognitive measurements.
Conclusions: Our findings indicate that diets of Indian children from a poor socio-
economic background were monotonous and dramatically low in energy, fat, PUFA 
and micronutrients. Introduction and/or expansion of school feeding programs and 
micronutrient interventions are urgently required in order to increase the energy 
and nutrient intakes to support children’s growth and development.
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Introduction
Nutritional deficiencies are a major problem among children in developing 
countries, in particular among those living in Africa and Asia (1). While the problem 
of undernutrition is most severe in children <5 years of age, also a significant 
number of older children are affected by micronutrient deficiencies. In India, 
approximately 40% of the schoolchildren suffer from iron deficiency (1), 23% 
from vitamin A deficiency (2) and 4% of 6-12 year-old children have goiter (3). 
Poverty and consumption of monotonous diets appear to be underlying causes 
of inadequate intakes of energy and micronutrients and subsequent nutritional 
deficiencies (4). Data on dietary intake patterns of families living in urban India 
are limited, and specific data for school-age children are lacking. The last national 
survey, conducted in 1993-1994 in families living in slums areas in India, showed 
that intakes of energy, iron, calcium, vitamin A and B-vitamins were below the 
Indian Recommended Dietary Allowances (RDA) (5). 
Malnutrition has important consequences on children’s physical growth and 
cognitive development. Studies have shown that deficits in energy, protein, fat, 
zinc and other micronutrient intake increase the risk of growth faltering and result 
in stunting (6-9). Protein-energy malnutrition (10) and micronutrient deficiencies 
(11) may also lead to impaired mental development. In school-age children, there 
is evidence from placebo-controlled intervention studies for an essential role of 
iodine and iron in intellectual development, while research on B-vitamins, zinc 
and omega-3 fatty acids and cognition is limited and inconclusive (11). Very few 
and relatively small studies have linked dietary intake of energy, protein, fat and 
micronutrients to cognitive performance in school-age children (12;13).
The objective of this paper was to investigate the associations between diet, 
including energy, protein and polyunsaturated fatty acid (PUFA) intake and 
micronutrient adequacy, and indicators of body size and cognitive performance in 
Indian schoolchildren. We hypothesized that intakes of energy, protein, PUFA and 
micronutrients would be positively related to anthropometric measurements and 
cognition. 
Subjects and Methods
Baseline data collected in the period of November 2005 - February 2006 of 
the Children’s Health And Mental Performance Influenced by Optimal Nutrition 
(CHAMPION) study were used to investigate energy and nutrient intake and their 
association with indicators of body size and cognitive performance. The study was 
designed to investigate the efficacy of foods fortified with omega-3 fatty acids 
and micronutrients on improving intellectual performance and growth in Indian 
children (14). The study protocol was approved by the ethics committees at St 
John’s National Academy of Health Sciences, Bangalore, India and Wageningen 
University, the Netherlands.
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Subjects
The study was conducted at two primary schools serving children from a poor 
socio-economic background in Bangalore city, India. All children aged 6-10 years, 
attending grades 2-5, were selected for participation in the study. Informed, written 
consent from the parents and verbal assent from their children was obtained from 
645 parent-child pairs. In- and exclusion criteria have been described elsewhere 
(14). A total of 598 children were enrolled in the study. 
Socio-demographic information
Socio-demographic information on household composition, parental education, 
income, and use of fortified foods was collected by a structured questionnaire 
which was administered to the mother or primary caretaker of the subjects. 
Dietary intake
Dietary intake of each child was assessed using the 24-h dietary recall method 
by interviewing both the child and the child’s mother or caretaker, individually, on 
separate occasions within the same week. Standard household measures of known 
volume were used during the recall to quantify the portion size of food items. The 
dietary recall by the mother or caretaker was taken as the basis for the child’s 
dietary intake and completed with additional food items reported by the child (which 
were mostly foods consumed out of home). Nutrient intakes were associated with 
biochemical indices (methods for biochemistry have been described elsewhere 
(14)). Correlation coefficients found were: between folate intake and erythrocyte 
folate r=0.08 (P=0.056); between vitamin B12 intake and plasma vitamin B12 
r=0.11 (P=0.009); between iron intake and blood hemoglobin r=0.03 (P=0.49), 
serum ferritin r=-0.01 (P=0.74), and serum transferrin receptor r=0.04 (P=0.38); 
between iodine intake and urinary iodine concentrations r=-0.05 (P=0.27); and 
between intake of eicosapentaenoic acid (EPA) plus docosahexaenoic acid (DHA) 
and erythrocyte DHA fatty acid concentrations r=0.02 (P=0.70).
Energy and nutrient intakes were calculated using a nutrient database which 
was specifically composed for poor socio-economic populations in Bangalore. 
For development of the database, raw ingredients for each recipe were weighed, 
and volume to weight conversions measured for each cooked food item was 
obtained. Nutrient composition of the food items were calculated using standard 
food conversion tables for Indian foods (15) and USDA nutrient database (16). 
Ingredients of different foods items were categorized into different food groups. 
Energy and macronutrient intakes were compared to WHO/FAO recommendations 
for energy (moderate activity) (17), protein (per kg body weight) (18) and total 
fat and fatty acids (19). 
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Probability of adequacy for micronutrients
The probability of adequacy (PA) for intake of micronutrients with a normal 
distribution was calculated by using the PROBNORM function in SAS on the difference 
of the reported micronutrient intake and Estimated Average Requirement (EAR) 
divided by the standard deviation (SD) of the EAR (20). EARs were calculated from 
RDA for vitamins and minerals by WHO/FAO (21). SDs of EARs were computed 
based on coefficients of variation for intakes of micronutrients by the Institute of 
Medicine’s Dietary Reference Intake reports (22;23). For zinc, the recommendation 
for a low bioavailability diet was used.
 For iron intake, which has a skewed distribution, the PA was computed 
according to methods described by Allen et al (1), using published tables for a 5% 
bioavailability of iron. For calcium intake, no EAR was available and the Adequate 
Intake (AI) has been used to calculate the PA as described by Foote et al (24). The 
Mean Probability of Adequacy (MPA) of micronutrients was defined as the average 
of the PA’s for 13 micronutrients in which PA’s ≥100% were set at 100%. 
Anthropometry
Anthropometric measurements were conducted in duplicate according to 
standard techniques (25). Height was recorded to the nearest 0.1 cm using a 
locally made stadiometer (Biorad, India) that was fixed to a wall. Body weight was 
recorded to the nearest 0.1 kg using a digital weighing scale (Breuer, Germany). 
Mid-upper arm circumference (MUAC) was recorded to the nearest 0.1 cm using a 
plastic tape. 
Cognitive performance
Cognitive performance was evaluated using age-appropriate, validated 
psychometric tests that were administered by seven masters-level psychologists 
in the local Kannada language. The cognitive test battery consisted of 11 subtests, 
including six subtests from the Kaufman Assessment Battery for Children (KABC-
II) for children 3-18 years. The test battery was adapted and validated to ensure 
its suitability in the local cultural context (26;27). For each subtest, a sum score 
was calculated and converted into a standardized z-score. The domain score was 
composed by taking the average of standardized z-scores for the tests constituting 
a domain. The average of the domain scores named the Mental Processing Index 
(MPI) was a composite measure of overall cognitive performance based on the 
KABC-II manual (28). 
Statistical analyses
Energy and nutrient intakes were divided in tertiles. Mean and 95% CI for height, 
weight, MUAC and cognitive outcomes were calculated for each tertile. The middle 
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and highest tertile were compared to the lowest; and the middle tertile to the 
highest. Analysis of variance (SAS General Linear Modeling procedure) was applied 
to investigate the relationships between energy and nutrient intake and body size 
indicators, using a model adjusting for age; and for nutrient intakes, the energy 
intake was added as a covariate to the model. To assess the associations between 
energy and nutrient intake and cognitive performance, the model also included the 
covariates gender, school, maternal education and assessor of cognitive tests. A P- 
value for linear trend was calculated with the energy or nutrient intake as continuous 
variable. A transformation with natural logarithm was applied to variables that did 
not have a normal distribution. All analyses were performed using SAS version 9.1 
statistical software package (SAS Institute Inc, Cary, NC).
Results
A total of 598 children completed the baseline measurements on dietary intake, 
anthropometry and cognitive performance. The baseline characteristics of the 
study population are presented in Table 1. Mean age of the children was 8.7 ± 1.2 
years and 49% of them were boys. Less than 4% of the children were vegetarian 
and none consumed micronutrient fortified foods. Iodized salt was used by 23.5% 
of the families.
Table 1. Characteristics of the study population 
Characteristic N
Gender (% males) 598 49
Age (y) 598 8.7 ± 1.21
Family income (Indian rupees/month) 598 2700 (2000, 3800)2
Uneducated mothers (%) 571 45.5
Vegetarian (%) 598 3.6
Use of iodized salt in household (%) 598 23.5
Use of fortified foods3 (%) 598 0
Height (m) 598 122.9 ± 7.8
Weight (kg) 598 21.4 ± 3.8
1 Mean ± SD (all such values).
2 Median (25th, 75th percentiles).
3 Including fortified biscuits, wheat flour or bread.
Food groups
In general, the diet of the children consisted of three main meals of rice with 
sambar (lentil and vegetable curry), and a glass of milk or tea with milk as an 
early morning drink. The general diet was largely cereal-based, and in addition, 
consisting of some legumes, vegetables, roots, nuts, fats and oils (see Table 2). 
Of the animal foods, milk and milk products were part of the diet of 94% of the 
subjects, while egg (7%), meat (2%) and fish (0%) were not regularly consumed.
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Energy and nutrient intake
An overview of median energy and nutrient intakes of the children can be found 
in Table 3. The age-specific energy intake was below the RDA in 98% of the 
children, and on average, only 61% of the energy requirements were met. When 
correcting the energy intake for body weight, 88% of the children still had intakes 
below the RDA. Most of the energy (72% of total energy (en%)) was provided by 
carbohydrates. Protein requirements (per kg body weight) were met by 91% of the 
children, and on average the amount of protein consumed (27.0 g/d) exceeded the 
requirements with almost 50%. 
Intakes of total fat and polyunsaturated fatty acids (PUFA) were below the 
recommendations of 20-30% and 5-10 en% for 100% and 91% of the children, 
respectively. Saturated fatty acid (SAFA) intake was too high (>10 en%) in 20% 
of the subjects. None of the children met the recommendations for a-linolenic 
acid (ALA) of 1-2 en%. Similarly, none of the children consumed >200 mg/d of 
EPA+DHA, which corresponds with the recommendation of 2 portions of fatty fish 
per week for prevention of chronic diseases (29), and the majority of children 
(92%) did not consume these fatty acids at all.
The MPA was 14.5%, meaning that less than 15% of the children had an adequate 
intake of micronutrients. Especially for niacin, folate, vitamin B12, iron and zinc PA’s 
were low (0-5%), whereas approximately 30% had adequate intakes for vitamin 
B6 and calcium. According to the calculations nearly 70% had adequate vitamin 
C intakes, mainly from vegetables sources. However, it must be noted that these 
calculations did not take into account the losses of vitamin C by cooking processes.
Associations of energy and nutrient intake with anthropometric 
measurements and cognitive performance
An overview of the associations of dietary intake with indicators of body size 
and cognitive performance can be found in Table 4. Energy intake adjusted for 
age was positively associated with anthropometric measurements and cognitive 
Table 2. Intake by different food groups 
Intake (g/d)
Children consuming 
food group (%)
Cereals 179.3 (156.9, 212.8)1 100
Legumes 24.6 (18.5, 34.6) 100
Vegetables 77.1 (55.2, 93.8) 100
Roots 25 (19.7, 33.4) 100
Nuts 7.7 (5.6, 11.6) 99
Fats and oils 8.0 (5.1, 13.1) 100
Sugars 9.7 (5.6, 14.3) 92
Fruit 1.7 (0, 5.8) 72
Egg 0 (0, 0) 7
Milk and milk products 106 (65.9, 132.9) 94
Fish 0 (0, 0) 0
Meat 0 (0, 0) 2
1 Median (25th, 75th percentiles) (all such values).
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performance (see Figure 1), with significant linear trends for height (P=0.03) 
and weight (P=0.01), and borderline significant linear trends for MUAC (P=0.10) 
and MPI (P=0.09). PUFA intake was positively related to cognitive performance, 
with a borderline significant linear trend for MPI (P=0.06), whereas no significant 
associations were found between PUFA intake and body size. No significant 
relationships were found between the indicators of body size and cognition and 
intake of protein and ALA, and micronutrient adequacy (MPA).
Discussion
This study showed that the diet of 598 children from a poor socio-economic 
background in Bangalore city was inadequate with regard to energy, protein, fat 
and micronutrients. Energy intake was positively related to height and weight, 
and possibly to MUAC of the children, whereas energy and PUFA intake may be 
positively associated with their cognitive performance. Intakes of protein and ALA 
and adequacy of micronutrients in the diet were not significantly linked to indicators 
of body size and cognitive performance.
Table 3. Energy and nutrient intake of 598 Indian children
Daily intake % of total energy PA (%)
Energy (MJ) 4.33 (3.78, 5.04)1
Energy (kcal) 1034 (902, 1203)
Macronutrients
Protein (g) 27.0 (23.0, 31.6) 10.2
Total fat (g) 19.7 (15.1, 25.9) 17.8
SAFA (g) 9.0 (7.3, 11.5) 8
MUFA (g) 5.6 (4.1, 7.8) 5
PUFA (g) 2.7 (1.8, 4.2) 3
Linoleic acid (g) 2.4 (1.5, 3.9) 2.7
a-Linolenic acid (g) 0.19 (0.16, 0.23) 0.2
EPA+DHA (mg) 0 (0, 0) 0
Carbohydrates (g) 185 (163, 215) 72.0
Micronutrients
Retinol (µg RE) 170 (143, 201) 7.6
Thiamin (mg) 0.51 (0.42, 0.64) 12.6
Riboflavin (mg) 0.51 (0.41, 0.63) 12.3
Niacin (mg) 5.8 (5.0, 7.1) 4.4
Pyridoxin (µg) 0.71 (0.60, 0.89) 30.1
Folate (µg) 108 (90, 140) 3.0
Vitamin B12 (µg) 0.40 (0.25, 0.51) 0.6
Vitamin C (mg) 34.5 (28.3, 40.5) 68.6
Vitamin E (mg) 2.56 (1.87, 4.01) 9.7
Calcium (mg) 283 (225, 366) 28
Iodine (µg) 44. 0 (37.7, 54.2) 8.7
Iron (mg) 4.9 (4.1, 6.2) 2.8
Zinc (mg) 4.19 (3.63, 4.94) 0
PA, probability of adequacy; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid RE, retinol equivalents.
1 Median (25th, 75th percentiles) (all such values).
Diet in relation to anthropometry and cognition                                                                                                                        125
T
a
b
le
 4
. 
E
n
er
g
y 
an
d
 n
u
tr
ie
n
t 
in
ta
ke
s 
in
 r
el
at
io
n
 t
o
 g
ro
w
th
 a
n
d
 c
o
g
n
it
iv
e 
p
er
fo
rm
an
ce
 o
f 
In
d
ia
n
 c
h
ild
re
n
H
ei
g
h
t1
N
=
5
9
8
W
ei
g
h
t1
N
=
5
9
8
M
U
A
C
1
N
=
5
9
8
M
en
ta
l 
Pr
o
ce
ss
in
g
 I
n
d
ex
2
N
=
5
7
1
M
ea
n
 (
9
5
%
 C
I)
P 
fo
r 
tr
en
d
M
ea
n
 (
9
5
%
 C
I)
P 
fo
r 
tr
en
d
M
ea
n
 (
9
5
%
 C
I)
P 
fo
r 
tr
en
d
M
ea
n
 (
9
5
%
 C
I)
P 
fo
r 
tr
en
d
E
n
er
g
y 
(k
ca
l)
<
9
4
8
1
2
2
.3
 (
1
2
1
.5
-1
2
3
.0
)
0
.0
3
2
1
.1
 (
2
0
.6
-2
1
.4
)
0
.0
1
1
7
.0
 (
1
6
.8
-1
7
.2
)
0
.1
0
0
.0
0
 (
-0
.1
2
, 
0
.1
1
)
0
.0
9
9
4
8
-1
1
4
2
1
2
2
.9
 (
1
2
2
.2
-1
2
3
.7
)
2
1
.4
 (
2
1
.0
-2
1
.8
)
1
7
.0
 (
1
6
.8
-1
7
.2
)
0
.0
7
 (
-0
.0
4
, 
0
.1
8
)
>
1
1
4
2
1
2
3
.4
 (
1
2
2
.7
-1
2
4
.2
2
1
.8
 (
2
1
.4
-2
2
.2
)
1
7
.2
 (
1
7
.0
-1
7
.4
)
0
.0
6
 (
-0
.0
6
, 
0
.1
7
)
Pr
o
te
in
 (
g
)
<
2
4
.2
1
2
1
.8
 (
1
2
0
.8
-1
2
2
.8
)
0
.9
5
2
1
.3
 (
2
0
.7
-2
1
.9
)
0
.6
2
1
7
.0
 (
1
6
.8
-1
7
.2
)
0
.3
7
0
.1
1
 (
-0
.0
2
, 
0
.2
3
)
0
.1
0
2
4
.2
-2
9
.9
1
2
3
.5
 (
1
2
2
.8
-1
2
4
.2
)
2
1
.7
 (
2
1
.2
-2
2
.1
)
1
7
.1
 (
1
6
.9
-1
7
.3
)
0
.0
3
 (
-0
.0
8
, 
0
.1
4
)
>
2
9
.9
1
2
3
.3
 (
1
2
2
.3
-1
2
4
.4
)
2
1
.3
 (
2
0
.7
-2
1
.9
)
1
7
.1
 (
1
6
.9
-1
7
.3
)
-0
.0
3
 (
-0
.1
8
, 
0
.1
1
)
PU
FA
 (
g
)
<
2
.0
1
2
2
.9
 (
1
2
2
.1
-1
2
3
.7
)
0
.1
9
2
1
.6
 (
2
1
.1
-2
2
.0
)
0
.1
4
1
7
.1
 (
1
6
.9
-1
7
.3
)
0
.9
4
0
.0
1
 (
-0
.1
1
, 
0
.1
2
)
0
.0
6
2
.0
-3
.6
1
2
3
.1
 (
1
2
2
.4
-1
2
3
.9
)
2
1
.5
 (
2
1
.0
-2
1
.9
)
1
7
.0
 (
1
6
.9
-1
7
.2
)
0
.0
3
 (
-0
.0
8
, 
0
.1
5
)
>
3
.6
1
2
2
.6
 (
1
2
1
.9
-1
2
3
.4
)
2
1
.3
 (
2
0
.8
-2
1
.7
)
1
7
.0
 (
1
6
.8
-1
7
.2
)
0
.0
8
 (
-0
.0
4
, 
0
.1
9
)
a
-L
in
o
le
n
ic
 a
ci
d
 (
g
)
<
0
.1
7
0
1
2
2
.6
 (
1
2
1
.8
-1
2
3
.4
)
0
.1
2
2
1
.5
 (
2
1
.0
-2
2
.0
)
0
.8
7
1
7
.1
 (
1
6
.9
-1
7
.2
)
0
.5
4
0
.0
8
 (
-0
.0
5
, 
0
.2
0
)
0
.7
4
0
.1
7
0
-0
.2
1
6
1
2
3
.0
 (
1
2
2
.2
-1
2
3
.7
)
2
1
.4
 (
2
1
.0
-2
1
.8
)
1
7
.0
 (
1
6
.8
-1
7
.2
)
0
.0
2
 (
-0
.0
9
, 
0
.1
3
)
>
0
.2
1
6
1
2
3
.1
 (
1
2
2
.2
-1
2
3
.9
)
2
1
.4
 (
2
0
.9
-2
1
.9
)
1
7
.1
 (
1
6
.9
-1
7
.3
)
0
.0
3
 (
-0
.0
9
, 
0
.1
5
)
M
PA
 (
%
)
<
8
.4
1
2
2
.9
 (
1
2
2
.0
-1
2
3
.7
)
0
.1
5
2
1
.7
 (
2
1
.2
-2
2
.1
)
0
.0
7
1
7
.1
 (
1
6
.9
-1
7
.2
)
0
.9
2
0
.0
3
 (
-0
.0
9
, 
0
.1
5
)
0
.3
6
8
.4
-1
5
.8
1
2
3
.6
 (
1
2
2
.9
-1
2
4
.4
)
2
1
.8
 (
2
1
.3
-2
2
.2
)
1
7
.0
 (
1
6
.8
-1
7
.2
)
0
.0
3
 (
-0
.0
9
, 
0
.1
5
)
>
1
5
.8
1
2
2
.2
 (
1
2
1
.3
-1
2
3
.0
)
2
0
.9
 (
2
0
.4
-2
1
.4
)
1
7
.1
 (
1
6
.9
-1
7
.3
)
0
.0
6
 (
-0
.0
6
, 
0
.1
8
)
PU
FA
, 
po
ly
un
sa
tu
ra
te
d 
fa
tt
y 
ac
id
s;
 M
PA
, 
M
ea
n 
Pr
ob
ab
ili
ty
 o
f 
A
de
qu
ac
y 
of
 m
ic
ro
nu
tr
ie
nt
s;
 M
U
A
C
, 
m
id
-u
pp
er
 a
rm
 c
ir
cu
m
fe
re
nc
e.
1
 F
o
r 
en
er
g
y 
in
ta
ke
 a
 m
o
d
el
 a
d
ju
st
in
g
 f
o
r 
ag
e 
w
as
 a
p
p
lie
d
, 
fo
r 
o
th
er
 i
n
ta
ke
 v
ar
ia
b
le
s 
a 
m
o
d
el
 a
d
ju
st
in
g
 f
o
r 
ag
e 
an
d
 e
n
er
g
y 
in
ta
ke
 w
as
 u
se
d
. 
2
 F
o
r 
en
er
g
y 
in
ta
ke
 a
 m
o
d
el
 a
d
ju
st
in
g
 f
o
r 
ag
e,
 g
en
d
er
, 
sc
h
o
o
l,
 m
at
er
n
al
 e
d
u
ca
ti
o
n
, 
as
se
ss
o
r 
o
f 
co
g
n
it
iv
e 
te
st
s 
w
as
 a
p
p
lie
d
, 
fo
r 
o
th
er
 in
ta
ke
 v
ar
ia
b
le
s 
a 
m
o
d
el
 a
d
ju
st
in
g
 f
o
r 
ag
e,
 g
en
d
er
, 
sc
h
o
o
l,
 m
at
er
n
al
 e
d
u
ca
ti
o
n
, 
as
se
ss
o
r 
o
f 
co
g
n
it
iv
e 
te
st
s 
an
d
 e
n
er
g
y 
in
ta
ke
 w
as
 u
se
d
.
126                                                                                                                         Chapter 6
Based on comparable prevalences of anemia in the current study with those 
found in other studies conducted in surrounding areas in Bangalore (30), we 
assume that the current study population is representative for school-age children 
of low socio-economic backgrounds in Bangalore city. Though a 24-h dietary recall 
is not the most accurate method to estimate energy and nutrient intakes, data is 
considered to be sufficient to provide insights in usual nutrient and food intake 
patterns on a group level (31). Compared to actual intakes, a 24-h recall has 
been shown to have good validity for estimating energy, protein, calcium and zinc 
intakes, but not for B-vitamins and iron (31). Correlation analyses of micronutrient 
intake with biochemical indices showed weak significant correlation coefficients for 
folate and vitamin B12, while iron, iodine and fatty acid intakes were not related 
to their corresponding biochemical parameters. The findings did not alter after 
correcting for possible confounders and may be attributed to a low variation in 
intake of the nutrients. 
One of the strengths of the study concerns the robust measurements of 
anthropometry and cognitive performance in a relatively large group of children. 
The cognitive test battery was thoroughly adapted to local language and culture 
and showed good internal and external validity, which is essential to detect any 
associations between cognitive functioning and nutritional status (32). Furthermore, 
we adjusted our findings for several confounding factors, such as age, gender and 
Figure 1. Associations between energy intake and anthropometric measurements and cognitive 
performance of Indian children. Bars and error bars represent means and 95% confidence intervals 
in height, weight, mid-upper arm circumference (MUAC) and Mental Processing Index (MPI) of three 
groups of children with ascending energy intakes.
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maternal education. However, the cross-sectional design of the current study does 
not allow us to assert causal relations.
Our findings on energy and protein intakes correspond with the results of the 
country wide survey in urban slums in India, which showed that Indian diets were 
short of energy but adequate in protein (5). However, as most protein in the diet 
came from rice, the protein quality may have been suboptimal, and in fact, 35% 
of the children in our study did not meet the requirements for lysine (18). Total 
fat intakes of the children were too low (18 en%), which has also been shown in 
adults in South India with average intakes of 22 en% (33). The low fat intake in 
children is of concern as fat intakes below 25 en% may increase the risk of poor 
growth and inadequate intake of vitamins and minerals (34). Requirements for 
PUFA were not met, while SAFA intake exceeded the recommendations in 20% of 
the subjects. Furthermore, none of the children consumed fish, which is in line with 
observations in pregnant women from urban slums in Bangalore (35). Our findings 
indicate a possible public health threat because low PUFA intakes may increase the 
risk of later chronic diseases (36), which is of particular concern for societies in 
transition (37).
Only 15% of the children had an adequate intake of micronutrients, and even if 
the diet would be sufficient in energy, the requirements for iron, zinc, and vitamin 
B12 in particular would not be met by most of the children. This may be explained 
by the low intake of animal products, such as eggs, fish and meat, and the low 
bioavailability of iron and zinc in the present diet. 
Our findings of a positive association of energy intake with body size and 
cognitive performance, but not for intakes of other nutrients after controlling for 
energy intake, may be explained by the low variation in intakes of the nutrients 
because of the monotonous diets of the children. However, intervention studies 
have shown that adequate energy, protein and micronutrient intakes are essential 
for development of children <2 years of age (10) and may also benefit growth and 
cognitive performance in older children (38). Furthermore, in a cross-sectional 
study conducted in 83 Spanish 6 year-old children, iron and folate intake were 
positively related to intelligence scores after adjusting for gender, body mass 
index, maternal education, and vitamin B12 and C intakes (13). In contrast to the 
absence of an association between micronutrient intake and cognition observed 
in our study, data from these other studies suggest that enhancing the intake of 
micronutrients, such as iron, zinc, folate and vitamin B12, may benefit children’s 
intellectual development, especially when intakes are low.
In spite of low PUFA intakes, our data suggest a positive association of PUFA 
intake with cognition, which may have been stronger and significant when there 
was more variation in the intakes. Our finding has not been shown before in similar 
populations in developing countries, but is in line with a cross-sectional study 
in 6-16 year-old US children, in which a higher PUFA intake at the expense of 
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SAFA or carbohydrate intake was more beneficial for short-term memory (39). For 
ALA, no evidence exists for positive effects of higher ALA intakes on cognition in 
children, which is in line with our findings. In contrast, higher intakes of fish during 
pregnancy may benefit infant development (40-42). However, no such evidence 
is available for fish intake during childhood and in absence of fish consumption in 
our study population, we failed to investigate whether higher intakes of EPA+DHA 
would improve cognitive performance at school age.
In conclusion, our findings imply that current diets of poor Indian schoolchildren 
are dramatically low in energy and essential nutrients and therefore, there is a 
need for increasing intakes to support growth and development of these deprived 
children. This could be achieved, for instance, through dietary diversification, food 
fortification or school feeding.
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Main findings
The aim of this thesis was to investigate the role of multiple micronutrients and 
omega-3 fatty acids on cognitive performance in school-age children. Three major 
research questions were addressed and the answers to them are presented in 
Table 1 and will be summarized here:
1. To what extent do multiple micronutrient interventions influence different 
cognitive domains in children? 
Initially, we hypothesized that the size of the effect of multiple micronutrients 
on cognitive outcomes would be small to moderate, and that the domains of fluid 
intelligence, memory and learning, visual perception, retrieval ability, and cognitive 
speediness could be positively influenced. We found that the cognitive domain 
of fluid intelligence and academic performance may be improved by multiple 
micronutrient supplementation with small effects of 0.15-0.30 SD. Crystallized 
intelligence seems not affected and for the other domains the number of studies is 
currently too limited to draw conclusions (chapter 2).
2. What is the role of omega-3 fatty acids on children’s cognitive development?
Because DHA is a structural component of the brain and involved in 
neurotransmitter functioning, we expected that omega-3 fatty acid supplementation 
would be beneficial for cognitive performance in children. However, we did not 
find evidence that additional intake of omega-3 fatty acids, and that of DHA in 
particular, improves intellectual development at school age (chapter 3-6).
3. What is the effect of an intervention with different doses of micronutrients and 
omega-3 fatty acids on cognitive performance in schoolchildren in India? Is there 
an interaction between micronutrients and omega-3 fatty acids?
We postulated that higher doses of multiple micronutrients and omega-3 fatty 
acids would be more effective in improving intellectual development in children 
than lower doses, and that omega-3 fatty acids would have additional effects to 
micronutrients on cognitive outcomes. Our randomized controlled trial showed 
no differences between the high (100% of the Recommended Dietary Allowance 
(RDA)) and low (15% of the RDA) dose of micronutrients on overall cognitive 
performance in Indian schoolchildren. Neither there were any differences between 
the high and low dose of omega-3 fatty acids (chapter 5), nor any interactions 
between micronutrients and omega-3 fatty acids on cognitive parameters.
Besides answering these three research questions, a number of issues in the 
field of nutrition and cognition in children remain to be addressed. In the previous 
chapters, we elaborated on specific points for discussion referring to the study 
presented in each of these chapters. Here, we will focus on general aspects that 
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arose from the totality of research described in this thesis, including the study 
population, cognitive assessment methodology, impact of nutritional status on 
cognitive outcomes, optimal composition of multiple micronutrient supplement, 
and a reflection on findings of omega-3 fatty acids on cognition. The chapter will 
end with implications for public health and directions for future research. 
Table 1. Overview of main findings to research questions addressed in this thesis
1. To what extent do multiple micronutrient interventions influence different cognitive domains in 
children?
Design Main outcomes Conclusions
Meta-analysis 
(chapter 2)
Pooled effect sizes of micronutrient 
supplementation: 
Fluid intelligence 0.14 SD (95% CI: -0.02, 
0.29); P=0.083
Crystallized intelligence -0.03 SD (95% CI: 
-0.21, 0.15); P=0.74
Academic performance 0.30 SD (95% CI: 
0.01, 0.58); P=0.04. 
Effects of micronutrients tend to be small. 
Domains of fluid intelligence and 
academic performance may positively 
be influenced, while crystallized 
intelligence seems not affected.  For 
other domains, data is too limited to 
draw any conclusions. 
 
Cross-sectional study 
(chapter 4)
Blood hemoglobin concentrations were 
positively associated with fluid reasoning, 
short term memory, retrieval ability and 
cognitive speediness. Plasma vitamin B12 
concentrations were inversely related to 
short term memory and retrieval ability. 
Indicators of iron, iodine and folate status 
were not significantly linked to cognitive 
domains.
Randomized controlled 
trial (chapter 5)
Compared to the low dose, the high dose 
of micronutrients was less beneficial for 
fluid reasoning -0.12 SD (95% CI: -0.20, 
-0.04) and more beneficial for short term 
memory 0.06 SD (95% CI: -0.04, 0.16). No 
significant effects were found on retrieval 
ability and cognitive speediness.
2. What is the role of omega-3 fatty acids on children’s cognitive development?
Design Main outcomes Conclusions
Systematic review 
(chapter 3)
Only one cohort study in children aged 7 
years was reported in literature, which did 
not find significant associations between 
plasma DHA concentrations and cognitive 
performance.
Studies did not show benefits of 
omega-3 fatty acids on cognitive 
development in healthy children older 
than two years of age, and evidence is 
too limited to draw a conclusion.
Cross-sectional study 
(chapter 4)
No significant associations between 
erythrocyte DHA concentrations and 
cognition were found.
Randomized controlled 
trial (chapter 5)
Effect sizes of high versus low dose of 
omega-3 fatty acids after 12 months on 
Mental Processing Index: 0.00 SD (95% CI: 
-0.05, 0.05).
Cross-sectional study 
(chapter 6)
PUFA intake was positively related to cognitive 
performance (P for linear trend=0.06), but 
ALA intake was not.
3. What is the effect of an intervention with different doses of micronutrients and omega-3 
fatty acids on cognitive performance in schoolchildren in India? Is there an interaction between 
micronutrients and omega-3 fatty acids?
Design Main outcomes Conclusions
Randomized controlled 
trial (chapter 5)
Effects of high vs low dose of micronutrients 
after 12 months on Mental Processing Index: 
-0.02 SD (95% CI: -0.07, 0.03).
Effects of high vs low dose of omega-3 fatty 
acids after 12 months on Mental Processing 
Index:  0.00 SD (95% CI: -0.05, 0.05).
No significant interactions between 
micronutrients and omega-3 fatty acids were 
detected.
On overall cognitive performance, 
there were no differences between 
high and low doses of micronutrients 
and between high and low doses of 
omega-3 fatty acids. No interactions 
between micronutrients and omega-3 
fatty acids were found.
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Study population
Methodological issues 
The subjects of research described in this thesis were healthy school-age 
children, without clinically diagnosed developmental disorders. In this section, we 
will address two methodological issues with regard to the selection of our study 
population which may have influenced the study outcomes, including selection bias 
and age.
Selection bias occurs when the characteristics of the subjects selected for the 
study differ systematically from subjects who are not. For the trials included in the 
meta-analysis (chapter 2), we were unable to assess this type of bias due to lack 
of information in the publications. For our randomized controlled trial (chapter 4, 5 
and 6), we do not have evidence that selection bias has occurred, because children 
who completed the study were not different with regard to socio-demographic and 
nutritional factors at baseline compared to children who were lost to follow-up. 
Furthermore, the prevalence of anemia in our study population was similar to that 
measured in other studies conducted in Bangalore city and its surroundings (1), 
indicating that the children in our study were representative for children from a 
poor socio-economic background in Bangalore.
Secondly, age may have had an influence on the study outcomes, since the 
largest brain growth and major events in cognitive development take place before 
the age of 5 years. Therefore, effects of nutrition on cognitive performance may 
have been larger in young children than in children of school age. However, brain 
development is continuing into early adulthood, in particular development of frontal 
lobes, which are involved in executive functioning, such as reasoning and planning 
(2). Moreover, by the age of 5 years, cognitive functions have matured sufficiently 
and therefore it is possible to measure all cognitive domains in older children. In 
younger children, psychological assessments are more general and may be less 
sensitive to effects of nutrition interventions (3). Thus, by studying children older 
than 5 years of age, we were able to assess to what extent micronutrients and 
omega-3 fatty acids influenced the different cognitive domains.
Interpretation of findings 
Our meta-analysis showed that effects of multiple micronutrients on cognitive 
performance in schoolchildren 5-16 years of age were small. We failed to compare 
studies conducted in children <5 years with those performed in children aged 
5-16 years, due to the limited number of studies in younger children (chapter 2). 
However, two (4;5) out of the three (4-6) studies in children <5 years showed 
positive effects on gross motor development, implying that micronutrients may 
also improve development at younger ages. 
In contrast to our findings, two systematic reviews on interventions with iron 
only have demonstrated convincing evidence for beneficial effects on mental 
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development in children >2 years but not in children <2 years (7;8). However, 
there is no adequate explanation that younger children would not benefit from iron 
supplementation. Possibly, psychological assessment methods may have been too 
general to detect effects, or other factors influencing mental development, such as 
lack of social stimulation, may have overruled the effects of iron supplementation 
(8). 
Furthermore, since development of the brain structures and cognitive functions 
takes place at different times and build on each other (2), small disturbances 
in these processes early in life –for example through undernutrition– can have 
consequences for later cognitive performance (9). Therefore, the timing of nutrition 
interventions is important and experts have recently recommended that public 
health programs targeted at younger children are most effective to improving 
mental development (10).
Conclusion
The limited number of studies in children <5 years gives no clear indication 
that effects of multiple micronutrients on mental development are different from 
those in children >5 years of age. Because of the rapid development of the brain 
and cognitive functions in the early years of life, it is expected that the impact of 
nutrition interventions is larger and therefore easier to detect at this age. However, 
research in older children has the advantage that specific cognitive functions have 
more matured and are therefore better measurable, which increases the chances 
of detecting possible effects in efficacy trials. On the other hand, for policy-making, 
more research in younger children would be of interest to conclude at what age 
supplementation with micronutrients would be most efficacious for improving 
cognitive development on both short and longer term. 
Cognitive assessment
Methodological issues 
In this section, we will focus on a number of aspects that were important for 
the methodology used to assess cognitive performance in children in our studies, 
including the application of the general model of intelligence to non-western 
populations and validity and reliability of cognitive tests. 
General model of intelligence
In our meta-analysis (chapter 2), we categorized the cognitive tests used in the 
trials into cognitive domains proposed in Carroll’s model of general intelligence 
(11) and added sustained attention and academic performance. Although the 
model is based on analysis of 460 datasets reported in psychometric literature, 
covering about six decades of intelligence testing in various populations, there may 
be some uncertainty regarding its validity in non-western populations. However, 
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Carroll indicated that there was little evidence that the model would differ in any 
systematic way across genders and different cultures, but differentiations may 
occur due to variations in education or other environmental factors (11). Moreover, 
similar models of general intelligence have shown to be valid in other cultures 
(12-14). Therefore, it is justified to apply Carroll’s model to trials in non-western 
populations.
Also the Kaufman Assessment Battery for Children, second edition (KABC-II), 
used in our intervention study (chapter 4, 5 and 6), measures several cognitive 
domains that can be interpreted in the context of the model by Carroll (15). This 
test battery has been carefully developed to minimize the influence of language and 
cultural knowledge on test results, indicating that the designers of the test battery 
also felt that the structure of cognitive domains can be used in other cultures. After 
the cross-cultural adaptation of the test battery used in our intervention, we could 
confirm that the test measured the same psychological concepts as in the culture 
of test origin (16), indicating a good validity. 
Validity and reliability of cognitive tests
A limitation of the meta-analysis was that we were unable to assess the validity 
and reliability of the cognitive tests used in the different studies. Tests with a low 
quality may have been less sensitive to detect effects of the intervention. Indeed, 
the effects of micronutrients on fluid intelligence were less visible in developing 
countries compared to developed countries, which may be attributed to use of less 
robust tests in the trials in developing countries. However, other factors that differ 
between developed and developing countries, such as environmental factors (e.g. 
poverty) may also have influenced the results. 
The cognitive tests used in our intervention study (chapter 4, 5 and 6) were 
thoroughly adapted for use in the local setting by a process of translation and 
back-translation, followed by a pilot study during which the tests were fine-tuned 
based on observations and feedback from the local psychologist administering the 
tests to children in a non-standard way (17). As already indicated in the previous 
section, the test battery showed good validity and reliability.
Interpretation of findings 
In this section, we will discuss the interpretation of findings for the meta-analysis 
and the randomized controlled trial separately.
Meta-analysis (chapter 2): 
The meta-analysis suggested that multiple micronutrients were beneficial for 
fluid intelligence, which is the cognitive domain with the highest correlation with 
general intelligence. No effects were observed for crystallized intelligence and 
evidence was inconclusive for the other cognitive domains because of limited data 
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(Figure 1). Furthermore, academic performance assessed by school exams may 
also be influenced by micronutrients. 
It has been hypothesized that during cognitive development, not all domains 
would mature at a similar rate. Development of some of the domains could be 
stimulated by nutritional interventions while at the same time development of 
other domains may stand still or even reverse (18). The finding that crystallized 
intelligence may not be influenced by multiple micronutrients could possibly be 
attributed to the relatively short duration of studies preventing them from showing 
significant differences in acquired skills and knowledge. In fact, studies on the 
effect of protein-energy supplements provided in the first two years of life, have 
shown to benefit children’s verbal and reading skills at school age (19), suggesting 
that nutrition interventions may also benefit this domain but with a longer time-
lag. 
Furthermore, environmental factors may be more important determinants of 
certain cognitive domains, such as crystallized intelligence and therefore effects of 
micronutrient interventions may not become apparent. This hypothesis has also 
been suggested as explanation for the lack of effects of iron supplementation on 
development of young children (8). 
Finally, the cognitive tests assessing various cognitive domains may differ in 
sensitivity. Therefore, it would be of interest to make an inventory of individual 
cognitive tests used in trials investigating micronutrients that are most responsive. 
For instance, the digit span test that measures short-term memory was sensitive 
to micronutrient interventions in a number of trials (20-22).
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Figure 1. Model of intelligence adapted from Carroll (23). 
The cognitive domains in stratum II marked with an asterisk were expected to be influenced by 
micronutrient interventions (24), while the cognitive domain marked with a circle was positively 
affected by multiple micronutrient supplementation according findings of the meta-analysis.
General Discussion                                                                                                                        139
Intervention study (chapter 5): 
Compared to the low dose of micronutrients, we found a small positive effect of 
the high dose of micronutrients on short-term memory and a small negative effect 
on fluid reasoning (including tests of both fluid intelligence and visual perception 
domains). We do not have a good explanation why these domains were affected 
whereas the other domains were not. Because micronutrient status at baseline and 
compliance to consumption of the study products did not influence the cognitive 
outcomes, we concluded that the effects found for short-term memory and for fluid 
reasoning may have been due to chance. 
Conclusion
We showed that micronutrients seem to have small effects on fluid intelligence 
and therefore, it is recommended to include tests assessing this domain in future 
studies. Tests measuring crystallized intelligence may only be included in studies 
with a long duration of more than a year, as no effects are expected on shorter 
term. For a robust assessment of a particular cognitive domain, 2-3 different tests 
per domain are required. In addition, for future studies in developing countries 
in particular, the cognitive tests need a thorough adaptation which is essential to 
ensure their validity in a local setting. 
Impact of nutritional status on cognitive outcomes
Methodological issues 
An important question, which could not be adequately answered by the research 
in this thesis, is whether nutritional status at baseline has a significant impact on 
the effect of micronutrient supplementation on cognition. Findings from the meta-
analysis indicated that the development status of the country was a significant 
factor explaining the heterogeneity between studies, which could be attributed 
to differences in nutritional status of subjects between developed and developing 
countries (chapter 2). Unfortunately, data on prevalence of stunting and hemoglobin 
concentration of the study population were lacking. Therefore, it was not possible 
to explore whether baseline nutritional status would be a significant predictor of 
cognitive outcomes. 
For the intervention study, we chose to conduct the study in a population of 
children from a poor socio-economic background because a high prevalence of 
nutritional deficiencies was expected (chapter 4, 5 and 6). However, the prevalence 
of anemia appeared to be 9% only, which was similar to that found in other studies 
in deprived children in Bangalore and its surroundings conducted at the same time 
(1). Despite inadequate intakes of micronutrients in ~85% of the children, only 
20-30% of the children in our study suffered from other iron, folate or vitamin B12 
deficiencies. The lower prevalence of micronutrient deficiencies may be attributed 
to introduction of sanitation programs in slums resulting in reduced morbidity and 
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prevalence of worm infestations. In addition, vitamin A supplementation twice per 
year (a program which was stopped during our intervention) and use of iodized 
salt in subsidized school meals or at home may have contributed to decreasing the 
prevalence of micronutrient deficiencies. Consequently, our intervention may have 
been less efficacious in improving cognitive performance of the children compared 
to a population of children who all have micronutrient deficiencies. However, our 
findings did not alter when we adjusted our analyses for initial nutritional status. 
In contrast, in cross-sectional analyses (chapter 4), we showed that baseline body 
size indicators and hemoglobin concentrations were positively associated with 
cognitive performance across all domains, indicating that nutritional status may 
influence intelligence in children.
Interpretation of findings 
We postulated that children in developing countries who often have a higher risk of 
micronutrient deficiencies would benefit more from micronutrient supplementation 
than their peers in developed countries. Contrary to our expectations, the overall 
effect size of multiple micronutrient supplementation on fluid intelligence among 
the studies conducted in developed countries using micronutrient tablets was 
significantly larger compared to studies in developing countries using fortified 
foods (chapter 2). As indicated above, it might be that cognitive test batteries 
used in developing countries were less sensitive due to problems with validity. 
Other explanations may be that the diet of children living in developing countries 
is usually inadequate in energy and protein, which is reflected in high prevalence of 
stunting and wasting. Possibly, the beneficial effect of micronutrients may become 
more apparent when energy and protein intakes are adequate, which is usually 
the case in children in developed countries. This has also been observed in a trial 
conducted in Australia and Indonesia, which showed that a micronutrient fortified 
beverage improved learning and memory in Australian children, while these effects 
were only seen in Indonesian girls (23). Thus, the extra energy provided by the 
fortified foods used in studies in malnourished children in developing countries 
may overrule the effect of micronutrients on cognitive performance. 
Whereas we did not find evidence for differences in effects of multiple 
micronutrient interventions on the cognitive outcomes with a poorer micronutrient 
status at baseline (chapter 5), some studies have found that nutritional status 
at baseline did modify the effect of the intervention. In a study in schoolchildren 
in the Philippines, effects of a multiple micronutrient beverage on non-verbal 
abilities were significant in iron and iodine deficient children, while overall no 
effects were found (24). In addition, the effect seemed larger in children with 
more severe deficiencies. Similarly, a study in South African schoolchildren showed 
a larger effect of micronutrient fortified biscuits on cognitive function in children 
who had a poorer iron status or goiter at baseline (20). Also, a meta-analysis 
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on iron supplementation on mental development in children demonstrated that 
supplementation was more effective in iron deficient and anemic children (7). Taken 
together, these studies indicate the iron and iodine status at baseline influences 
the outcomes of micronutrient interventions on intellectual performance.
Conclusion
Although evidence is limited, children who suffer from iron and iodine deficiency 
in particular may gain more from multiple micronutrient interventions compared to 
children with adequate iron and iodine status. Therefore, we keep our assumption 
that children in developing countries would experience greater cognitive benefits 
of multiple micronutrient interventions than children in developed countries; 
although this was not confirmed in our meta-analysis (chapter 2). In order to 
increase the chances of detecting effects of micronutrient interventions on cognition 
in developing countries, trials should preferably use designs enabling them to 
disentangle effects of energy versus effects from micronutrients. 
Composition of multiple micronutrient supplements 
Methodological issues 
The term ‘multiple micronutrients’ was defined as ≥3 vitamins and minerals and 
this definition has been used in other meta-analyses (25;26). This definition is 
broad and covered a wide variation of micronutrient interventions used in different 
studies that were included in the meta-analysis (chapter 2). Unfortunately, the 
number of studies in the meta-analysis was too small for adequate investigation 
on type and dose of vitamins and minerals in relation to cognitive performance. 
However, in most studies, iron and iodine were included in the micronutrient mix 
and more than 10 different micronutrients were provided. 
In the intervention study, a high dose (100% of the RDA) of micronutrients was 
compared to a low dose (15% of the RDA) (chapter 5). A limitation of the study 
design was the lack of a group not receiving any micronutrients and/or a group 
receiving a dose in between 15 and 100% of the RDA, in order to investigate a 
dose response effect on cognition. The low dose of micronutrients of 15% of the 
RDA increased the intake of micronutrients considerably (with 25-50%) compared 
to the habitual intakes of vitamins and minerals. Furthermore, the fact that all 
children received substantial amounts of energy and protein of 40-50% in addition 
to their habitual diet may have blurred the effects of the micronutrients. 
Interpretation of findings 
Data on effects of different doses of multiple micronutrients on cognition are 
limited to one trial conducted in US children aged 12-16 years. In this study, no 
significant differences were found among doses of 50, 100 and 200% of the RDA 
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(27). These findings are in line with those of our intervention study (chapter 5). 
It has been questioned whether additional micronutrient supplementation in 
well-nourished populations, with micronutrient status within the normal range, 
would be potentially harmful (28). Data at the end of our intervention study showed 
that none of the children in the high micronutrient group had concentrations 
of hemoglobin or body iron stores above the higher cut-off levels (chapter 5); 
indicating that iron stores were filled and plateau levels were reached. Furthermore, 
the fact that extra micronutrients were beneficial for fluid intelligence in children in 
developed countries (chapter 2), suggests that even well-nourished children may 
have a suboptimal micronutrient status with regard to cognitive function. However, 
more research is required to assess the optimal micronutrient status for cognitive 
performance. In addition, dose-response studies should be conducted to identify a 
cost-effective and safe dose of micronutrients for optimizing children’s intellectual 
development.
Since iron and iodine have the strongest link to mental performance in 
schoolchildren (29), it is clear that ensuring adequate intake of these micronutrients 
is a pre-requisite for optimizing cognitive performance. Moreover, most of the 
studies in the meta-analysis included folate, vitamin B12 and zinc in addition to 
iron and iodine in the multiple micronutrient intervention, suggesting that these 
micronutrients are considered to be important for cognitive development (chapter 
2). Furthermore, results from the meta-analysis indicated that a higher number of 
micronutrients yielded larger effects on fluid intelligence (chapter 2). Therefore, 
also other vitamins and minerals that are not directly related to cognitive function 
may be required to optimize cognitive performance. Since investigation of all 
possible combinations of micronutrients is inefficient, selection of the type of 
micronutrients to be included in future studies may be based on the prevalence of 
individual micronutrient deficiencies and/or the role of vitamin or mineral in brain 
function. 
Conclusion
Our study and one other trial (27) suggest that lower doses of micronutrients 
(<50% of the RDA) are as effective as higher doses (≥100% of the RDA) for 
improving cognitive function. Our meta-analysis indicates that a higher number 
of micronutrients would be more effective, and because of the strong evidence 
with cognition in children, iron and iodine should be included in the supplements. 
However, the number of studies is currently too limited to provide exact guidance 
on dose and composition of micronutrients that would be required for optimizing 
cognitive development in children and therefore more studies are needed. 
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Reflection on findings of omega-3 fatty acids
Methodological issues 
Since no effects of omega-3 fatty acids were found on cognitive performance in 
children, we may question whether our intervention study in Indian children was 
adequately designed. The children had low intakes of ALA and very low intakes 
of DHA, because of limited presence of meat and eggs and absence of fish in 
the habitual diet. This was reflected in a study population with less variation in 
erythrocyte fatty acid concentrations and dietary intake of omega-3 fatty acids, 
which may have been too homogenous to investigate associations with cognitive 
function (chapter 4 and 6). In contrast, for the intervention study (chapter 5), the 
poor omega-3 fatty acid intake should have maximized the likelihood of finding 
effects of additional omega-3 fatty acid supplementation on cognitive performance. 
However, the amounts of ALA and DHA in the high dose may have been too low to 
improve cognitive test scores in spite of a significant increase in erythrocyte DHA 
concentrations.
Interpretation of findings 
Evidence for role of omega-3 fatty acids in schoolchildren
Overall, a limited number of studies have investigated the role of omega-3 
fatty acids on cognition in healthy children. The findings of the intervention study 
(chapter 5) are in agreement with two other studies in children in which no effects 
of doses 100-1000 mg DHA were found on tests of intelligence (23;30). Limitations 
of these and our studies was that either the dose may have been too low (23) or 
duration may have been too short (30) to detect effects. However, also for other 
age groups, evidence for benefits of DHA on cognitive function is inconclusive 
(infants) or not existing (preschoolers and elderly) (31-34).
 Another explanation for not finding effects of omega-3 fatty acids on cognitive 
outcomes may be that the amount of ALA in the diet is sufficient and that the 
conversion of ALA to DHA is adequate to supply the brain. In fact, the median ALA 
intake in our study population (190 mg ALA/d) corresponds with the recommendation 
of a minimum of 0.2% of total energy for ALA required to prevent deficiency set 
by the British Nutrition Foundation (35). Moreover, animal studies have shown 
that synthesis of DHA in the liver is enhanced and the turnover of DHA in the 
brain is reduced when diets were low in a-linolenic acid and free of DHA (36). 
This explanation is supported by the absence of a positive association between 
erythrocyte or plasma fatty acid status and cognitive performance in children as 
observed in the current (chapter 4) and other studies in schoolchildren (37). 
Biomarkers of omega-3 fatty acid status in relation to cognitive function
As no significant associations were found between plasma or erythrocyte DHA 
status and cognitive function, it may be questioned whether these biomarkers 
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are representative for brain DHA status. A recent study in adults postulated that 
approximately 3.8 mg of DHA is daily transported from the unesterified DHA plasma 
pool into the brain (38). Since the amount of DHA consumption by the brain seems 
relatively small and the observations that DHA turnover is decreased when dietary 
intake of omega-3 fatty acids is low (36), it may be speculated that erythrocyte 
and plasma fatty acids status may not be suitable indicators for assessments of 
DHA sufficiency in the brain. 
Another gap in knowledge concerns the question to what extent brain DHA status 
is related to cognitive function in humans. Therefore, studies involving positron 
emission tomography (PET) to image the incorporation of DHA in the brain (38), 
may be helpful to further study the role of omega-3 fatty acids in different brain 
regions and related cognitive functioning. 
Effects of omega-3 fatty acids versus fish consumption on cognition
Although there is limited evidence for effects of DHA supplementation on 
cognitive development (chapter 3), a number of observational studies indicate 
a significant positive association of fish consumption during pregnancy and 
cognitive development of infants (39-41). These cross-sectional findings do not 
proof causality between fish consumption and cognition, and may be due to other 
differences in dietary habits and lifestyle. However, a randomized controlled trial 
has demonstrated significant beneficial effects of fish flour, rich in EPA and DHA, 
versus a bread flour on verbal learning of South-African children aged 6-9 year 
old (42). The positive effects on cognition found following fish consumption but 
not with EPA and DHA supplementation, may be attributed to other components 
in fish that may benefit mental development of children, such as iodine (43) or 
phospholipids (44). These nutrients may act synergistically with the fish fatty acids 
on improving cognitive performance.
Interactions of omega-3 fatty acids and multiple micronutrients 
No significant interactions between the micronutrient and omega-3 fatty acid 
treatments were found on neither cognitive nor biochemical outcomes of the 
children (chapter 5), which is in line with findings of another study in children of 
similar age (23). Also, no interactions of PUFA and micronutrient supplementation 
on behavioral problems in children with attention-deficit hyperactivity disorders 
(45). Since evidence for positive effects of omega-3 fatty acids on cognitive 
development of children is currently lacking, it is not surprising that the addition 
of DHA to micronutrients has also no effect. Furthermore, interactions may be 
expected only from interventions with ALA and not DHA, since micronutrients may 
enhance the conversion of ALA to DHA (46). In addition, other factors influencing 
the conversion may be more important such as single nucleotide polymorphisms 
in the gene encoding δ6-desaturase (FADS2) or its regulatory elements, which 
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result in different conversion rates of ALA to EPA and DHA (47;48). Subjects with 
the genetic variations resulting in lower conversion rates may benefit from extra 
dietary EPA and DHA intake and subsequently improve their cognitive performance.
Conclusion
The research in this thesis added to a number of studies showing no evidence 
for an effect of additional dietary intake of omega-3 fatty acids on cognitive 
performance in healthy children; or in populations with low intakes of ALA and 
DHA, such as in the Indian schoolchildren. Since the current studies were either 
too short of duration or too low in doses of DHA, a trial using a high dose (>200 
mg DHA per day) and sufficiently long duration (>4 months) is needed to conclude 
whether DHA supplementation would benefit cognition at school age. Lastly, it may 
be of interest to conduct studies in populations with variation in δ6-desaturase 
encoding genes to conclude whether additional EPA and DHA intake in specific 
subgroups with low conversion rates of ALA to DHA will benefit cognitive function.
Implications for public health
Current public health strategies to optimize children’s cognitive 
development
Based on strong scientific evidence of the detrimental effects of iodine and iron 
deficiency on brain development and cognitive function, public health authorities 
of the United Nations declared in the 1990s to make all efforts to eliminate 
these deficiencies globally. To combat iodine deficiency, programs to promote 
consumption of iodized salt and monitor iodine status have been implemented 
world wide (49). To eradicate iron deficiency, multiple strategies to improve iron 
intake including dietary improvement, food fortification and supplementation have 
been introduced (50). Although schoolchildren also benefit from these programs, 
they are not specifically targeted to them. 
With regard to omega-3 fatty acids and possible benefits on cognition there are 
no specific public health programs to improve the intakes of ALA and DHA. Official 
international recommendations for children on intake of fatty acids are currently 
lacking. However, consumption of fish as part of a healthy diet is also considered 
important for children (51).
Public health nutrition programs, targeted at schoolchildren, focus mostly on 
improving general health and well-being of children, thereby indirectly improving 
cognitive development (52). For instance, school feeding programs have been 
introduced in children from deprived backgrounds to improve energy and 
micronutrient intakes by providing a breakfast, mid-morning snack or lunch at 
school, thereby also increasing school attendance rates (53). Our findings of the 
dramatically low intakes of energy, essential fatty acids and micronutrients in 
Indian children (chapter 6) support the need for such programs. 
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Implications for public health resulting from research described in this 
thesis
In this section, we will focus on the consequences of our research for public 
health on the basis of the three main research questions that were addressed in 
this thesis.
With regard to the first research question, we showed that there is suggestive 
evidence for a beneficial effect of multiple micronutrient supplementation on fluid 
intelligence in schoolchildren. Since evidence is in particular strong for children 
living in developed countries, we can not exclude the possibility that the intake 
of micronutrients in apparently well-nourished children could be improved for 
optimal cognitive development. However, at present it is too early to recommend 
massive public health campaigns to increase micronutrient intake in children to 
improve their intellectual performance. Therefore, further research will be needed 
to conclude whether a higher micronutrient status above the current cut-off values 
for deficiencies would be related to better cognitive development of children; 
thereby including measurements of cognitive performance in addition to regular 
functional parameters of growth and health.
For malnourished children in developing countries, such as the Indian children 
studied in this thesis, it is currently unclear whether multiple micronutrients would 
improve their cognitive development. This may be attributed to an overall lack of 
energy and protein in the habitual diet and other factors associated with poverty. 
Therefore, our findings underline the need for current public health initiatives to 
increase the intakes of energy and essential nutrients to improve general health 
and development of children living in deprived environments.
The answers to our second research question indicate that there is no evidence 
to substantiate recommendations aiming to enhance intellectual development by 
increasing intakes of omega-3 fatty acids, and of DHA in particular. In developing 
countries, where diets tend to be low in ALA and absent of DHA, no benefits of 
additional DHA intakes were found on cognitive performance. However, higher 
PUFA intakes may be associated with better cognitive performance, suggesting 
that public health authorities may consider strategies to improve the intake of 
omega-3 and omega-6 fatty acids. In addition, for prevention of chronic disease 
(54;55), and possibly cognitive functioning (56) in later life, children may benefit 
from higher intakes of the long chain omega-3 fatty acids. An evaluation of the 
current evidence on this topic is needed to develop recommendations on fatty acid 
intake for children’s future health.
For the third research question, we attempted to elucidate on doses of 
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micronutrients needed to improve cognitive performance in children. Our study 
showed that lower doses may be as adequate as higher doses (chapter 5) and 
therefore policy-makers may consider the use of lower doses in public health 
programs for reasons of safety and cost-effectiveness. However, further research 
is required to confirm our observations in other countries, and to investigate the 
effect of different doses on other functional outcomes, such as growth. In addition, 
besides the importance iron and iodine for cognitive development in children, more 
guidance is needed on the composition of multiple micronutrient supplements for 
use in public health strategies aimed at improving cognition.
Recommendations for future research
As indicated above, a number of gaps in knowledge on the role of micronutrients, 
omega-3 fatty acids and cognitive performance in children are remaining and need 
to be addressed in future studies. 
With regard to effect of multiple micronutrients on cognitive performance in 
schoolchildren, further research is needed to determine the impact on cognitive 
domains other than fluid intelligence, and to identify a cost-effective micronutrient 
supplement to optimize cognitive performance in children. Given the limited number 
of studies conducted in developing countries, more research should be conducted 
in malnourished populations to determine whether effects of micronutrients on 
cognition depend on nutritional status.
More specifically, future trials are recommended to investigate:
• The effects of multiple micronutrients on different cognitive domains, e.g. 
fluid intelligence, short-term memory, visual perception, retrieval ability, 
cognitive processing speed, sustained attention and academic performance. 
• Different doses of micronutrients, e.g. 0, 30, 50 and 100% of the RDA.
• The effect of single (i.e. iron or iodine) versus multiple micronutrients.
• The influence of baseline micronutrient status on the effect of micronutrients 
on cognitive outcomes.
• The effect of energy and protein versus multiple micronutrients on cognition 
in malnourished children.
To end the current debate whether DHA may improve cognitive performance in 
children of school age, a trial using a high dose of DHA (>200 mg/d) and adequate 
duration (>4 months) will be required. In addition, future research may clarify 
whether populations with lower conversion rates of ALA to DHA due to genetic 
variation may benefit from additional dietary DHA with regard to cognitive function. 
Finally, methods to assess cognitive performance in children need to be sensitive 
to detect small effects of nutritional interventions. Therefore, it is important to use 
well-adapted valid cognitive tests with adequate psychometric properties. Besides 
tests assessing different cognitive domains, more advanced measures such as 
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structural and functional brain imaging techniques may be added to investigate 
the effects of nutrition in the brain. Combining brain imaging techniques with 
assessments of cognitive performance in future trials is recommended to more 
precisely understand the role of nutrients in the brain and relate this to functional 
outcomes.
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In spite of decades of efforts by public health organizations to eliminate 
the problem of undernutrition, millions of children are not reaching their 
full developmental potential because of nutritional deficiencies. Poverty and 
monotonous diets are underlying causes of inadequate intakes of micronutrients 
and omega-3 fatty acids, which may have severe consequences for intellectual 
development of children. Whereas single micronutrient interventions with iron and 
iodine have been proven to enhance cognitive performance, there are indications 
from a relatively large number of studies that multiple micronutrient interventions 
improve mental development of children, but a systematic approach to evaluate 
the evidence is currently lacking. Omega-3 fatty acids are important for normal 
development of children. While some studies have shown that supplementation 
with docosahexaenoic acid (DHA) may benefit mental development of infants, it 
is presently unclear whether additional intake of omega-3 fatty acids improves 
cognitive performance in children of school age. 
This thesis aims to investigate the role of multiple micronutrients and omega-3 
fatty acids on cognitive performance in school-age children living in deprived 
environments (chapter 1), thereby addressing three main research questions:
1. How large is the impact of multiple micronutrient interventions on different 
cognitive domains in children? 
2. What is the role of omega-3 fatty acids on children’s cognitive development?
3. What is the effect of an intervention with different doses of multiple 
micronutrients and omega-3 fatty acids on cognitive performance in 
schoolchildren in India? Is there an interaction between multiple micronutrients 
and omega-3 fatty acids?
The current literature on the effect of multiple micronutrients on different 
cognitive domains in schoolchildren was systematically reviewed in chapter 2. 
Randomized controlled trials investigating the effect of ≥3 micronutrients versus 
placebo on cognition in healthy children aged 0-18 years were included. The 
cognitive tests used in the trials were grouped into several cognitive domains, 
including fluid intelligence (i.e. reasoning abilities), crystallized intelligence (i.e. 
acquired knowledge), short-term memory, visual perception, retrieval ability, 
cognitive processing speed, attention and academic performance. Pooled random 
effect sizes were calculated per domain. Seventeen trials were retrieved in children 
aged 5-16 years. Findings indicated a small positive effect of multiple micronutrient 
supplementation on fluid intelligence of 0.14 SD (95% CI: -0.02, 0.29; P=0.083), 
while crystallize intelligence seemed unaffected with a pooled effect of -0.03 SD 
(95% CI: -0.21, 0.15; P=0.74). Limited data from four trials yielded a significant 
positive effect on academic performance (0.30 SD; 95% CI: 0.01, 0.58; P=0.044). 
For the other domains, there were too few studies to draw a clear conclusion. 
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Investigation of heterogeneity indicated that the positive effects on fluid intelligence 
were more pronounced in the studies conducted in developed countries, in which 
micronutrient tablets (instead of fortified foods) were provided. Furthermore, 
effects were larger in studies with a higher number of different micronutrients.
Chapter 3 comprises an evaluation of the most recent randomized controlled 
trials assessing the efficacy of the omega-3 long chain polyunsaturated fatty acid 
(LCPUFA) supplementation (i.e. eicosapentaenoic acid (EPA) and DHA) during 
pregnancy, lactation, infancy and childhood on cognitive development. Available 
evidence suggested a beneficial effect of maternal omega-3 LCPUFA supplementation 
during pregnancy and lactation on mental development of infants and children, 
while evidence for an effect supplementation during infancy was inconclusive. For 
healthy children older than two years of age, data were too limited to conclude 
whether supplementation with EPA and DHA would benefit cognitive performance. 
After the review was performed, two additional trials in schoolchildren and one 
study in preschoolchildren have not showed effects of DHA supplementation on 
cognitive outcomes. 
A randomized controlled nutrition intervention study was conducted to 
investigate the effect of two different concentrations of a combination of 
micronutrients and omega-3 fatty acids on indicators of growth and cognitive 
performance in 598 marginally nourished Indian schoolchildren aged 6-10 years. 
The Kaufman Assessment Battery for Children II was used to measure four 
cognitive domains, including fluid reasoning, short-term memory, retrieval ability 
and cognitive speediness. Scores were combined into an overall measure, named 
Mental Processing Index (MPI). Baseline data of this trial were used to explore 
associations between indicators of body size, fatty acid and micronutrient status 
on cognitive performance using analyses of variance adjusting for age, gender, 
school, maternal education and cognitive tester (chapter 4). Results showed that 
body size indicators and hemoglobin concentrations were significantly positively 
related to all cognitive domains and MPI, while vitamin B12 concentrations were 
significantly inversely associated with short-term memory, retrieval ability and MPI. 
Other indicators of iron, iodine, folate and fatty acid status were not significantly 
related to cognition. The findings for body size, fatty acids and micronutrients were 
in agreement with previous observational studies, but the inverse association of 
vitamin B12 was unexpected and needs further study.
For the intervention study described in chapter 5, children were randomly 
allocated to one of four intervention groups to receive foods fortified with either 
100% or 15% of the Recommended Dietary Allowance (RDA) of micronutrients in 
combination with either 900 mg a-linolenic acid (ALA) plus 100 mg DHA or 140 mg 
ALA for 12 months duration. Children receiving the high micronutrient treatment 
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(100% of the RDA) significantly improved on linear growth at 12 months (0.19 
cm; 95% CI: 0.01, 0.36) and short-term memory at 6 months (0.11 SD; 95% CI: 
0.01, 0.20), while they performed less well on fluid reasoning at 6 (-0.10 SD; 95% 
CI: -0.17, -0.03) and 12 (-0.12 SD; 95% CI: -0.20, -0.04) months compared to 
children receiving the low micronutrient treatment (15% of the RDA); while there 
were no significant differences for weight and other cognitive parameters. Neither 
significant differences between the n-3 treatments nor an interaction between 
omega-3 fatty acids and micronutrients were found on cognitive outcomes. It was 
concluded that with some small differential effects, higher micronutrient doses 
were as effective as lower doses for improving cognitive performance.
In chapter 6, baseline data of the trial in Indian schoolchildren were used 
to investigate relationships between energy and nutrient intake, anthropometry 
and cognitive performance using analyses of variance, adjusting for confounding 
factors. The diets of the children were monotonous and dramatically low in energy, 
fat, PUFA and micronutrients. Energy intake was positively related to height, 
weight, mid-upper arm circumference and cognitive performance. After correction 
for energy, PUFA intake was positively associated with cognitive performance, while 
no such relationships could be detected for protein, ALA and micronutrient intake. 
The findings indicate the need for public health programs aiming to increase dietary 
intake of energy and nutrients through dietary diversification, food fortification or 
school feeding.
In conclusion, this thesis showed that multiple micronutrient supplementation 
may be associated with a small increase in the cognitive domain of fluid intelligence 
in children, and possibly with academic performance. However, it is currently too 
early to recommend massive public health campaigns to increase micronutrient 
intake in children to improve their intellectual performance (chapter 7). Since 
effects were particularly strong for children in developed countries, research is 
required to assess whether a higher micronutrient status, above the current cut-off 
values for deficiencies, is related to better cognitive development. 
For children in developing countries, public health programs are needed to 
improve the intake of energy and essential nutrients for general health and well-
being, which will indirectly improve cognitive performance. Our findings of diets 
dramatically low in energy, fatty acids and micronutrients in Indian children strongly 
support the need for such programs.
Based on our results that lower doses of micronutrients were as effective doses, 
policy-makers may consider the use of lower doses in public health programs. 
However, more research is required to confirm our observations. In addition, 
guidance is needed on the composition of multiple micronutrient supplements.
Regarding the role of omega-3 fatty acids on mental development in children, 
findings of the research described in this thesis add to those of existing studies 
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that additional intake of omega-3 fatty acids, and of DHA in particular, does not 
improve cognitive function. Therefore, there is currently no evidence to substantiate 
recommendations for enhancing intellectual development in school-age children 
through increasing intakes of omega-3 fatty acids.
Further research is required 1) to determine the impact of multiple micronutrients 
on cognitive domains other than fluid intelligence; 2) to identify the optimal 
composition of a multiple micronutrient supplement; and 3) to assess the impact 
of nutritional status on cognitive outcomes of micronutrient interventions. To end 
the current debate whether DHA may improve cognitive performance in children 
of school age, a trial using an adequately high dose of DHA and sufficiently long 
duration will be needed. Finally, combining cognitive tests assessing different 
cognitive domains with more advanced measures such as structural and functional 
brain imaging techniques is recommended for a better understanding of the role of 
nutrients in the brain and related cognitive function.
Samenvatting
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In de afgelopen decennia hebben publieke gezondheidsorganisaties getracht 
het probleem van ondervoeding op te lossen. Toch zijn er nog steeds miljoenen 
kinderen in de wereld die lijden aan ondervoeding. Door armoede en eenzijdige 
voeding hebben deze kinderen een te lage inname van micronutriënten en omega-3 
vetzuren, dat ernstige gevolgen kan hebben voor hun intellectuele ontwikkeling
Interventiestudies met één enkel micronutriënt, zoals bijvoorbeeld ijzer of 
jodium, hebben overtuigend aangetoond dat het cognitief functioneren van kinderen 
kan worden verbeterd. Tevens zijn er aanwijzingen dat suppletie met meerdere 
micronutriënten de mentale ontwikkeling van kinderen ook kan bevorderen. Echter, 
tot op heden ontbreekt een systematische evaluatie van deze onderzoeken. 
Omega-3 vetzuren zijn belangrijk voor normale groei en ontwikkeling van 
kinderen. Sommige studies hebben aangetoond dat suppletie met het omega-3 
vetzuur docosahexeenzuur (DHA) de mentale ontwikkeling van zeer jonge kinderen 
kan bevorderen, maar het is onduidelijk of extra inname van omega-3 vetzuren 
ook bij schoolkinderen het cognitief functioneren kan verbeteren.
In dit proefschrift wordt de rol van multivitaminen en mineralen en omega-3 
vetzuren op het cognitief functioneren van in armoede opgroeiende schoolkinderen 
onderzocht (hoofdstuk 1). Hierbij zullen drie hoofdvragen beantwoord worden:
1. Hoe groot is het effect van multivitaminen en mineralen op de verschillende 
cognitieve domeinen bij kinderen?
2. Wat is de rol van omega-3 vetzuren op de cognitieve ontwikkeling van kinderen?
3. Wat is het effect van een interventiestudie met verschillende doseringen 
multivitaminen en mineralen en omega-3 vetzuren op het cognitief functioneren 
van schoolkinderen in India? Is er een interactie tussen multivitaminen en 
mineralen en omega-3 vetzuren?
De huidige literatuur over het effect van interventies met multivitaminen en 
mineralen op de verschillende cognitieve domeinen in kinderen is systematisch 
geëvalueerd in hoofdstuk 2. Hierbij werden alleen gerandomiseerde, 
gecontroleerde interventie studies bekeken die het effect van drie of meer 
micronutriënten versus een placebo op cognitie in gezonde kinderen van 0-18 jaar 
onderzochten. De cognitieve testen die gebruikt werden in deze studies werden 
gegroepeerd in verschillende cognitieve domeinen, waaronder logisch redeneren, 
verworven kennis, het korte termijn geheugen, visuele perceptie, het lange termijn 
geheugen, cognitieve snelheid, concentratie en schoolprestaties. Samengestelde 
random effecten werden per cognitief domein berekend. In totaal werden 17 studies 
gevonden bij kinderen in de leeftijd van 5-16 jaar. Er werd een klein positief effect 
gevonden op domein “logisch redeneren” van 0.14 standaarddeviatie (SD) (95% 
betrouwbaarheidsinterval (btbh-i): -0.02. 0.29; P=0.083), terwijl er geen effect 
was op het domein “verworven kennis” -0.03 SD (95% btbh-i: -0.21. 0.15; P=0.74). 
Vier studies vonden een significant positief effect van multivitaminen en mineralen 
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op schoolprestaties (0.30 SD; 95% btbh-i: 0.01, 0.58; P=0.044). Er waren echter 
te weinig studies beschikbaar om een goede conclusie te trekken voor de andere 
cognitieve domeinen. Onderzoek naar de heterogeniteit tussen de verschillende 
studies liet zien dat de positieve effecten op het domein “logisch redeneren” meer 
naar voren kwamen in de studies die uitgevoerd werden in westerse landen, 
waarin de micronutriënten in de vorm van supplementen in plaats van verrijkte 
voedingsmiddelen werden gegeven. Daarnaast waren de effecten groter in studies 
waarin meerdere verschillende micronutriënten werden verstrekt. 
Hoofdstuk 3 omvat een evaluatie van de meest recente gerandomiseerde, 
gecontroleerde interventie studies naar de effectiviteit van suppletie met langketige 
omega-3 vetzuren (namelijk eicosapenteenzuur (EPA) en DHA) gedurende de 
zwangerschap, lactatie, het eerste levensjaar en kindertijd. Tevens werden effecten 
op de cognitieve ontwikkeling van het kind geëvalueerd. De beschikbare literatuur 
suggereerde dat suppletie met langketige omega-3 vetzuren bij de moeder de 
mentale ontwikkeling van haar kind zou kunnen bevorderen, terwijl het effect van 
suppletie gedurende het eerste levensjaar nog onduidelijk is. Wegens onvoldoende 
studies in kinderen ouder dan 2 jaar, was het niet mogelijk te concluderen of 
suppletie met DHA de cognitieve prestaties van kinderen zouden kunnen verbeteren. 
Nadat deze evaluatie had plaatsgevonden, hebben 2 studies in schoolkinderen 
en 1 studie in kleuters geen effect kunnen aantonen van suppletie met DHA op 
cognitieve uitkomsten. Hiermee is er momenteel geen bewijs dat extra inname van 
omega-3 vetzuren een positief effect kan hebben op de cognitieve ontwikkeling 
van kinderen ouder dan 2 jaar. 
Vervolgens werd een gerandomiseerde, gecontroleerde voedingsinterventie 
studie uitgevoerd waarbinnen het effect van twee verschillende doseringen van 
een combinatie van micronutriënten en omega-3 vetzuren werd onderzocht op 
groei en cognitie bij 598 marginaal gevoede Indiase schoolkinderen van 6-10 jaar. 
Verschillende cognitieve domeinen, waaronder logisch redeneren, het korte en 
lange termijn geheugen en cognitieve snelheid, werden gemeten met testen van 
de Kaufman Assement Battery for Children II. Scores werden gecombineerd tot 
een totaal score, genaamd de Mental Processing Index (MPI). Gegevens verzameld 
aan het begin van het onderzoek van deze studie werden gebruikt om het verband 
tussen indicatoren van lichaamsgrootte, vetzuur- en micronutriëntstatus en 
cognitie te onderzoeken (hoofdstuk 4). Dit werd gedaan door middel van variantie 
analyse, waarbij gecorrigeerd werd voor leeftijd, geslacht, school, opleidingsniveau 
van de moeder en de afneemster van de cognitieve testen. Het onderzoek toonde 
significant positieve associaties aan van indicatoren van lichaamsgrootte en 
hemoglobine concentraties met alle cognitieve domeinen en de MPI. In tegenstelling 
werden vitamine B12 concentraties in plasma significant negatief geassocieerd 
met het korte en lange termijn geheugen en de MPI. Overige indicatoren van 
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ijzer-, jodium-, folaat- en vetzuurstatus hielden geen verband met cognitie. De 
bevindingen voor lichaamsgrootte, vetzuren en micronutriënten kwamen overeen 
met eerdere observationele studies. Vervolgonderzoek is aanbevolen om het 
omgekeerde verband van vitamine B12 met cognitie verder te bestuderen.
In de voedingsinterventie studie (hoofdstuk 5) werden kinderen willekeurig 
verdeeld over vier interventiegroepen en kregen gedurende 12 maanden 
voedingsmiddelen verrijkt met 1) 100% van de dagelijkse aanbevolen hoeveelheid 
(ADH) van micronutriënten met 900 mg a-linoleenzuur (ALA) en 100 mg DHA; 
2) 100% van de ADH van micronutriënten met alleen 140 mg ALA; 3) 15% van 
de ADH van micronutriënten met 900 mg ALA en 100 mg DHA; of 4) 15% van 
de ADH van micronutriënten met alleen 140 mg ALA. De kinderen die de hoge 
dosering micronutriënten (100% van de ADH) kregen, waren na 12 maanden 
significant meer gegroeid (0.19 cm; 95% btbh-i: 0.01, 0.36) vergeleken met 
kinderen die de lage dosering micronutriënten (15% van de ADH) kregen. Tevens 
presteerden kinderen die de hoge dosering micronutriënten kregen na 6 maanden 
significant beter op testen van het korte termijn geheugen (0.11 SD; 95% btbh-i: 
0.01, 0.20), maar presteerden zij minder goed op testen van het domein “logisch 
redeneren” na 6 (-0.10 SD; 95% btbh-i: -0.17, -0.03) en 12 maanden (-0.12 SD; 
95% btbh-i: -0.20, -0.04). Er werden geen verschillen waargenomen tussen de 
interventiegroepen met betrekking tot gewicht en andere cognitieve domeinen. 
Ook werden er geen verschillen waargenomen tussen groepen met hoge en lage 
omega-3 vetzuur doseringen, en was er geen interactie tussen micronutriënten 
en omega-3 vetzuren op groei en cognitieve domeinen. Er is geconcludeerd dat 
de hoge en lage dosering, met enige kleine verschillen op sommige cognitieve 
domeinen, even effectief waren voor het verbeteren van de cognitieve prestaties.
In hoofdstuk 6 werd het verband onderzocht tussen inname van energie 
en nutriënten en met anthropometrie en cognitie. Voor dit onderzoek werden 
gegevens gebruikt die verzameld zijn aan het begin van de interventie studie bij 
Indiase schoolkinderen. De kinderen hadden een eenzijdig voedingspatroon, en 
een dramatisch lage inname van energie, vet, meervoudig onverzadigde vetzuren 
en micronutriënten. Variantie analyse met correctie voor mogelijke confounders 
liet zien dat energie inname positief geassocieerd was met lengte, gewicht, 
bovenarmomtrek en cognitieve prestaties. Na correctie voor energie, was de inname 
van meervoudig onverzadigde vetzuren positief geassocieerd met cognitie, terwijl er 
geen verbanden werden gevonden met inname van eiwit, ALA en micronutriënten. 
Deze resultaten suggereren dat er dringend publieke gezondheidsprogramma’s 
nodig zijn om de inname van energie en nutriënten te verhogen door middel van 
een meer gevarieerde voeding, verrijking van voedingsmiddelen of het verstrekken 
van maaltijden op scholen.
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Samenvattend laat het onderzoek in dit proefschrift zien dat suppletie met 
multivitaminen en mineralen mogelijk geassocieerd is met een kleine verbetering 
in het cognitieve domein “logisch redeneren” en schoolprestaties van kinderen. 
Toch is het momenteel te vroeg om aanbevelingen te doen voor grootschalige 
publieke gezondheidsprogramma’s om de inname van micronutriënten te 
verhogen om de cognitieve ontwikkeling te bevorderen (hoofdstuk 7). Aangezien 
de effecten vooral zichtbaar waren bij kinderen in westerse landen is er meer 
onderzoek nodig om vast te stellen of een betere micronutriënten status, boven 
de officiële grenswaarden voor micronutriëntentekorten, gerelateerd is aan een 
betere cognitieve ontwikkeling.
Voor kinderen in ontwikkelingslanden zijn gezondheidsprogramma’s nodig die 
zich richten op een adequate inname van energie en essentiële nutriënten om de 
algehele gezondheid te verbeteren en hiermee indirect de cognitieve prestaties 
te verhogen. Onze bevinding, dat de voeding van Indiase kinderen zeer laag in 
energie, vetzuren en micronutriënten was, onderstreept de noodzaak voor zulke 
programma’s.
Onze conclusie dat de lage dosering micronutriënten net zo effectief was als de 
hoge dosering, duidt er op dat beleidsmakers mogelijk een lage dosering zouden 
kunnen gebruiken voor het samenstellen van publieke gezondheidsstrategieën om 
de cognitieve ontwikkeling te verbeteren. Er is echter meer onderzoek nodig om 
onze resultaten te bevestigen.
Wat de rol van omega-3 vetzuren in de mentale ontwikkeling van kinderen 
betreft, sluiten de bevindingen in dit proefschrift aan bij de resultaten van andere 
studies die geen verbetering in het cognitief functioneren zien na extra inname van 
omega-3 vetzuren, en van DHA in het bijzonder. Er is daarom momenteel geen 
wetenschappelijk bewijs om de inname van omega-3 vetzuren te verhogen ten 
bate van het intellectuele vermogen van schoolkinderen.
Meer onderzoek zal nodig zijn om vast te stellen 1) wat het effect is van 
multivitaminen en mineralen op andere cognitieve domeinen dan logisch redeneren; 
2) wat de optimale samenstelling van een multivitaminen en mineralen supplement 
is; en 3) wat het effect is van de micronutriënten status op de cognitieve uitkomsten 
van interventiestudies met micronutriënten.  Om een einde te maken aan de 
huidige discussie of DHA de cognitieve prestaties van schoolkinderen zou kunnen 
beïnvloeden, zou een studie nodig zijn met een voldoende hoge dosering van DHA 
en voldoende lange duur van de suppletieperiode. Tot slot is het aanbevolen om in 
toekomstige studies gebruik te maken van een combinatie van cognitieve testen 
met meer geavanceerde technieken die de structuur en het functioneren van de 
hersenen in beeld brengen. Met deze combinatie kan de rol van nutriënten in de 
hersenen en het cognitief functioneren beter worden begrepen.
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